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“If the mind is to emerge unscathed  
from this relentless struggle 
with the unforeseen, two qualities 
 are indispensible: first, an intellect 
that, even the darkest hour, retains some  
glimmer of the inner light which leads  
to the truth; second, the courage to follow this light 
wherever it may lead.” 
 
       Carl Von Clausewitz 
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 During estrus, the pig will ovulate 14-16 oocytes while the national average litter 
size is approximately 10 piglets (Perry and Rowlands, 1962; Pope and First 1985).  
During days 10 through 15 of gestation, the porcine embryo undergoes three rapid and 
dynamic morphological changes (Heuser and Streeter, 1929).  It is during this time that 
majority embryonic mortality occurs through an unidentified selection mechanism.  To 
increase litter size it is imperative to understand the conceptus and endometrial factors 
involved in the establishment of pregnancy and survival of porcine embryos. 
Essential functions of the endometrium during gestation include a prolific 
environment for embryonic development, a vital source of macro/micro nutrients for 
developing embryos, and a sufficient attachment site for apposition of the elongated 
conceptuses.  Uterine capacity (Webel and Dziuk 1974) and the rapid changes in 
conceptus morphology (Giesert et al., 1982, Pope et al., 1990) have been theorized to be 
the predominate limiting factors associated with early embryonic mortality tes in the 
pig.   
Embryonic mortality has been demonstrated to occur through endocrine 
disruption of the uterine environment in the pig.  Exogenous estrogen administration to 
pregnant gilts on days 9 and 10 of pregnancy results in complete embryonic mortality by 
day 30 of gestation (Pope et al., 1986).  Using this endocrine disruptor model, Morgan et 
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al. (1987) discovered that complete embryonic mortality actually occurs by day 16 of 
gestation and this event is associated with a dysfunctional breakdown of the uterin
glycocalyx needed for conceptus attachment to the uterine surface (Blair et al., 1991).   
The mechanism by which early administration of estrogen causes conceptus loss 
has yet to be elucidated in the literature.  Furthermore, the origin of dysfunction has not 
been localized to the conceptus or maternal tissues specifically.  The current investigation 
attempts to clarify the uterine dysfunction caused by early estrogen exposure in pigs 
through removing the conceptus contributions through construction of an endocrine 
disrupted psuedopregnant pig model.  The following review of literature will focus on the 
areas of early gestation which is the temporal window in which a significant amount of 
embryonic mortality occurs, the potential mechanisms involved in those areas, and how 






LITERATURE REVIEW  
 
Porcine Estrous Cycle 
The pig is a polytocous species which ovulates approximately 16-18 oocytes per 
estrus.  The estrous cycle in the pig consists of two major phases (follicular, lute l)
resulting from an orderly sequence of changes associated with the actions of uterine,
ovarian, and higher brain hormones.  Porcine estrous cycle, which is 21 days in duration, 
is comprised of four major stages (proestrus, estrus, metestrus, and diestrus).  Proe trus 
(Days 17-20) is initiated following the regression of the corpora lutea (CL) and the 
decline of plasma progesterone.  Proestrus is distinguished by a rapidly growing pool of 
multiple ovarian, estrogen active follicles recruited by release of follicle stimulating 
hormone (FSH) from the anterior pituitary.  Estrus is dominated by ovarian follicular 
secretion of estradiol-17β, the major type of estrogen produced from the growing 
graafian follicles with  peak plasma concentrations of 45 pg/ml occurring on days 18-20 
of the estrous cycle (Henricks, et al., 1972).  Estrogen released from the growing follicles 
stimulates a positive feedback on the basal medial nuclei of the hypothalamus to increase 
the frequency of pulse release of FSH and luteinizing hormone (LH).  Ovulation is 
stimulated through the surge release of LH during estrus. In the pig, ovulation is variable, 
occurring during a 40 to 72 h window during the expression of estrus.  Metestrus follows
the cessation of estrus and lasts about 1-2 days post-ovulation.  Metestrus is the stage 
where transformation of corpora hemorrhagica to corpora lutea occurs.  The development 
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of fully functional CL initiates the stage of diestrous.  Elevated plasma progesterone 
concentrations exert a negative feedback on the hypothalamic preovulatory center 
allowing only for the tonic release of gonadatrophin releasing hormone (GnRH).  
Follicular growth and estrogen synthesis is suppressed through the low frequency rel ase
of FSH and LH until the CL regresses. High concentrations of progesterone in the blood 
(9ng/mL) inhibit myometrial contractions while exerting a positive response  the 
endometrial gland secretion to provide a suitable environment for potential embryonic 
development in the pregnant gilt.  In the absence of conceptus stimulation, progesterone 
concentrations decline starting at day 15 (Masuda et al., 1976), reaching a nadir (less than 
1ng/mL) by day 16 of the estrous cycle (Guthrie et al., 1972).  The high concentration of 
plasma progesterone from the CL for 10 days of the estrous cycle will provide a 
mechanism from which uterine originated secretion of prostaglandin F2α (PGF2α) 
stimulates regression of the CL (Cavazos et al., 1969).  The mechanism for this action 
will be extensively reviewed in a later portion of this literature review.  Briefly, 
progesterone receptor (PR) exhibits an inverse expression in regards to the p65 subunit of 
the master transcription factor nuclear factor kappa B (NF-κB).  NF-κB provides an ideal 
mechanism for the release of prostaglandins used during luteolysis.  Porcine CL 
synthesize and secrete oxytocin which increases in plasma during luteolysis.  An increase 
in oxytocin is associated with an increase in uterine secretion of PGF2α (Kotwica et al., 
1990).  The phosphoinositide pathway is postulated as the principal signaling pathway 
which endometrial oxytocin receptors initiate luteolysis in the cycling pig (Whiteaker et 
al., 1994).  
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Embryonic Development in the Pig  
Regulation of Conceptus Morhpology 
 Porcine conceptus development is regulated through the uterine secretory changes 
that are driven by the first release of progesterone from the functional CL into the ovarian 
vein (Roberts et al., 1993).  Following hatching of the porcine blastocyst from the zona 
pellucida on day 8 of pregnancy, peri-implantation conceptus morphogenesis 
encompasses four critical developmental stages prior to trophoblast attachment to th  
uterine surface: spherical, ovoid, tubular, and filamentous (Anderson 1978).  Free 
floating conceptuses will space themselves equidistantly throughout the uterine lumen in 
preparation for trophoblastic elongation (Pope et al., 1982). 
 Porcine conceptuses undergo an ordered transformation in morphology during 
early gestation (Geisert et al., 1982b).  Heuser and Streeter (1929) were the first o 
describe conceptus transformation from a spherical to filamentous morphology between 
Days 10 and 12 of gestation.  Between days 10 and 11.5 of gestation, conceptus size can 
range from 4 mm to 10 mm spherical diameter.  Growth or expansion of the spherical 
conceptus diameter occurs at an approximate rate of 0.25 mm/h (Geisert et al., 1982b) 
Increase in spherical diameter of the conceptus occurs largely through cellular 
hyperplasia (Geisert et al., 1982b).  Prior to period of the rapid trophoblast elongation on 
approximately day 12 of gestation, 10 mm spherical conceptuses undergo a conversion to 
the tubular morphology.  Once initiated, the tubular morphology is attained 
approximately 2 to 4 h before rapid expansion of the trophoblast occurs   Trophoblast 
expansion from tubular to the filamentous (reaching 100 mm to 200 mm) morphology 
will occur within 1 to 2 h (Geisert et al., 2006). Upon initiation of rapid trophoblastic 
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elongation, there is a temporal increase in conceptus steroidogenesis to increase est ogen
synthesis through activation of aromatase expression (Conley et al., 1992).  Increased 
aromatase activity allows conceptuses to have a surge release of estrogen into the uterine 
lumen, where it serves as the maternal recognition of pregnancy signal in the pig (Geisert 
et al., 1982, Bazer 1986).  Mattson et al. (1990) proposed that the cytoskeletal changes 
for trophoblast expansion involved actin filaments which they classified into three 
different activities.  The activities involving actin included: (1) rearrangement of the 
trophectodermal plasma membrane during conceptus expansion, (2) generation of 
adequate force to bring about expansion of the conceptus, and (3) mobilization of cortical 
actin to assist in differentiation and maintenance through stabilization of epithelial 
transport properties.  With the information at hand one could propose that the conceptus 
morphological changes occur through an autocrine mechanism which is independent of 
maternal uterine signaling and does not involve maternal signaling.  Although early 
conceptus development and survival is dependent upon conceptus synchrony within the 
developing uterine secretory environment, rapid trophoblastic elongation is clearly 
conceptus driven.  The presence of multiple conceptus morphologies can be observed in 
any single pregnancy indicating that trophoblast elongation is initiated by reaching a 
specific stage of spherical growth (10 mm).  The process of conceptus expansion in the 
pig is critical to subsequent survival as each conceptus strives to increase th maximum 
uterine surface area possible for placental attachment as it competes against 
contemporary littermates.   
 
Factors Associated with Embryonic Vitality and Survival 
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An increase in uterine placental contact will allow the conceptus to increase its 
nutrient uptake, giving it a selective advantage over slower developing conceptuses when 
ovulation rates exceed uterine capacity (Geisert and Yelich, 1997).   
 Increase in uterine lumenal fluid content of insulin-like growth factor (IGF’s) on 
days 11 to 12 of gestation has been proposed to be involved with stimulation of 
conceptus aromatase (P450arom) activity to enhance conceptus estrogen synthesis during 
the period of trophoblast elongation (Letcher et al., 1989).  Secretions of IGF could be 
important for conceptus differentiation and attachment to the uterine luminal surface after 
initial expansion through the uterine horns. 
  The IGF system has been characterized in a multitude of biological systems (Simmens 
et al., 1992; Choi et al., 1997; Irwin et al., 2001; Sato, et al., 2002) and is composed of 
three ligands (IGF-I, -II, and insulin), five regulatory binding proteins (IGFBP-2 through 
6), and three cell surface receptors (IGF-I receptor, IGF-II receptor, insulin receptor) 
(Jones et al., 1995).  The porcine conceptus has been reported to express mRNA for 
insulin-like growth factor I receptor (IGF-RI) (Corps et al., 1990).  Although gene
expression for IGF-RI was demonstrated, Chastant et al. (1995) was unable to detect the 
presence of IGF-IR in the trophoblast, but did localize the IGF-RII.  Conceptus 
expression of the IGF-RI mRNA and the presence of trophoblast IGF-RII indicate that 
uterine IGF secretion could serve an integral part in early porcine conceptus d velopment 
and survival. 
Importance of IGF’s in early porcine conceptus development and uterine 
receptivity for implantation is demonstrated by the precise alteration in thepres nce of 
IGFBPs that occurs during the period of conceptus expansion (Lee et al., 1998; Geisert et 
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al., 2001).  Uterine IGFBP’s are present in the porcine uterine lumen from days 5 to 10 of 
the estrous cycle and during early gestation (Lee et al., 1998; Geisert et al., 2001).  
However, the porcine uterine luminal IGFBP’s are proteolytically cleaved after day 11 in 
both cyclic and pregnant gilts.  Activation of proteolytic enzymes such as the serin
protease, tissue kallikrein and the matrix metalloproteinases degrade IGFBPs in the 
uterine lumen allowing IGF stimulation of the conceptuses during a critical period of 
development in the pig (Vonnahme et al., 1999; Geisert et al. 2001).   
Up regulation of IGF-I mRNA and IGF-I ligand released into the uterine lumen is 
synchronous with acute increase in conceptus estrogen production on day 12 of gestation 
(Ashworth et al., 2005).  Fischer et al. (1985) indicated the capacity of the endometrium 
to synthesize estrogen is negligible, therefore estrogen present in the uterin l men is 
almost totally originates from the conceptuses.  The biphasic patterns of conceptus 
estrogen synthesis and release during elongation and placental attachment to the uterine 
surface (Day 12 and Day 15 to 30) is paramount in prolonging the lifespan of the corpora 
lutea for maintenance of pregnancy throughout gestation in the pig (Geisert et al., 1990).  
Initial estrogen synthesis by the conceptuses on day 12 of pregnancy may serve a tri-fold 
role: equidistant spacing of conceptuses within the uterine horns, regulation of growth 
factors essential for conceptus differentiation and survival, and maternal recognition of 
pregnancy.  The free floating conceptuses awaiting apposition to the uterine surface are 
exposed to a variety of uterine growth factors that are secreted following conceptus 
release of estrogen.  Receptors for the various growth factors are express d on the pre and 
post-elongated conceptus (Geisert and Yelich, 1997).  For example, Vaughan et al. 
(1992) demonstrated epidermal growth factor (EGF) receptors were present on the 
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trophoblast of the conceptus between days 8 to 12 of pregnancy with greatest binding 
observed in day 10 conceptuses.  Appearance of high affinity binding regions for EGF 
suggests that conceptus development and growth may be dependent on an assortment of 
maternally derived growth factors.  Clearly, although trophoblast elongation is under 
conceptus regulation, endometrial growth factor secretion and conceptus estrogen 
secretion are critical for proper signaling in regards to embryonic growth and survival. 
 
Maternal Recognition of Pregnancy 
 Short (1969) was the first to coin the term “maternal recognition of pregnancy” 
for the extension of the corpora lutea beyond normal length of an estrous cycle by the 
conceptus.  Corpora lutea maintenance provides a continual source of progesterone 
needed to support conceptus development and survival throughout gestation in the pig 
(Nara et al., 1981).  Bazer et al. (1982) first established that estrogen is the maternal 
recognition of pregnancy signal in the pig.  Estrogen synthesis and secretion by the 
conceptuses occur in a biphasic pattern with an acute, intermediate peak on day 12 of 
gestation, followed by a chronic sustained release of estrogen from days 15 to 28 of
gestation (Geisert et al., 1990).  Dhindsa and Dziuk (1968) demonstrated that conceptuses 
must be present in both uterine horns until at least day 18 of pregnancy to extend 
gestation beyond 30 days in the pig.  Dzuik et al. (1968) also indicated prior to day 18 
there must be at least two conceptuses per uterine horn for a successful pregnancy to be 
established in the pig.  The need for a minimal number of conceptuses in each horn can 
be attributed to the extensive surface area of the uterine horns which synthesizes PGF2α 
to regress the CL during the estrous cycle.  Conceptuses equidistantly space themselves 
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throughout the uterine horns prior to trophoblastic elongation so that following 
expansion, sufficient inhibition of the luteolysin PGF2α occurs within the uterus.  
Adequate distribution of estrogen throughout the length of both uterine horns is therefore 
accomplished through the rapid trophoblast elongation on day 12 of pregnancy.  
Conceptuses must inhibit PGF2α in both uterine horns because the porcine lungs fail to 
metabolize about 82% of the systemic PGF2α that moves through in one passage.  Thus, 
the pig has a systemic as well as local pathway for luteolysis (Davis et al., 1979)   
 
Endocrine ExocrineTheory for Porcine CL Maintenance 
The mechanisms and processes of maternal recognition of pregnancy in the pig 
have been comprehensively reviewed (Bazer et al., 1982, 1984, 1986, 1989; Geisert et al., 
1990).  Bazer and Thatcher (1977) presented the original theory that pregnancy 
recognition in the pig involved an estrogen stimulated alteration in PGF2α movement 
within the uterus during early pregnancy.  These authors proposed the classical 
endocrine/exocrine theory for CL maintenance in the pig which still holds today.  These 
researchers suggest that conceptus estrogen synthesis redirects movement f ndometrial 
PGF2α release towards the uterine lumen in an exocrine pathway.  In contrast, 
endometrial PGF2α release is directed in an endocrine pathway through the stroma into 
the uterine vasculature network in the cyclic pig.  Release of PGF2α into the utero-ovarian 
portal vessels allows transport to the CL for induction of luteolysis.  
 
Uterine Architectural Changes Produced During the Implantation Window 
ECM Remodeling for Receptivity of the Porcine Uterus. 
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  The extracellular matrix (ECM) in the uterus is a complex network comprised of 
a plethora of molecules involved with cell migration and cell-to-cell interactions (Bost et 
al., 1998).  In the pig, the endometrial ECM expression on the epithelial apical surface 
prevents conceptus invasion into the uterine endometrium forming the epitheliochorial 
type of placentation.  However, conceptus exposure to tissue and matrices outside of the 
uterus results in cellular erosion and invasive activity (Samuel and Perry, 1972).  These 
data indicated that the porcine conceptus is highly proteolytic and the maternal ut rine 
environment inhibits active invasion through the uterine surface epithelium.  The 
architecture of the endometrial epithelium is dictated through changes in ovarian steroids, 
growth factors, cytokines and other regulatory molecules such as integrins.   
 Spatiotemporal alterations in uterine epithelium are paramount for successf l 
remodeling of the uterine ECM in preparation for attachment of rapidly developing 
porcine conceptuses.  Cell to cell and cell to ECM interactions are arbitrated through a 
family of cell transmembrane glycoproteins known as integrins (Lessey et al., 1995).  
Cell surface expression of the repertoire of integrins can be altered in respos  to 
inflammation (Heino et al., 1993), cell differentiation (Damsky et al., 1993) and are 
involved with tumor malignancy transformation (Plantefaber et al., 1989).  Integris are 
comprised of an α and β subunit that function as a  transmembrane heterodimer receptor 
involved with cellular signaling proteins (Clark et al., 1995).  Currently, 16 different α 
and 8 β subunits have been identified within the 22 possible integrin combinations 
identified in cells (Luscinskas et al., 1994).  The various subunit combinations determine 
specificity for ECM ligands and functionality of the uterine integrins (Hynes et al., 1992).  
In the human, 9 integrin combinations have been characterized in uterine endometrium 
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(Lessey et al., 1992).  In the pig uterus, α1, α3, α4, α5, αv β1, and β3 integrin subunits have 
been identified and characterized (Bowen et al. 1996).  Conceptus trophectoderm and 
uterine epithelium express α4, α5, αv, β1 and β3 in peak levels on days 11 to 15 of gestation 
which is the period of trophoblast attachment to the uterine surface epithelium.  
Heterodimers: α1β1, α5β1, and αvβ1 serve as receptors for the fibronectin ligand, while 
αvβ1 and αvβ3 serve as receptors for the vitronectin ligand (Hynes et al., 1992).  Day 12 
and 15 conceptuses contain fibronectin on their trophoblast surface, which would allow 
adhesion to the luminal epithelial surface integrins (Tuo and Bazer, 1996).  Furthermore, 
Bowen et al. (1996) also demonstrated the presence of vitronectin at the site of conceptus 
attachment to uterine luminal epithelium, inferring interaction of integrins and their 
ligands between both the uterine surface and trophectoderm. 
 
Mucin Involvement During Conceptus Attachment 
 Prior to the time of trophoblast attachment to the uterine luminal surface, the 
porcine uterine surface epithelial apical microvilli contains a thick extracellular 
glycocalyx, which becomes reduced in density following conceptus attachment (Dantzer 
et al., 1985).  Mucin-1 (MUC-1) is a heavy glycosylated integral transmembrane 
glycoprotein expressed on the surface of epithelial cells which inhibit conceptus 
attachment to the uterine surface.  Bowen et al. (1996) demonstrated that gene expr ssion 
of MUC-1 is diminished by day 10 of gestation in the pig.  Decrease of MUC-1 
expression on the uterine epithelium corresponds to down regulation of progesterone 
receptors within the uterine surface epithelium, which appears to be the opening of the 
implantation window for conceptus attachment.  The decline observed in MUC-1 
13 
expression by Bowen and coworkers (1996) is consistent with loss of MUC-1 expression 
prior to implantation in rodents (Braga and Gendler, 1993).  These results suggest a loss 
of MUC-1 expression may allow intimate contact of the conceptus trophectoderm with 
uterine epithelium for placental attachment.   
The expression sialomucin complex (MUC-4) an additional cell surface marker, is 
also reduced in the uterine epithelium during implantation in rodents [McNeer et al., 
1998; Carraway and Idris, 2001].  Furthermore, Ferrel et al. (2003) demonstrated an 
increased expression of MUC-4 protein expression during placental attachment in the p g.  
Placentation in the pig is a non-invasive attachment while the porcine conceptuses 
themselves are extremely invasive ex utero (Samuel and Perry, 1972).  One could infer 
the harmonized expression of mucins such as MUC-1 and MUC-4 are both required to be 
tolerant for attachment but may play a regulatory role in controlling magnitude of 
conceptus proteolytic activity.  In contrast to the pig, rodents appear to down-regulate 




 Stabilization of the ECM is accomplished through a family of protease inhibitors 
known as the inter-α trypsin-inhibitors (ITI) (see review Bost et al., 1998).  The ITI 
family is comprised of a combination of four heavy chains (HC1, HC2, HC3, HC4), and 
one light chain referred to as bikunin (Salier et al., 1996).  All four heavy chains contain a 
Von Willebrand type A domain, which serves as a binding domain for heparin, 
proteoglycans, collagen, and integrins (Colombatti and Bonaldo, 1991).  Bikunin, 
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contains a 4-chondrotin sulfate glucosaminoglycan (GAG) chain that binds to ITIH1, 
ITIH2, and ITIH3.  Bikunin, binds to ITIH3 to form pre-α-inhibitor a positive acute phase 
protein, or to ITIH1 and ITIH2 to form ITI which is a negative acute phase protein 
(Daveau et al., 1993).  ITI’s belong to the family of kunitz-type protease inhibitors (see 
review Salier et al., 1996), which contain a domain that is inhibitory to serine proteases.  
In contrast, ITIH4 does not contain a bikunin binding region (Salier et al., 1996; Bost et 
al., 1998) and is readily cleaved by the serine protease tissue kallikrein (Nishimura et al., 
1995). Geisert et al. (1998) suggested that the ITIH’s serve to inhibit an acute phase 
reaction from occurring in the endometrium during the inflammatory type stimulation 
caused by the attaching conceptuses.  These researchers indicated that ITIH4 expression 
in the endometrium was present throughout the estrous cycle and early gestation.  Gene 
expression appeared enhanced under the influence of progesterone in the mid-luteal 
phase of the estrous cycle and during placental attachment in early gestation (Geisert et 
al., 1998).  ITIH4 has been characterized as an acute phase protein (Gonzales-Ramon et 
al., 1995), which can be induced by interleukin-6 (IL-6), a transcriptional regulator 
associated with acute phase reactions (Sarafan et al., 1995).  Bhanumathy et al. (2002) 
demonstrated that murine liver explants dramatically increased ITIH4 expression 
following treatment with IL-6.  However, the proinflammatory cytokines interleukin 1β 
(IL-1β) and tumor necrosis factor alpha (TNFα) do not invoke an increase in ITIH4 
expression, suggesting it may play an integral part in stabilizing the ECM (Chen et al., 
1994).  Geisert et al. (1998) suggested a role for ITIH4 stabilization of the uterine 
epithelial surface glycocalyx to prevent conceptus cellular erosion and invasio  into the 
uterine stroma. 
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Hyaluronin Acid Synthase Invovlment with ECM Stabilization 
 The ITI’s are involved with ECM stabilization through the binding to hyaluronic 
acid (HA), which is synthesized in the plasma membrane by the enzyme hyaluronan 
synthase (HAS) (Prehm et al., 1989).  To date, three isoforms of HAS (HAS-1, HAS-2, 
HAS-3) have been identified (Itano and Kinata, 1996, Spicer et al., 1996, 1997).  
Hyaluronic acid size (polymer length) and the rate of synthesis may be attri uted to the 
differential expression from the three distinct isoforms of the HAS enzyme (Itano et al., 
1999).  HAS-1 expression has been characterized in murine dermal fibroblastic cell , 
while HAS-2 expression has been observed in most tissues of the developing murine 
embryo (Sugiyama et al., 2002).  Deletion of HAS-2 is fatal to mouse embryo by day 9.5 
of gestation mainly resulting from defects in cardiovascular morphogenesis (Camenisch 
et al., 2000).  In the human, articular chondrocytes have been shown to express both 
HAS-2 and HAS-3 (Nishida et al., 1998).  All three HAS enzymes have been localized in 
human cartilage (Recklies et al., 2001).  Studies have demonstrated that insulin-like 
growth factor-1 (IGF-1) (Honda et al., 1991), tumor growth factor-β (TGF-β) (Sugiyama 
et al., 1998) and bone morphogenic protein 7 (BMP-7) (Nishida et al., 2000) stimulate 
HA synthesis through activation of HAS in a variety of cell types.  Hyaluronic acid has 
been implicated in cell to cell, cell to matrix interactions, and cellular mig ation (Fraser et 
al., 1992).  To date, only the ITI family referred to as serum derived hyaluronan 
associated proteins (SHAP) bind covalently to HA.  The SHAP-HA complex (HA + HC1 
or HC2) form when plasma and HA are mixed together (Huang et al., 1993).  In the 
mouse ovary, the formation of the SHAP-HA complex further stabilizes the expanding 
oocyte cumulus ECM via releasing bikunin from ITI’s during formation, enhancing its 
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serine protease inhibitory activity.  Coupling of ITI-HA is dependent on the presence of 
Ca+2 ions and is paramount for normal fertility in the mouse (Sato et al., 2001).  Studies 
with rheumatoid arthritis patients have demonstrated that increased concentrations of ITI-
HA in synovial fluids are associated with chronic inflammation (Hutadilok et al., 1988).  
During inflammation tumor necrosis factor-stimulated gene 6 (TSG-6) is detected in 
synovial fluid (Wisniewski et al., 1993, 1997).  Secretion of TSG-6 in rheumatoid 
arthritis patients allows binding to HA and either ITIH1 or ITIH2 (Mukhopadhyay et al., 
2001), which can act as a crosslinker between different SHAP-HA molecules to stabilize 
the ECM in attempt to inhibit erosion of joints.  The large mosaic hyaluronan-
proteoglycan aggregated complexes may anchor to cells through hyaluronan binding to 
cell surface receptors such as CD44 (Chow et al., 1995).  During stabilization of the 
ECM, HC1 and HC2 are released from its covalent bond with bikunin and transferred to 
HA (Jessen and Odem, 2003).  Furthermore, bikunin released from the complex can 
suppress inflammation through inhibition of plasmin (Wisniewski et al., 1996).   
 
MMP/TIMP Remodeling of the Uterine Endometrium 
 Site and specificity of uterine tissue remodeling and ECM turnover is 
accomplished primarily through the matrix metalloproteinase (MMP) system.  The MMP 
system consists of an assortment of zinc and calcium dependent matrixins and their 
endogenous inhibitors TIMPS (tissue inhibitors of matrix metalloproteinases).  Generally, 
MMP’s are implicated in tissue remodeling due to their ability to degrade all ECM 
components (Woessner et al., 1991).  A disruption in the balance of MMP’s and TIMP’s 
usually results in a serious pathological condition such as fibrosis (Nagase et al., 1997).  
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MMP’s are synthesized and secreted in a latent pro-form (Sato et al., 1994).  Various 
pathological conditions (rheumatoid and osteoarthritis), demonstrates that excessive 
amounts of activated MMP expression accelerates connective tissue breakdown (Aherns 
et al., 1996).  Arthritis and cancer are pathological examples where the tightly regu ated 
MMP system is functioning outside of normal conditions, and irreversible catastrophic 
degradation has occurred.   
 In the pig and most other ungulates, conceptus attachment does not involve deep 
trophoblastic invasion into the uterine mucosa (Dantzer et al., 1985).  However, uterine 
MMP-2, MMP-3 and MMP-9 are the predominate matrixins in the cow (Maj et al., 1997, 
Salamonsen et al., 1995, Menino et al., 1997) and TIMP 1, TIMP-2, and TIMP 3 are the 
MMP inhibitors expressed during the estrous cycle and early pregnancy of the pig.  
MMP-2 and MMP-9 are primarily responsible for type IV collagen degradation, which is 
the predominant constituent of the cellular basement membrane (Lenhart et al., 2001). In 
the pig, TIMP expression has been localized in the trophectoderm and endometrial 
stroma during early gestation (Menino et al., 1997), heavy expression of TIMP’s in 
uterine endometrial stroma and absent in the epithelium, may account for the lack of deep
uterine invasiveness displayed by the conceptus in the receptive porcine uterus.  In 
summary, it is apparent that the MMP system is involved with many aspects of uterine 
remodeling and conceptus attachment during early pregnancy.  However, the specific
action through which proteases permit remodeling while retaining specialized tissue 
functions still requires further investigation. 
` 
Immunomodulation of Pregnancy 
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Universal Immune Function during Pregnancy 
 In the pig, the role and regulation of uterine immunity is poorly understood.  
Successful pregnancy in the pig is associated with acute and long term inflammation 
(Bischof et al., 1994).  Proinflammatory mediators, such as IL-1β, are secreted 
maximally on day 12 of gestation by the rapidly developing conceptuses, inferring local 
immunity involved in uterine responses to pregnancy (Ross et al., 2003).  Studies in the 
pig have suggested that during pregnancy, the uterine immune system plays an active role 
in establishing pregnancy (Koch et al., 1985).  
Distinguishing “self” from “nonself” to remove a potential pathogen is a 
rudimentary function of the mammalian immune system.  However, during pregnancy, 
the maternal immunological system must be diverted to accept the nonself allogenic 
fetus, as self.  Exposure of potential pathogenic substances begins with copulation and 
exposure to male semen (Lovell and Getty, 1968). Upon mating, the female reproductive 
tract must be tolerant of two non-self products in semen: 1) spermatozoa, which contain
paternal cell antigen markers, and 2) “nonself proteins” originating from the seminal 
plasma.  During gestation, the female must be tolerant to the contribution of the antigens 
presented to the maternal immunological system.  Although one would theorize rejection 
of the fetus and its extraembryonic membranes should be a high probability, maintenance 
of the mammalian pregnancy is normally highly successful. 
 Immune responses are classified into two major categories called innate and 
adaptive.  Innate immunity serves as the first line of defense against pathogens in the 
mammalian body; however this system lacks the ability of long term immunity such as 
reinfection prevention.  Activation of the compliment cascade that generates components 
19 
that can bind tissues, recruits effector cells, and invokes an inflammatory respons .  
Activation of the complement system has emerged as a potential factor in recurrent fetal 
loss (Chaucheteux et al., 2003).  Studies have demonstrated that murine trophoblast 
produces high levels of proteins that inhibit complement component proteins (Tedesco et 
al., 1993).  Furthermore, murine trophoblast devoid of these inhibitory proteins resulted 
in embryonic death (Xu et al., 2000).  The adaptive system is reliant on specialized 
lymphocytes that have been selected based on their tolerance for non-reactive self 
recognition, and a diverse repertoire of cell surface receptors.  The adaptive sys em can 
store theses specialized lymphocytes in very small numbers in the body when they are not 
needed and rapidly employ them through clonal expansion to eliminate pathogens of 
prior exposure in a very short time period.  Successful pregnancies in the porcine uterine 
environment must circumvent both systems (innate and adaptive) in order to preserve 
gestation (Georgieva et al., 1984, Croy et al., 1987,) 
 
Specialized Immune Cell Function during Early Pregnancy  
  In the pig uterus, it is well documented that during early pregnancy (early as 
D10), trophoblastic cells recruit lymphocytes (T-cells, NK cells) to the uterine 
endometrial stroma beneath attachment sites (Englehardt et al., 2002).  Guimond et al. 
(1997) demonstrated that NK cells not T-cells, controlled trophoblastic cytokine 
production.  Further, the above author demonstrated mice deficient of NK cells caused 
placental hypotrophy.  These data suggest uterine cells involvement in allorecognition 
may belong to the uterine NK cells rather than the traditional T-cells.   
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 The porcine trophoblast produces and secretes large amount of two types of 
interferons (IFN), (La Bonnardiere et al., 1991).  Interferon gamma (IFN γ) and 
interferon delta (IFN-δ) are the two forms of IFN’s in the pig, and unlike bovine, are not 
postulated as maternal recognition signals.  IFN-γ is the most abundant type of IFN found 
in the porcine uterus, which is predominantly secreted by the trophoblast starting arou d
day 13 of pregnancy.  Tuo et al. (1993) demonstrated, INF-γ can have a stimulatory role 
on the activity of NK cells in vitro, suggesting NK cells may play a pivotal role in 
placentation.  The function of IFN-γ has not been clearly defined in the pig uterus.  
Porcine trophoblastic cells producing substantial amounts of IFN-γ beginning on day 13 
of gestation may suggest a possible role in implantation based on the timing of its 
appearance, since day 13 is the opening of the implantation window.  Furthermore, IFN-γ 
at its highest expression has been localized to the trophoblast on day 15 concomitant with 
greatest levels of uterine IL-18 (also termed IFN- γ inducing factor) (Joyce et al., 2005). 
 The standing T-cell shift (Th1 to Th2) paradigm suggest that successful 
pregnancies are associated with an alteration in the maternal T-cell repertoir  from Th1 
(IFN-γ, IL-2) to predominantly Th2 (IL-4, IL-10), bathing the conceptus in a series of Th2
cytokines (Lin et al., 1993).  The Th1/Th2 paradigm significantly oversimplifies the 
immunoregulatory action at the conceptus-maternal interface.  The identification of NK 
cell involvement has undermined the foundation of the Th1/Th2 shift paradigm.  Data 
generated from Croy’s lab has demonstrated that NK cells have a two-fold inv vement 
with pregnancy establishment; 1) maternal vascularzation through its secretion of 
angiopoietin 2 (ANG-2)  (Croy et al., 2000), and 2) NK cell regulation of trophoblastic 
interleukin 10 (IL-10) production, which is a Th2 cytokine (Chaouat et al., 1998).  NK 
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cell involvement abrogated the Th1/Th2 paradigm, but it was through characterization of 
interleukin 18 (IL-18) that instigated contemplation of this once accepted paradigm.  
Muranaka et al. (1998) demonstrated that pregnancy was lost when mouse IL-18 was co-
administered with IL-12.  Further examination of IL-18 revealed that mice that when 
selected based on abortive prone tendencies, they exhibited suppressed levels of IL-18 at 
the fetal-maternal interface.  In contrast, non-abortive mice when mated produced 
elevated levels of IL-18 suggesting a Th1/Th2 divergence (Ostojic et al., 2003).  In 
conclusion, most literature questions the paradigm that a maternal shift from Th1 to Th2 
immune cells is necessary for establishment of a successful pregnancy.  Furthermore, the 
possibility exists that using the Th1/Th2 shift paradigm to explain what is happening in 
the uterus during early pregnancy may be oversimplifying a complex inflammatory 
process.   
 
Transcriptional Regulation of Gene Expression during Cyclicity and Early 
Pregnancy 
 
Master Transcription Regulation and Activation 
The NF-κB transcription factor superfamily regulates tissue immune function, the 
inflammasome, and acute phase reactions (McKay and Cidlowski, 1999). NF-κB 
activation targets a plehtora of genes, which include cytokines, growth factors, and cell 
adhesion molecules. NF-κB is comprised of a dimer from the Rel family of transcription 
factors (Ali and Mann, 2004).  NF-κB receptor activation can come through a diversity of 
stimuli such as bacterial endotoxin lipopolysaccharide, oxidative stress, and the specific 
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cytokines such as tumor necrosis factor-α (TNFα) and interleukin-1β (IL-1β). NF-κB is 
constituentively located in the cytoplasm as a heterodimer compiled from the Rel family 
of proteins that include: p50, RelB (p100), p105 and RelA (p65), RelB (Ghosh et al., 
1998).  The heterodimer of p50 and p65 is generally thought of as the inducible NF-κB 
transcription factor found in eukaryotes, where as a homodimer of p50 is considered to be 
for constituent expression in the tissue. IκB’s inhibitory effect on NF-κB renders it 
inactive while in the cytoplasm (Ali and Mann, 2004). Receptor activation of the known 
cytokines IL-1β and TNFα can also stimulate the pathway for phosphorylation of two 
serine residues contained within the IκB.  Furthermore, IκB kinase is comprised of the 
two catalytic subunits: (IKKα and IKKβ) and a regulatory subunit IKKγ.  NF-κB 
complex liberation is a direct result of phosphorylation of IκB which is ultimately 
targeted for polyubiquitination and degradation by the 26S proteasome (Ghosh et al., 
1998).  Upon liberation of the IκB allows the NF-κB heterodimer (p65:p50) translocation 
into the nucleus where binding to κB-sites will activate transcription. Nuclear κB site will 
stimulate IκB binding to the NF-κB complex where it will be inactivated and recycled 
back to the cytoplasm.  κB sites contained within certain genes are transcriptionally 
regulated by NF-κB and may include a plethora of cytokines (TNFα, IL-1β, IL-6, and 
GM-CSF), chemokines (RANTES) and enzymes such as cyclooxgenase-2 (COX-2) (Ali 
and Mann, 2004). Steroid regulation of implantation/placentation and uterine 
receptiveness are modulated through activation of pathways involving adhesion 
molecules, cytokines, and growth factors which are ultimately NF-κB regulated (see 
Cross et al., 1994; Carson et al., 2000).   
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Implantation in the pig involves many events that mimic an acute inflammatory 
response. Regulation of of the estrous cycle and early pregnancy would be an ideal 
regulatory pathway of NF-κB. Furthermore, endometrial NF-κB activation is postulated 
as a key regulator of implantation in the human (Reznikov et al. 2000; King et al. 2001; 
Page et al., 2002) and mouse (Nakamura et al., 2004a,b). During the estrous cycle and 
early pregnancy in the pig, p65 is localized in the cytoplasm of the porcine uterine 
luminal and glandular epithelium (Ross and Gesiert, unpublished results).  The porcine 
endometrium secretes a number of NF-κB regulated cytokines (IL-6 and LIF) and growth 
factors (KGF) during the period of rapid conceptus development on day 12 to 15 of 
pregnancy (see Geisert and Yelich, 1997).  Ross et al. (2003) found that conceptus 
secretions of IL-1β are greatest on day 12 of gestation and falling to nadir level by day 
15.  An increase in epithelial KGF expression may be a resultant of conceptus estrogen, 
IL-1β, or a synergy caused by both.  During early gestation, concentrations of peripheral 
progesterone are high (25 ng/ml), which provides the source for down regulation of 
uterine epithelial PR after 10 days of stimulation (Geisert et al., 1994).  Down-regulation 
of PR in the uterine epithelium may indirectly up-regulate KGF expression thr ugh 
activation of NF-κB genes (Kalkhoven et al., 1996).  The p65 subunit of the transcription 
factor NF-κB acts to repress the PR protein in a reciprocated negative fashion.  As PR is 
down-regulated from uterine epithelium through presence of the ligand, the transcription 
factor NF-κB is activated.  Although the specific mechanism of KGF in porcine gestation 
has yet to be elucidated, uterine stroma would appear to control the function of the 
uterine epithelium following down-regulation of the epithelial PR on day 10 of gestation.  
KGF-R expression of conceptus trophoblastic origin and KGF production by uterine 
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epithelial cells may indicate an embryo maternal crosstalk regulation of the conceptus 
and surface uterine extracellular matrix.   
There is an 80-fold increase in endometrial COX-2 gene expression between days 5 
to 12 of the estrous cycle and pregnancy (Ashworth et al., 2006).  Moreover, the increase 
in endometrial COX-2 gene expression from days 10 to 15 of the estrous cycle and 
pregnancy is compartmentalized to the uterine luminal and glandular epithelium, which 
occurs after the window of epithelial PR down-regulation (Geisert et al., 1994). NF-κB 
localized in the uterine epithelium (Ross and Gesiert, unpublished results) with an 
increase in cyclooxgenase in the luminal and glandular epithelium (Ashworth et al., 
2006), leads one to postulate NF-κB involvement in regulation of uterine function during 
the estrous cycle and early pregnancy. 
During the attachment window of the placenta to the epithelium, embryonic IL-1β 
expressed concomitantly with estrogen secretion may establish an immunological dialog 
between the foreign conceptus tissues and the maternal endometrium.  Caspase-1, also 
refered to in the literature as IL-1β-converting enzyme (ICE), cleaves the 31 kDa inactive 
form of IL-1β to its biologically active 18 kDa form.  Although IL-1β secretion is severly 
attenuated by day 15 of pregnancy, there is a sustained second phase of conceptus 
estrogen secretion necessary to maintain CL function beyond 28 days of gestation 
(Geisert et al., 1987). This second phase of conceptus estrogen secretion is temporally 
associated with a pregnancy specific 8-fold increase in endometrial caspase-1 gene 
expression (Ashworth unpublished data). Increase in endometrial caspase-1 expr ssion is 
not associated with endometrial release of IL-1β as lumenal content of IL-1β protein is 
greatly decreased on day 15 and 18 of pregnancy suggesting an alternative substrate may 
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be involved (Ross et al., 2003b). Pro-IL-18, which has structural similarities to IL-1β, is 
involved with modulation of the immune system through induction of interferon-γ is 
another substrate for caspase-1 (Fantuzzi and Dinarello, 1999). Although similar to IL-
1β, IL-18 binds to its IL-18 receptor; however it does not activate the NF-κB pathway 
(Lee et al., 2004). IL-18 is expressed by murine endometrial epithelium (Yoshino et al., 
2001) and has been localized to the porcine endometrial epithelium (Ashworth 
unpublished results).  
 
Estrogen and Estrogen Receptor Involvement During Early Pregnancy  
The general effects of estrogen on tissues have been studied dating as far back as 
the 1930’s with the first isolation of the steroid molecule, which was followed by 
subsequent isolation of its receptor followed in the 1960’s (Jensen et al., 1962).  It has 
been well established that the estrogen signaling system plays a pivotal role in the 
physiology of the reproductive organs.  Estrogens are a group of C18 sterol compounds 
that are derived from cholesterol.  Numerous physiological ligands exist that are 
recognized by the ligand binding domain of the ER such as: 17β-estradiol, 17α-estradiol, 
estrone, and estriol (Kuiper et al., 1997)  Estrogen receptors (ER) modulate transcription 
through ligand binding to a broad range of related ligands,  including plant originated 
phytoestrogens, aflatoxins, as well as synthetic estrogens such as DES.   
To date, two known estrogen receptors have been characterized: ERα, and ERβ.   
Bigsby and others in 2002 demonstrated that signaling through ERα, and ERβ play a 
critical role in proliferation of the endometrium.  Furthermore, in the rodent uteri ERα 
has been determined to be the predominant receptor gene in the luminal and glandular 
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epithelium (Wang et al., 1999).  In addition to proliferation, estrogens and ER’s play an 
regulatory role of the inflammosome and specific cytokines such as TNFα (Yu et al., 
1998);  In contrast, IL-1β appears to be present in greatest abundance concomitantly with 
estrogen, but as observed in a recent study, appears to not be induced by estrogen 
(Ashworth, Geisert, and White unpublished results).  Estrogen has been demonstrated to 
have some regulation over other key immune pathways such as: T-lymphocyte cytokine 
secretions, B-lymphocytes population energetics, and deemed critical for inducible nitric 
oxide synthase (iNOS) levels (Pfeilschifter et al., 2002).   
In the early porcine conceptus, the machinery is present to rapidly convert steroid 
precursor molecules into estrogen (Perry et al., 1973, 1976).  Geisert et al., 1990 
determined that estrogen appearance during early pregnancy in the pig is bimodal with a 
very transient appearance around day 12, and reappearing as a sustained secretion around 
day 16 of pregnancy.  Furthermore, this increase in conceptus estrogen has been 
attributed to the biological increases in uterine blood flow during early pregnancy (Ford 
and Christenson 1979).  As previously discussed, Bazer and Thatcher determined that the 
ligand estrogen is responsible for the sequestering of prostaglandins within the uterus and 
avoiding luteolysis and termination of the pregnancy.  
  
Porcine ER Expression during the Estrous Cycle and Early Pregnancy 
Geisert et al. (1995) characterized changes in the expression patterns of ER in the 
porcine endometrium during the estrous cycle and early pregnancy.  Concentrations of 
nuclear ER in the endometrium increased from days 0 to 12 when followed by a decline
in ER starting around day 15 regardless of status (cyclic, pregnancy).  Furthermore, 
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quantification of mRNA confirmed the ER nuclear findings.  Immunocytochemical 
localization of protein revealed intense ER expression in the stomal cells and only 
moderate expression in the surface and glandular epithelial cells during est us (Day 0 and 
Day 18).  However, ER expression in the stroma was absent from days 5 to 15 of the 
estrous cycle but began to increase on day 18.  In contrast to the cyclic pigs, on day 18 of 
pregnancy, ER remained low on day 18 of pregnancy (Geisert et al., 1995).  
 
Porcine Embryonic Mortality and Endocrine Disruption 
Estrogenic micotoxins in moldy corn results in complete embryonic loss when 
present in the diet of pregnant sows fed between days 7-10 of pregnancy (Long and 
Diekman 1986).  However, administration of estrogenic compounds on either days 2 to 6 
or 11to 15 of gestation, does not disrupt pregnancy.  Early estrogen exposure does not 
affect spacing or elongation of conceptuses, but rather modifies the uterine environment 
(Long et al., 1987).  Endocrine disruptors can modulate ovarian steroid hormone function 
on the uterus.  Changes in steroid hormone actions can be altered due to the antagonistic 
binding of endocrine disrupting compounds (EDC) (Table 2.1) to the steroid receptors.  
Exposures to EDC’s affect the functions of E2 and P4 on the uterus and the hypothalamic-
hypophyseal axis as well.  EDC’s have the potential to alter the estrous cycle, ovulation, 
and gestation in the domestic pig.    
In the pig, the majority of embryonic mortality occurs prior to day 30 of gestation 
(Perry et al., 1954).  Embryonic losses during early gestation of the pig was first recorded 
by Corner et al. (1923), and was estimated by counting corpora lutea present on the ovary 
to determine ova ovulated, and viable conceptuses flushed from uterine horns at various 
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stages of gestation.  Using the slaughter house material, Perry et al. (1954) indicated an 
average loss of embryos in the pig was between 20-48% based on the live number of 
embryos present and corpora lutea on the ovary.   
There are two time periods during pregnancy which the majority of embryonic 
loss of embryo in the pig.  The periimplantation period (Days 10 to 15), and post-
placental attachment and expansion (Days 18 to 40) have been shown to be the periods of 
greatest loss of the possible litter size.  Pope et al (1994) estimated 30% of conceptus 
death occurs in early gestation (Days 10-18).  Early conceptus loss has been postulated 
from differences in conceptus size and development based on order and timing between 
ovulations due to the variable length of estrus in the sow (Pope et al., 1982). 
When conceptuses were transferred to a more advanced uterine environment, 
lesser developed conceptuses were not as responsive to the advanced uterine secretions 
(Pope et al., 1990).  Further, Geisert et al. (1982) demonstrated that exogenous estrogen 
administered on day 11 or 12 of the estrous cycle advanced uterine secretions.  Based on 
Geisert’s findings, more developed conceptuses in the same litter may possess the ability 
to initiate steriodogensis (producing E2) first may advance uterine secretions prior to 
lagging conceptuses ability to acquire and use these secretions.  Another disadvantage for 
the retarded conceptuses resides in the fact that once contemporaries produce estrogen, 
the uterus begins to compartmentalize into discrete segments limiting uterine su face 
availability.   
In the Meishan sow, conceptuses develop at a slower rate than standard European breeds 
of swine.  The slow sustained release of Meishan conceptus estrogen may allow more 
time to establish properly segmented sections (micro-environments) in the Meishan 
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uterus aiding in conceptus uterine synchrony.  Uterine capacity and endometrial surface 
area of the dam in the uterus has been postulated as another limiting factor in cont olling 
the number of embryos that can survive to term (Webel and Dziuk, 1974).  Christenson et 
al. (1987) defined uterine capacity as maximum number of fetuses adequately supported 
by uterine tissues with unlimited viable conceptuses available.  Further studies suggest 
that placental efficiency may be a regulating factor in regards to maximum uterine 
capacity of the pig (Wilson et al., 1999).  
 
Porcine Pregnancy Specific Endocrine Disrupted Systems   
Pope et al. (1986) demonstrated that administration of estradiol-17β (8 mg/Day) 
on days 9 and 10 of pregnancy resulted in complete embryonic mortality by day 30 of 
gestation.  Morgan et al. (1987) indicated that pregnant gilts exposed to estrogen on days 
9 and 10 of pregnancy resulted only in fragmented and degenerated conceptuses 
recovered by day 16 of gestation.  On days 14-16 of gestation, Gries et al. (1989) 
observed alterations in uterine protein content in the flushings of gilts receiving arly 
estrogen.  Embryonic death due to early estrogen exposure is highly correlated to a 
complete break down in the uterine glycocalyx occurring approximately day 14 of 
gestation (Blair et al., 1991).   
Presence of ERα in the endometrial LE and GE and the possible role of estrogen 
in modulating NF-κB stimulated genes suggest that premature exposure to estrogen may 
disrupt pregnancy through aberrant gene expression between days 12 to 15 of pregnancy 













Table 2.1.  Endocrine disruptor chemicals with E2 activity present in food and the 
environment 










Estrogen agonist-ER alpha 
 
Alters steroid metabolism 
/transport 
DDT Food, environment, 
workplaces 
Estrogen activity 
Organochlorine insecticides Food, environment, 
workplace 
Homeostasis of estrogen 
Triazoles, Imidazoles Food, environment, 
workplace 






Estrogen agonist-ER alpha 
Bisphenol A Plastics, consumer 
products 
Estrogen agonist-ER alpha 




Phthalates Food, consumer products Steroid biosynthesis 
Parabens Cosmetics, toiletries, and 
pharmaceuticals 
Estrogen agonist- ER alpha 
and beta 
UV-screen Consumer products Estrogen agonist- ER alpha 
Isoflavones, lignans Food (Soy-based food), 
consumer products 
High affinity for ER beta 
Adapted from Caserta et al., 2008 
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unigene cDNA array constructed from porcine uterine, ovarian and conceptus tissue 
(Whitworth et al., 2005) to evaluate alteration in endometrial gene profile following 
treatment of gilts with estrogen on days 9 and 10 of pregnancy.  The vast majority of 
endometrial genes altered by early estrogen treatment occurred on day 13 and 5 of 
pregnancy. Many of the genes identified are factors involved with cell attachment, 
immunology, transcription regulation and metabolism. Osteopontin (OPN) mRNA 
expression is advanced in estrogen-treated gilts, which was confirmed in the LE by in situ 
hybridization (White et al., 2005).  Osteopontin, a proposed mediator of trophoblast 
adhesion to the endometrial LE through integrin receptors present on the LE apical 
surface (Johnson et al., 2003), is stimulated by IL-1β, TNF-α, interferon-γ and estrogen. 
Alternation in OPN expression (NF-κB regulated gene) may cause failure of proper 
glycocalyx formation needed for conceptus attachment. 
Early estrogen administration also alters the pattern of COX-2 expression in the 
uterine LE (Ashworth et al., 2006) supporting a mistiming of NF-κB activation. The 
importance of COX-2 expression in LE during establishment of pregnancy has not bee  
investigated. The importance of endometrial COX-2 gene expression during implantation 
and decidualization was established using COX-2 null mice that have an altered 
inflammatory response resulting in reproductive defects in implantation (Lim et al., 
1997). Pharmacological inhibition of PG synthesis through inhibition of COX does not 
affect trophoblast elongation in pigs (Geisert et al., 1986).  However, it does increase 
embryonic mortality during the period of placental attachment to the uterine surface 
(Kraeling et al., 1985). Induction of COX-2 expression promotes PGE synthesis 
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(Murakami and Kudo, 2004). Endometrial secretion of PGE may function in stabilization 
of the extracellular matrix, inflammation and immune function in the pig  
Early exposure of pregnant gilts to estrogen disrupts the normal synchrony in the 
presence of insulin-like growth factors in uterine lumen during the time of rapid 
conceptus elongation on day 12.  Concentration of IGF-I is elevated within the uterine
lumen prior to and during rapid trophoblast expansion on days 10 to 12 of pregnancy 
(Simmen et al, 1995; Geisert et al., 2001).  The high uterine content of IGF-I is thought 
to have a direct effect on augmenting conceptus steriodogenesis via enhancement of P-
450arom gene expression and enhancing aromatase activity (Simmen et al., 1995). Content 
of IGF-I in uterine flushings decreases dramatically following conceptus elongation and 
the initiation of placental attachment to the uterine surface epithelium on day 13 of 
gestation.  The high amounts of IGF-I in the uterine lumen of the pig are closely 
associated with detection of insulin-like growth factor binding proteins in the uterine 
lumen (Lee et al., 1998; Geisert et al., 2001).  However, there is a complete loss of 
uterine luminal IGFBPs on day 12 of either the estrous cycle or pregnancy (Geisert et al., 
2001).  Disappearance of IGFBP’s observed in uterine luminal flushings on day 12 is due 
to an increase in IGFBP proteolysis rather than down-regulation of IGFBP mRNA (Lee 
et al., 1998).  The proteolysis of IGFBPs in the porcine uterine lumen may occur through 
activation of the serine protease, tissue kallikrein and/or metalloproteinases (Lee et al., 
1998; Geisert et al., 2001).  IGF’s are regulated and stabilized through tertiary binding to 
IGFBPs.  The degradation of IGFBP’s within the uterine lumen may in part be 
responsible for the decreased content of IGF-I collected in uterine flushings after day 13. 
It is possible IGFBPs helps to sequester IGF-I in the uterine lumen for release during the 
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sensitive period of conceptus differentiation and trophoblast elongation.  The precise 
nature of the loss of uterine luminal IGFs following conceptus elongation suggest that the 
release of IGFs during days 12 and 13 of pregnancy is very critical for down-stream 
development and survival of pig embryos.  Administration of estrogen to gilts on days 9 
and 10 of pregnancy causes premature proteolysis of uterine luminal IGFBPs on day 10 
and an earlier (48 h) decline of IGF-I on days 10 and 11 (Ashworth et al., 2005). 
Although the study cannot demonstrate a causal effect of premature loss of IGFs with 
later conceptus death, early estrogen administration clearly causes a dramatic decline in 
IGFs before the critical period of conceptus elongation and differentiation.   Mice devoid 
of the IGF-RII undergo in-utero mortality during gestation (see review Jones and 
Clemmons, 1995).  Studies have demonstrated that the IGF-RII is fundamental in 
embryonic development in the mouse (Barlow et al., 1991), and provides major roles in 
tissue remodeling and translocation of newly synthesized cathepsins to the lysosome  
(Dahms et al., 1989).  Thus, alteration in the normal synchrony of IGF release in the 
uterine lumen during early pregnancy may cause aberrant endometrial and/or conceptus 
gene expression during implantation. 
 
Regulatory RNA (miRNA) involvement during early pregnancy 
 
General Regulatory Action 
In order to elicit a biological response in the cell, mRNA translation into a prtein 
is normally required; these proteins are regulated at the transcriptional and translational 
level through single stranded hairpin loop and dsRNA (miRNA/siRNA respectfully).  
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Furthermore, the quantity and temporal expression of these proteins are a critical control 
point regulated through a servant (protein) and master (ncRNA) relationship (Neilson t 
al., 2007).   
 Lee et al. (1993) was the first to discover and report miRNA transcripts.   
miRNA are an endogenous RNA species that range between 18-24 nt in length (Bartel et 
al., 2004).  The miRNA task and organization begins with transcription of the 
endogenous miRNA transcript into a hairpin shaped oligonucleotide of around 90 nt 
termed pri-miRNA (primary miRNA) (Lee et al., 2002).  This transcription process is 
very similar to mRNA transcription where RNA polymerase II is the predominate 
polymerase driving the transcription process (Bartel et al., 2004).  The phenotype of the 
pri-miRNA is only of polyadenylation with methyl caps similar to mRNA (Lee et al., 
2002).  Step 1 of nuclear processing of the miRNA is accomplished through the enzyme 
Drosha, which separates the 60 nt stem-loop structure (miRNA) from the total pre-
miRNA sequence; furthermore, these pri-miRNA transcripts can be located in an intron 
or exon of the mRNA coding sequence and are most likely cut out after the 
transcriptional processing.  Moreover, the exact time and way these miRNA’s are cut out, 
and wether it’s during or after splicing has yet to be elucidated.  Once the miRNA is 
processed (now termed pre-miRNA), the protein receptor Exp-5 (exportin 5) facilitates 
transport of the pre-miRNA from the nucleus to the cytoplasm (Lund et al., 2004).  Once 
in the cytoplasm, the enzyme Dicer processes the ds loop-stem structure resulting in a 
mature miRNA (Lee et al., 2004).  The mature miRNA is relatively short ranging 
between 18-22 nt in length.  A helicase enzyme will come in and separate the miRNA
strand from its complementary strand from the mature miRNA, the complementary ds 
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portion more than likely inhibits Drosha from processing it all the way down in the 
nuclear processing portion.  The newly activated mature miRNA is now ready to bind to 
the mRNA transcript and either repress translation or inhibit the process all together 
depending on binding homology.  The mature miRNA apposition and attachment to the 
miRNA binding domain is facilitated through a complex of interacting proteins to form 
the RNA Silencing Complex (RISC) (Lee et al., 2004).  RISC, using the miRNA as a 
navigating tool, contains an endonuclease which will cut the mRNA in the middle of the 
miRNA binding site (which may contain numerous sites) (Tang et al., 2003).  In contrast 
to miRNA, siRNA diverges in its origin and processing.  While siRNA and miRNA share 
a similar expression end point, the major difference is that siRNA’s are products that 
have been created from the formation of dsRNA, transposons, and viruses, while mRNA 
origin is from loci located within the genome (Bartel et al., 2004).   
The miRNA mechanism was first clarified using the amount of lin-4 transcript 
that is complementary to lin-14 and lin-28.  These genes play a developmental role in 
early to late C. elegans larva stage (Lee et al., 1993).  As the author measured the 
translated product he noticed about a 88-90% attenuation, while lin-14 mRNA was 
unchanged and lin-28 mRNA was reduced to less than 50%.  These findings seemed 
confounded at the beginning; however the study nicely demonstrated that silencing 
worked at the transcription and translational levels.  Target recognition occurs through 
basically the first 8 residues of the miRNA (5’end) which is complementary to the 3’ 
untranslated region (UTR) of the mRNA target, which has been tagged for 
posttranscriptional gene silencing (PTGS).  Furthermore, the strength of complementary 
Watson-Crick base paring of the miRNA’s to the 3’UTR mRNA determines which type 
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of silencing will be used; strong complementary paring will usually activ te mRNA 
degradation, where a lower degree of complementary binding will target the gene for 
repression at translation level.   
 
Regulatory RNA Involvement during the Female Menstrual Cycle 
The review of literature for this section will reside primarily to humans due to a 
void in the literature.  To date, approximately 600 miRNA’s have been confirmed and 
around 1000 have been predicted (Berezikov et al., 2006).  Furthermore, each single 
miRNA could potentially target hundreds of genes while several hundred miRNA’s could 
target the same gene (Brennecke et al., 2005).   
In the human, the endometrium undergoes very distinct and dynamic biochemical 
and morphological changes due to changes in sex hormone appearances and 
concentrations.  Numerous studies have demonstrated that gene expression and 
regulatory functions are tightly controlled throughout the menstrual cycle(Horcajadas et 
al., 2007).  Recently, Pan et al., (2007) indentified hundreds of miRNA’s specifically 
localized to the human epithelial and stromal layers of the uterine endometrium.  In the 
previous study, approximately 300 hundred miRNA’s were isolated in the human 
endometrium where 65 miRNA’s where localized to the epithelial cells.  Moreover, half 
of the 65 miRNA’s profiled were in the glandular epithelial cells and the other half in the 
lumenal epithelial cells suggesting a different mechanism in regards to gene regulation in 
the same cell type but involved with different functions.  Using a defined cell culture 
system model, endometrial cells were cultured and used to characterize th  regulatory 
role ovarian steroids (E2 and P4) have on miRNA populations (Pan et al., 2007).  The 
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endometrial cell culture system was subjected to E2 then subsequently exposed to P4 to 
establish miRNA’s influence under steroid regulation.  Upon examination of selected 
miRNAs the authors carefully predicted target genes which included: TGF-β, TGF-β-
receptor, ER, PR, and CYP-19A1 (aromatase) (Pan et al., 2007).  TGF-β is one of the 
predominate uterine cytokines and a key regulator of inflammatory responses which are 
instrumental in regards to regulation of protease activity and extracellular matrix integrity 
(Chegini et al., 2002). 
 
RNA Regulation during the Inflammatory Response 
A plethora of miRNAs have been identified as playing a regulatory role in the 
immune and inflammatory response under mediators such as: let7, miR-17-5P, miR-20a, 
miR-106a, miR-125b, miR-146, miR-155 (Meng et al., 2007, Tili et al., 2007).  Of these 
newly discovered miRNAs, miR-125b and miR-155 are of great importance due to their 
involvement in proper T and B lymphocyte development (Tili et al., 2007).   
miR-155 has been shown to target the lipopolysaccaride (LPS) system and its 
ancillary signaling proteins (Tili et al., 2007).  Furthermore this study demonstrated that 
with the addition of miR-155 enhanced the translation of TNF-α, while adding miR-125b 
repressed TNF-α translation.  Endometrial appearance of these miRNAs expressed 
concomitantly with proinflammatory cytokines increased NF-κB activity (Pan et al., 
2007).  In monocytes, miR-146 is induced through the NF-κB system and causes an 
inhibition of TNF-α receptor associated factor 6 (TRAF6) and interleukin-1 associated 
kinase (IRAK1) expression.  Furthermore, both of these factors are downstream from toll 
like receptors (TLR) and cytokine signaling pathways (Taganov et al., 2007).  How the 
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NF-κB system is able to induce the miR-146 molecule has yet to be elucidated, however 
some studies suggest it is triggered through cell surface receptors and not intracellular 
receptors such as TLRs.  Moreover, the study also postulated that initial activ tion of 
miRNAs within the uterine environment may originate from a nucleic acid viral source 
(O’Connell et al., 2007).  Given these data, one could easily speculate the viral source to 
be endogenous.   
 
RNA Regulatory Control of Endometrial Apoptosis 
Selam et al., (2001) indicated that apoptosis within the endometrium was 
controlled through ovarian steroid exposure and a delicate balance between pro-apoptotic 
genes and anti-apoptotic genes.  During early pregnancy and the window of implantation, 
a controlled inflammatory response is obligatory for success of the pregnancy.  Man  
miRNAs have been identified or predicted to regulate apoptosis, cell cycle, and various 
types of cancer through controlling expression of certain genes (Matasubar  et al., 2007).  
A plethora of miRNAs associated with triggering apoptosis are: miR-10a, miR-28, miR-
196a, miR-337, miR-96, miRNA-145, miR-150, miR-155.  Furthermore, altered 
expression patterns of miR-155 has been shown in studies to differentially regulate some 
of the caspases and Fas-Asscociated Death Domain proteins (FADD) which are both key 
machinery involved with apoptosis activation and signaling (Garafalo et al., 2008).  
Lastly, one of the hallmark signs of apoptosis control is the release of the Bcl2 family of 
transport proteins from the electron transport complex termed “cytochrome C”.  Recent 
studies have demonstrated that aberrant expression of the Bcl2 transport protein during 
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apoptosis is regulated through the expression of miR-15a and miR-16-1 (Cimmino et al., 
2005). 
 
Regulatory RNA Control of Implantation 
 Implantation and maternal acceptance of the fetal tissues is a complex issu  that 
requires precise synchrony from maternal and embryonic dialog, and has yet to be fully 
elucidated.  Ovarian hormones and their receptors present in a spacio-temporal fashion 
are mandatory for a successful pregnancy.  Crosstalk between fetal and maternal tissues 
involves growth factors, chemokines, and cytokines which are all plausible constitue ts 
for miRNA regulation during this period.  Specific miRNAs have been identified in the 
murine pregnancy model during peri-implantation and pre-implantation periods which 
may serve as potential candidates that regulate implantation (Chakrabarty et al., 2007).  
Furthermore, of the 32 miRNAs indentified in connection with implantation, 3 (miR-101, 
miR-144, miR-199a) were specifically predicted to target cyclooxygenase-2 (COX-2).  
The expression of these 3 miRNAs displayed a direct correlation with the expression of 
COX-2 during delayed implantation in the mouse, inferring a potential role with 
implantation (Chakrabarty et al., 2007).  In addition to these direct miRNA regulators 
there are a plethora of other molecules that regulate COX-2 expression like cyto ines, 
growth factors, and chemokines. 
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 Statement of the Problem 
Over the years, there have been a plethora of conceptus and endometrial factors 
identified that contribute to the successful establishment pregnancy and yield larger litter 
size in pigs.  Unfortunately, from a reproductive standpoint in the United Statesthe pig is 
far from optimal.  Of the 20 to 46 % conceptus mortality rate realized throughout 
gestation in the pig, a majority is directly related to the events during the peri-
implantation stage of development.  Three critical events must occur during early 
pregnancy: 1) the rapid elongation of the conceptus trophoblast and delivery of the 
maternal recognition signal, estrogen; 2) the uterine response to conceptus secreted 
estrogen, and 3) the down-regulation of the luminal epithelial progesterone recepto  and 
the uterine receptivity associated with it.  Temporally, these three biologica  processes all 
occur within a very narrow time frame (Days 10 to 18 of gestation).  As important as they 
are regarding the establishment of pregnancy in the pig, little biological information is 
available delineating the mechanisms that regulate these events. 
 Ford et al. (1997) attributes the larger litter size of the Meishan sows to the ability 
of the conceptuses to regulate the uniformity and the extent to which they expand their 
trophoblast.  Geisert and Schmitt (2000) suggested that the ability to regulate the 
simultaneous initiation of trophoblastic elongation would result in more consistent 
placental size and uterine space among littermates potentially increasi g litter size.  
 Estrogen, while a required component of pregnancy establishment in the pig also 
plays integral roles during pregnancy establishment.  Copious amounts of estrogen 
delivered by the conceptus during days 11 to 12 of gestation appear to be required as too 
few conceptuses are incapable of establishing pregnancy.  While amount of estrogen 
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stimulation appears to have a requirement, the timing of the estrogen stimulation is also 
critical as ill-timed administration or ingestion of estrogen has been shown to cause a 
total loss of pregnancy in the pig.  While certain events such as the redirecting of 
endometrial PGF2α secretion are attributed to conceptus estrogen stimulation, very little is 
known regarding the endometrial molecular mechanisms and events following estrogen 
exposure.  A deeper understanding of the regulatory roles that estrogen serves during 
pregnancy establishment in the pig will lend insight to steroidogenic factors affecting 
pregnancy outcome in pigs.  Furthermore, the biological understanding of estrogen’s 
impact on endometrial function may also be applicable to women who suffer from 
preeclampsia and endometriosis which are pathological conditions associated with 
elevated estrogen and progesterone circulation and dysfunctional blood flow and 
implantation window. 
 Lastly, the critical molecular events associated with the opening of the 
implantation window and the period of uterine receptivity is poorly described in most 
species.  While the up-regulation of the Muc genes and down-regulation of the 
progesterone receptor in the luminal epithelium is associated with uterine rceptivity in 
most species, the biological forces driving that phenomenon are not well described.  
Certainly, the regulation of specific transcription factors and the downstream activation 
of their regulated products contribute to the establishment or disruption of pregnancy i 
the pig.   
 
Approach to the problem 
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While biotechnological advancements have been rapid over the past few years, 
bioinformatics resources have made exceptional progress recently.  The ability to link 
microarray data acquisition platforms to bioinformatics tools has dramatically ch nged 
the capability to identify differentially expressed genes in a biological system and then 
accurately annotate the biological themes associated with the alterations in the system 
evaluated.  Also, the significant amount of expressed sequence tags from the pig 
deposited into GenBank has prompted the development of the GeneChip® Porcine 
Genome Array by Affymetrix®.  The 23, 937 probe set interrogates 23, 256 transcripts 
representing 20, 201 porcine genes.  Utilization of array platforms and modern 
bioinformatics approaches will help identify the biological processes that are ssociated 
with both endometrial response to estrogen stimulation as well as the factors that ae
involved with opening of the window of implantation during early endometrial 
development.  Identification and characterization of the changes in mRNA expression 
that are related to trophoblastic elongation, endometrial estrogen stimulation and uterine 
receptivity as a result of transcription factor activation will provide a better understanding 
of the biological events necessary for embryonic survival, implantation and a successf l 




Porcine Conceptus Induction of Endometrial Caspase 1 Expression and Interleukin-




 Interleukin (IL)-18 is a pleiotropic cytokine expressed in the reproductive tract of 
the mouse and human during the establishment of pregnancy.  The role of uterine IL-18 
expression during the noninvasive type of conceptus implantation and placental 
development in the pig has not been investigated.  Pro-IL-18 is a 24-kDa inactive product 
which can be secreted following cleavage to the active 18 kDa form by caspase-1.  In the 
current study, we characterized endometrial IL-18 and caspase-1 expression during the 
estrous cycle and early pregnancy of the pig.  Gilts were hysterectomized on either day 0, 
5, 10, 12, 15 and 18 of the estrous cycle or day 10, 12, 15 and 18 of pregnancy.  
Endometrial IL-18 and caspase-1 gene expression was evaluated with quantitative RT-
PCR and IL-18 in uterine flushings by ELISA.  Caspase-1 endometrial gene expression 
did not change across the estrous cycle; however, endometrial caspase-1 gene expression 
was 6 and 10-fold greater on day 15 and 18 of pregnancy.  IL-18 endometrial gene 
expression was not affected by reproductive status but increased more than 5-fold from 
day 10 to 18.  Total uterine luminal content of IL-18 increased in pregnant compared to 
cyclic gilts on day 15 and 18.  The current study provides evidence for a conceptus 
induced activation of endometrial caspase-1 and release of IL-18 during the period of 
placental attachment in the pig.  We propose that IL-18 may play an important role in 
regulation of the maternal immune system during the establishment of pregnancy.  
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INTRODUCTION 
 The noninvasive attachment of the porcine conceptus forms an epitheliochorial 
type of placentation through its adhesion to the extracellular glycocalyx present on the 
apical surface microvilli of the uterine luminal epithelium (King et al., 1982; Stroband 
and Van der Lende, 1990).  Following removal of the anti-adhesive factors expressd on 
the uterine surface epithelium (Bowen et al. 1996), trophoblast attachment to the uterin  
luminal epithelium involves a coordinated program of events in progesterone stimulated 
uterine environment that are mediated by actions of estrogen in the pig (Geisert and 
Yelich, 1997).  Trophoblast attachment to the uterine surface in the pig immediately 
follows the rapid elongation of the trophoblast and the acute increase of conceptus 
estrogen synthesis on day 12 of pregnancy (Geisert et al., 1990).  Release of estrogen by 
the elongating conceptuses will induce endometrial receptivity for placental attachment to 
the uterine surface (Keys et al., 1990; Burghardt et al., 1997; Jaeger et al., 2001).   
 Transient release of estrogen during rapid trophoblast elongation is concomitant 
with conceptus release of the proinflammatory cytokine, interleukin-1β (IL-1β), which 
has been proposed to serve as the initial stimulus for conceptus attachment to the uterine 
surface in the pig (Ross et al., 2003).  Furthermore, Ross et al. (2003) demonstrated that 
the periimplantation porcine conceptuses secrete the greatest amount of IL-1β into the 
uterine lumen during the filamentous stage of morphology (day 12-15), which rapidly 
decreases to nadir levels by day 18 of gestation.  The decline in conceptus IL-1β 
secretion suggests that another closely related cytokine may function at the conceptus and 
maternal uterine surface interface to continue regulation of the immunological 
interactions necessary for establishment of pregnancy in the pig.  A possible candidate 
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cytokine would be IL-18, which is a member of IL-1 family (Okamura et al. 1995).  IL-
18, formerly known as interferon-γ inducing factor, is a pro-inflammatory cytokine that is 
believed to play a significant role in implantation.  Implantation in the rodent requires the 
presence of IL-18 at the maternal fetal interface as indicated by abortive prone mice 
which have suppressed IL-18 levels at the fetal-maternal interface (Muranaka et l. 
1998).  In contrast, non-abortive mice produced elevated levels of IL-18 at the maternal 
fetal interface suggesting a Th1/Th2 divergence (Ostojic et al., 2003).  Like Il-1β, the 
proform of IL-18 is stored in the cytoplasm and must be proteolyically cleaved to be 
secreted and exhibit biological activity.  Caspase-1 cleaves and activates he proforms of 
IL-1β and IL-18 (Hentze et al., 2003) to the biologically active molecule with signaling 
capacity.  Expression of IL-18 by the conceptus and/or endometrium is suggested as 
interferon γ (IFN-γ) increases following trophoblast elongation in the pig (Cencic and 
Bonnardier, 2002). 
 The present study was undertaken to determine the expression of caspase 1 and 
IL-18 during the estrous cycle and early pregnancy in the pig.  We also investigat  the 
possible alteration of caspase 1 and IL-18 expression following early exposure of 
pregnant gilts to estrogen which causes conceptus degeneration after Day 15 of 
pregnancy.  
    
MATERIALS AND METHODS  
Animals 
Research was conducted in accordance with the Guiding Principles for Care and 
Use of Animals promoted by the Society for the Study of Reproduction and approved by 
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the Oklahoma State Institutional Care and Use Committee.  Crossbred cycling gilts of 
similar age (8-10 mo) and weight (100-130 Kg) were checked twice daily for estrus 
behavior (estrus onset = Day 0 of estrous cycle) with intact males.  Gilts assigned to be 
bred were naturally mated with fertile crossbred boars at first detection of estrus, and 
subsequently at 12 and 24 h post-estrus detection. 
 
Experiment I:  Endometrial Caspase-1 and IL-18 Expression in Cyclic and Pregnant 
Gilts. 
 Gilts were hysterectomized through midventral laparotomy on either days 0, 5, 10 
12, 15 and 18 of the estrous cycle (n =24) or days 10, 12, 13, 15 and 18 of pregnancy (n 
=16) as previously described by Gries et al. (1989).  Following induction of anaesthesia 
with 1.8 ml i.m. administration of a cocktail consisting of 2.5 ml cocktail (Xylazine: 
100mg/ml: Miles Inc., Shawnee Mission, KS) and 2.5 ml Vetamine (Ketamine HCl: 100 
mg/ml Molli Krodt Veterinary, Mundelein, IL) in 500 mg of Telazol (Tiletamine HCl and 
Zolazepum HCl: Fort Dodge, Syracuse, NE), anesthesia was maintained with a closed 
circuit system of halothane (5% flurothane) and oxygen (1.0 liters/min).  The uterus was 
exposed via midventral laparotomy and uterue and ovaries excised.  Uterine horns were 
injected with 20 mL phosphate buffered saline (PBS, pH 7.4) via the isthmus and 
flushings were recovered in a petri dish.  Conceptuses were removed from flushings of 
pregnant gilts, snap frozen in liquid N2, and stored at -80°C.  Uterine flushings were 
centrifuged (1000 x g, 10 min, 4°C), supernatant collected and clarified uterine flushings 
stored at -20°C.  Endometrial tissue was removed from the antimesometrial side of the 
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uterine horn, immediately snap frozen in liquid nitrogen and stored at-80°C until utilized 
for extraction of protein and RNA.   
 
Experiment II: Endometrial Caspase-1 and IL-18 Gene and Protein Expression following 
Early Exposure of Pregnant Gilts to Estrogen 
Bred gilts were randomly assigned one of the following treatment groups:  
Control (n = 20), i.m. injection of corn oil (CO) (2.5 ml) on days 9 and 10 of gestation or 
estrogen (E) (n = 20), 5 mg i.m. injection of estradiol cypionate (A.J. Legere, Scottsdale, 
AZ) on days 9 and 10 of gestation.  Gilts belonging to the CO and E treatment groups 
were hysterectomized on either day 10, 12, 13, 15 and 17 of gestation as described in 
experiment 1.  Uterine horns were flushed with 20 ml PBS, conceptuses were collected, 
flushings centrifuged to remove cellular debris, and the superatnant stored at -20°C. 
Endometrial tissue was harvested from the uterine horn and either fixed for in situ 
hybridization or snap frozen in liquid nitrogen and stored at-80°C until utilized for 
extraction of protein and RNA.  
 
Uterine Tissue Fixation Procedures 
 Endometrial tissue sections (~1.0 cm) were excised from the bottom 40 cm of the 
uterine horn which was not flushed with PBS.  Tissue sections were placed in freshly 
prepared 4% paraformaldehyde in PBS (pH 7.2) and gently agitated at r.t. for 24 h.  
Solution was replaced with 70% EtOH (v/v in H20), gently agitated for an additional 24 
h.  Fixed endometrial tissue was dehydrated in a series of graded ethanol changes
48 
followed by xylene, and then embedded in Paraplast-Plus (Oxford Labware, St. Louis, 
MO). 
 
In situ hybridization  
 Caspase-1 mRNAs were localized in paraffin-embedded porcine uterine tissue by 
in situ hybridization using methods previously described (Johnson et al., 2000). Briefly, 
deparaffinized, rehydrated, and deproteinated u rine cross-sections (5 µm) were 
hybridized with radiolabeled antisense or sense porcine caspase-1 cRNA probes 
synthesized by in vitro transcription with [α-35S]uridine 5-triphosphate (PerkinElmer Life 
Sciences).  After hybridization, washes, and RNase A digestion, autoradiography was 
performed using NTB-2 liquid photographic emulsion (Eastman Kodak, Rockchester, 
NY).  Slides were exposed at 4°C for 6 days, developed in Kodak D-19 developer, 
counterstained with Harris’ modified hematoxylin (Fisher Scientific, Fairlawn, NJ), 
dehydrated, and protected with coverslips. 
 
RNA Extraction  
 Total RNA was extracted from endometrial tissue using RNAwiz reagent 
(Ambion, Inc. Austin, TX).  Approximately 0.5 g of endometrial tissue was homogenized 
in 5.0 mL of RNAwiz using a Virtishear homogenizer (Virtis Company Inc., Gardiner, 
NY).  RNA was resuspended in nuclease free water and stored at -80°C.  Total RNA was 
quantified with a Nanodrop® spectrophotometer at an absorbance of 260 nm and purity 
was verified using the 260/280 ratio.   
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Quantitative 1-Step RT-PCR 
 Quantitative analysis of endometrial caspase-1 and IL-18 mRNA were analyzed 
using quantitative real time reverse polymerase chain reaction (RT-PCR) as previously 
described by our laboratory (Hettinger et al., 2001, Ashworth et al., 2006).  The PCR 
amplification was performed in a reaction volume of 15 µl using an ABI PRISM 7500 
Sequence Detection System (PE Applied Biosystems, Foster City, CA).  The transcripts 
were evaluated using dual labeled probes with 6-Fam (5’ reporter dye), and TAMRA (3’ 
quenching dye).  Primer and probe sequences for the amplification of caspase-1 and IL-
18 (Table 3.1) were generated from porcine sequences obtained using the NCBI 
genebank database.  Total RNA (100 ng) was assayed in duplicate using thermocycling 
conditions for one-step cDNA synthesis of 30 min at 48°C and 95°C for 10 min, followed 
by 45 repetitive cycles of 95°C for 15 sec and 60°C for 1 min.  Ribosomal 18S RNA was 
assayed in each sample to normalize RNA loading.   
Using the comparative CT method (Ashworth et al., 2006), relative quantification 
and fold gene expression difference between treatment and day were determin d for the 
endometrial samples (Table 3.2 and Table 3.3).  Differences in mRNA expression of 
caspase-1 and IL-18 were determined by subtracting target CT of each sample from its 
respective ribosomal 18S CT value, which provides the sample ∆CT value.  Calculation of 
the ∆∆CT involves using the highest sample ∆CT value as an arbitrary constant to subtract 
from all other ∆CT sample values.  Fold differences in gene expression of the target gene 




Enzyme-Linked Caspase-1 Competitive Binding Assays 
 Total luminal content of caspase 1 in the uterine flushings was quantified using a 
commercial ELISA kit (BenderMed Burlingame, CA) in accordance with manufacturer’s 
specifications.  Samples were analyzed in duplicate with a single assay.  The intra-assay 
coefficient of variation for the assay was 5.6%. 
 
Enzyme-Linked IL-18 Competitive Binding Assays 
 Total luminal content of IL-18 in the uterine flushings was quantified using a 
commercial ELISA kit (BenderMed Burlingame, CA) in accordance with manufacturer’s 
specifications.  Samples were analyzed in duplicate with a single assay.  The intra-assay 




 Data were analyzed by least squares ANOVA using the Proc Mixed model of th  
Statistical Analysis System (SAS, 1988).  The statistical model used to evaluate 
endometrial caspase-1 and IL-18 mRNA expression and uterine flushing content in 
expeiriment I included the effects of day (0, 5, 10, 12, 13, 15, and 17), reproductive status 
(cyclic, pregnant), and the day x status interaction.  If the status, day, or day*status 
interactions were significant, (P < 0.05), means were separated by using the PDIFF 
option of SAS.  Additionally, due to unequal variances of caspase-1 and IL-18 protein in 

















Table 3.1  PCR primer and probe sequences used for quantitative RT-PCR of         
      endometrial Caspase-1 and IL-18 mRNA expression. 
                           GeneBank 
Gene   Forward Primer/Reverse Primer/Probe                      Accession            
 
Caspase-1   
      Forward   5’ – CAA CAC TTC ACC CAC CAG TTC TTC-3’  NM214162 
      Reverse    5’ – TCC ATA AAT GTG GCC GAG GTC TAC-3’      
      Probe        5’ – TTC TGG CAA GAT GGG TCC TGG CTT CAC CAA-3’ 
 
 
IL-18       
      Forward   5’- ATG GCT GCT GAA CCA GAA GA -3’  NM213997 
      Reverse    5’- TGG TCG TTC AGA TTT CGT ATG ATT-3’  




The statistical model used to evaluate endometrial caspase-1 and IL-18 mRNA 
expression and uterine flushing content in experiment II included the effects of day (10, 
12, 13, 15, and 17), treatment (Con, E), and the day x treatment interaction.  If the day, 
treatment or day*treatment interaction was significant, (P < 0.05), treatment eans were 
then separated by using the PDIFF option of SAS.  Additionally, due to unequal 
variances of caspase-1 and IL-18 protein in the uterine flushings of the pregnant gilts, the 





Experiment I:  Cyclic and Pregnant Gilts. 
 
Conceptus Caspase-1mRNA Expression  
 
 Caspase-1 mRNA abundance (Figure 3.1) increased from day 12 to 13 followed 
by its lowest esxpression on day 14.  Conceptus caspase-1 increased from day 14, and its 




Table 3.2.  Comparison of endometrial Caspase-1 and IL-18 gene expression across days 
of the estrous cycle  and early pregnancy using the comparative threshold (CT) method. 
                   Average 
      Average     18s      
Target    Status  Day  Target CT
*     CT
*                  ∆CT
†,*         ∆∆CT
§ 
Caspase-1  
    Cyclic     0 27.18 ± 0.81 18.32 ± 0.19 8.04 ± 0.47ab   -1.41     
    Cyclic     5 27.17 ± 0.25 18.52 ± 0.19 9.18 ± 0.38a   0.54 
    Cyclic     10 27.99 ± 0.20 18.58 ± 0.11 9.53 ± 0.24a -0.21 
    Pregnant 10 29.64 ± 0.27 18.60 ± 0.07 9.02 ± 0.31a -0.00  
    Cyclic     12 29.12 ± 0.62 18.79 ± 0.58 8.99 ± 0.29bc -0.74  
    Pregnant 12 27.99 ± 0.47 18.32 ± 0.09 9.33 ± 0.53bc -0.32  
    Cyclic     15 27.35 ± 0.58 18.31 ± 0.05 9.27 ± 0.56bc -0.59  
    Pregnant 15 25.65 ± 0.53 18.40 ± 0.12 7.20 ± 0.46bc -2.55  
    Cyclic     18 27.12 ± 0.14 18.37 ± 0.05 8.99 ± 0.18bc -0.89  
    Pregnant 18 25.31 ± 0.32 18.51 ± 0.09 6.52 ± 0.49bc -3.23  
 
IL-18 
    Cyclic     0 28.63 ± 0.81 18.32 ± 0.19 10.17 ± 0.47ab -1.50     
    Cyclic     5 30.17 ± 0.25 18.52 ± 0.19 11.67 ± 0.38a  0.00 
    Cyclic     10 30.22 ± 0.20 18.58 ± 0.11 11.65 ± 0.24a -0.02 
    Pregnant 10 29.64 ± 0.27 18.60 ± 0.07 11.12 ± 0.31a -0.55  
    Cyclic     12 29.12 ± 0.62 18.79 ± 0.58 10.49 ± 0.29bc -1.18  
    Pregnant 12 28.12 ± 0.47 18.32 ± 0.09 10.24 ± 0.53bc -1.43  
    Cyclic     15 27.35 ± 0.58 18.31 ± 0.05   9.25 ± 0.56bc -2.42  
    Pregnant 15 28.15 ± 0.53 18.40 ± 0.12   9.77 ± 0.46bc -1.83  
    Cyclic     18 28.12 ± 0.14 18.37 ± 0.05   9.76 ± 0.18bc -1.91  
    Pregnant 18 27.61 ± 0.32 18.51 ± 0.09   8.52 ± 0.49bc -3.15  
CT
* = Cylic Threshold:  Cycle number where amplification crosses the threshold set in 
the geometric portion of the amplification curve. 
∆CT
† = Target (Caspase-1 and IL-18) – 18S Ribosomal CT:  Normalization of PCR 
cycles for the target with 18S ribosomal RNA.  Values with different superscripts for 
each of the target genes differ significantly (P<0.05) 
∆∆CT
§ = Mean ∆CT – highest mean ∆CT value:  The mean value of Day 10 pregnant and 
Day 5 cyclic (highest ∆CT; lowest gene expression for caspase-1 and IL-18 genes 
respectively) were used as a calibrator for caspase-1 and IL-18 to set the baseline for 




Endometrial Caspase-1mRNA Expression in the Cyclic vs Pregnant Gilts 
Quantitative RT-PCR analysis of endometrial c spase-1 mRNA abundances in 
cyclic and pregnant gilts (Table 3.2) detected a day x status interaction (P < 0.05).  
Endometrial caspase-1 mRNA abundances were approximately 3 and 5-fold greater in 
the pregnant gilts when compared to the cycling contemporaries on days 15 and 18 
respectively (Figure 3.2).  
 
Uterine Luminal Content of Caspase-1 Protein in Cyclic vs Pregnant Gilts 
Content of caspase-1 in the uterine flushings of cyclic and pregnant gilts (Figure 
3.3) exhibited a day by status interaction (P < 0.05).  Uterine luminal caspase-1 content in 
cyclic gilts was low on all days collected (27 to 123 pg).  Caspase-1 in uterine flushings 
from pregnant gilts was similar to cyclic females on days 10 and 12 but there as a 5-fold 
increase on days 15 and 17 of pregnancy (595 and 541 pg, respectively).     
 
Endometrial IL-18 mRNA Expression in the Cyclic vs Pregnant Gilts 
PCR amplification for the IL-18 product (438 bp) indicated that IL-18 mRNA 
expression (Figure 3.4) is limited to the endometrium and not expressed by the 
conceptuses.  Relative endometrial IL-18 mRNA abundances appeared greater on day 18 
of pregnancy which is the period of placental attachment in the pig.  A day effect (P < 
0.05) was detected for RT-PCR endometrial IL-18 mRNA expression.  Endometrial IL-
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18 mRNA abundances were significantly greater on day 18 when compared to day 10 and 
day 12 (Figure 3.5). 
 
Uterine Luminal Content of IL-18 Protein in Cyclic vsPregnant Gilts 
Content of IL-18 in the uterine flushings of cyclic and pregnant gilts (Figure 3.6) 
exhibited a day by status interaction (P < 0.05).  Uterine luminal IL-18 content i gilts 
was similar between cyclic and pregnant gilts on days 10 and 12 but there was an 
approximate 5-fold increase in uterine luminal IL-18 on days 15 and 17 pregnancy 
compared to cyclic gilts.  The greatest amounts of IL-18 uterine luminal content occurred 
on day 15 and 17 of gestation (1,123 and 725 ng, respectively) were preceded by lowest 
IL-18 content on day 12 of pregnancy (28 ng).   
 
Experiment II: Early Exposure of Pregnant Gilts to Estrogen 
 
Conceptus development 
 Conceptuses were present in the uterine flushings collected from CO gilts acros
all days of pregnancy evaluated (day 10, 12, 13, 15, and 17).  Normal conceptuses were 
collected from E gilts on days 10, 12 and 13 of gestation.  However, conceptus tissues 


















Figure 3.1.  A significant day effect on relative mRNA units (mean ± SEM) was 
identified for conceptus caspase-1 (P<0.05).  Abundance of mRNA was calculated from 
the real-time PCR analysis as described in Methods and Materials. Relative mRNA 
abundance is presented as mean ± SEM.  Bars without a common superscript represent a 
statistical difference (P<0.05) between endometrium when comparing days12, 13, 14, 15, 



































































Figure 3.2.  A significant day by treatment interaction on relative mRNA units (mean ± 
SEM) was identified for endometrial caspase-1 (P<0.05).  Fold differences in endometrial 
caspase-1 mRNA expression of cyclic (yellow bar), and pregnant (blue bar) gilt using 
real-time quantitative PCR.  Abundance of mRNA was calculated from the real-time 
PCR analysis as described in Methods and Materials. Relative mRNA abundance is 
presented as mean ± SEM.  Bars without a common superscript represent a statistical 
difference (P<0.05) between cyclic versus pregnant endometrium comparing d ys 0, 5, 
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Figure 3.3  Relative amounts of total caspase-1 protein in uterine flushings from gilts on 
days 0, 5, 10, 12, 15 and 17 of the estrous cycle and days 10, 12, 15 and 17 of pregnancy 
(n = 4/day/status).  Total content of caspase-1 (pg) in uterine flushing of cyclic (yellow 
bars) and pregnant (blue bars) gilts. Relative optical density for each sample was 
corrected for total protein concentration in the sample based on Serum Alb in levels.  











































































Figure 3.4  PCR amplification for the in situ hybridization product (438 bp) indicated 
that IL-18 gene expression is limited to the maternal tissues (day 15 of estrous cycle and 
day 18 of pregnancy) and devoid of any IL-18 mRNA in the conceptus (day 14, 15, 16, 
and 17).  Endometrial IL-18 mRNA abundance was greatest on day 18 of pregnancy 
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Figure 3.5.  A significant day effect on relative mRNA units (mean ± SEM) was 
identified for endometrial IL-18 (P<0.05).  Fold differences in endometrial IL-18 gene 
expression of cyclic (yellow bar), and pregnant (blue bar) gilt us ng real-time quantitative 
PCR.  Abundance of mRNA was calculated from the real-time PCR analysis as described 
in Methods and Materials. Relative mRNA abundance is presented as mean ± SEM.  
Bars without a common superscript represent a statistical difference (P<0.05) between 
cyclic versus pregnant endometrium comparing days 0, 5, 10, 12, 15, and 18 of the 




































































Figure 3.6 A day x treatment interaction (P < 0.05) was observed for relativ  amounts of 
total IL-18 protein in uterine flushing collected from gilts on days 0, 5, 10, 12, 15 and 17 
of the estrous cycle and days 10, 12, 15 and 18 of pregnancy (n = 4/day/status).  Total 
content of IL-18 (pg) in uterine flushing of cyclic (yellow bars) and pregnant (blue bars) 
gilts.  Days 10, 12, 15, and 18 were statistically similar; however, during pregnancy IL-
18 protein in the uterine luminal fluid were significantly elevated on days 15 and 17 as 

























































Endometrial Caspase-1 mRNA Expression in the Endocrine Disrupted Gilts 
 A day by treatment interaction (P < 0.05) was detected for endometrial caspase-1 
mRNA abundance in E compared to CO gilts (Table 3.3).  Caspase-1 mRNA abundance 
was lowest in E and CO gilts on days 10 and 12. However, caspase-1 mRNA abundance 
was increased on days 15 and 17 of pregnancy. 
 
Uterine Luminal Content of Caspase-1 Content in E and CO Treated Gilts 
Content of caspase-1 protein in the uterine flushings of CO and E-treated gilts 
(Figure 3.8) exhibited a day by treatment interaction (P < 0.05).  Caspase-1 was elev ted 
in both CO and E-treated gilts on days 15 and 17 of pregnancy.  However, E-treated gilts 
exhibited a premature increase in uterine luminal caspase-1 content on day 13 (650 pg) 
when compared to day 13 CO gilts (50 pg).   
 
Endometrial Caspase-1in situ mRNA Localization in the Endocrine Disrupted Gilts 
In situ hybridization indicated that caspase-1 mRNA expression was localized 
mostly to the uterine surface and glandular epithelium on Day 13 of pregnancy in 
endometrium of E gilts (Figure 3.9).  Caspase-1 mRNA expression was localized to the 
uterine epithelium on day 13 of pregnancy in E gilts, and day 17 of CO gilts. 
 
Endometrial IL-18 mRNA Expression in the Endocrine Disrupted Gilts 
There were no transcriptional differences (P > 0.05) in IL-18 endometrial mRNA 
expression (Table 3.3) in response to the early E-treatment (Figure 3.10).  
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Uterine Luminal Content of IL-18 in E and CO Treated Gilts 
Content of IL-18 in the uterine flushings of CO and E treated pregnant gilts 
(Figure 3.11) exhibited a day by treatment interaction (P < 0.05).  Uterine luminal IL-18 
content in CO gilts increased on days 15 and 17 compared to day 13 (7500, 6000 and 
1300 pg, respectively).  Uterine luminal content of IL-18 in E gilts did not increase on 
days 15 and 17 as compared to their CO contemporaries resulting in 50% less 
concentrations of IL-18 on days 15 and 17. 
Discussion 
The periimplantation period (Days 10 to 15), and post-placental attachment and 
expansion (Days 18 to 40) have been shown to be the periods of greatest embryonic loss 
in the pig.  Pope et al. (1994) estimated 30% of conceptus death occurs in early gestation 
(Days 10-18).  In the pig, initial placentation occurs between days 13 and 18 of gestation 
(King et al., 1982) in which day 13 appears to be the crucial point at which attachment is 
initiated by the conceptus and the implantation cascade proceeds.  Placental attachment in 
the pig is a noninvasive epitheliochorial type placentation which involves the attachment 
of the trophoblast to a sticky glycocalyx located on the surface of uterine epithelial 
microvilli (Dantzer et al., 1985).  The glycocalyx may serve as an intermediate 
attachment substrate allowing the trophoblast to interdigitate with the uterine surface 




Table 3.3  Comparison of endometrial Caspase-1 and IL-18 mRNA expression across 
days of gestation following either early estrogen or corn oil administration to pregnant 
gilts using the comparative threshold (CT) method. 
                     Average 
        Average       18s      
Target   Status    Day Target CT
*       CT
*                  ∆CT




  Control 10 26.98 ± 0.81 18.46 ± 0.19 7.63 ± 0.47ab -0.77     
  Estrogen 10 26.62 ± 0.25 18.52 ± 0.19 7.46 ± 0.38ab -0.94 
  Control 12 25.39 ± 0.81 18.46 ± 0.19 6.95 ± 0.47bc -1.45     
  Estrogen 12 27.53 ± 0.25 18.52 ± 0.19 8.40 ± 0.38a  0.00 
  Control 13 26.25 ± 0.81 18.46 ± 0.19 7.62 ± 0.47ab -0.78     
  Estrogen 13 25.74 ± 0.25 18.52 ± 0.19 5.37 ± 0.38d -3.03 
  Control 15 23.62 ± 0.81 18.46 ± 0.19 4.87 ± 0.47d -3.53     
  Estrogen 15 25.14 ± 0.25 18.52 ± 0.19 5.79 ± 0.38cd -2.61     
  Control 17 23.57 ± 0.81 18.46 ± 0.19 5.27 ± 0.47d -3.13     




  Control 10 26.57 ± 0.81 18.46 ± 0.19 8.11 ± 0.47a  0.00     
  Estrogen 10 28.04 ± 0.25 18.52 ± 0.19 9.52 ± 0.38a -0.83 
  Control 12 26.79 ± 0.81 18.46 ± 0.19 8.33 ± 0.47a -0.34     
  Estrogen 12 31.08 ± 0.25 18.52 ± 0.19 12.56 ± 0.38a -0.83 
  Control 13 26.82 ± 0.81 18.46 ± 0.19 9.50 ± 0.47a -1.09     
  Estrogen 13 28.11 ± 0.25 18.52 ± 0.19 10.77 ± 0.38a -0.66 
  Control 15 26.17 ± 0.81 18.46 ± 0.19 9.50 ± 0.47a -1.74     
  Estrogen 15 27.47 ± 0.25 18.52 ± 0.19 10.77 ± 0.38a -1.23 
  Control 17 29.32 ± 0.81 18.46 ± 0.19 9.50 ± 0.47a -0.80     
  Estrogen 17 28.52 ± 0.25 18.52 ± 0.19 10.77 ± 0.38a -1.33 
 
CT
* = Cylic Threshold:  Cycle number where amplification crosses the threshold set in 
the geometric portion of the amplification curve. 
∆CT
† = Target (Caspase-1 and IL-18) – 18S Ribosomal CT:  Normalization of PCR 
cycles for the target with 18S ribosomal RNA.  Values with different superscript  for 
each of the target genes differ significantly (P<0.05) 
∆∆CT
§ = Mean ∆CT – highest mean ∆CT value:  The mean value of Day 5 cyclic (highest 
∆CT; lowest gene expression for caspase-1 and IL-18 genes) were used as a calibrator 
for caspase-1 and IL-18 to set the baseline for comparing differences in ∆CT values 
















Figure 3.7. A significant day by treatment interaction was observed on relativ  mRNA 
units (mean ± SEM) was identified for endometrial c spase-1 (P<0.05).  Fold differences 
in endometrial caspase-1 mRNA expression of control (orange bar), and early estrogen 
exposure (black bar) gilts using real-time quantitative PCR.  Abundance of mRNA was 
calculated from the real-time PCR analysis as described in Methods and Materials. 
Relative mRNA abundance is presented as mean ± SEM.  Bars without a common 
superscript represent a statistical difference (P<0.05) between control and estrogen 





























































Figure 3.8.  A day x treatment interaction (P < 0.05) was observed for relativ  amounts 
of total caspase-1 protein in uterine flushing collected from gilts on days 10, 12, 13, 15 
and 17 of pregnancy (orange bars) and early estrogen treated (black bars) gilts (n = 
4/day/treatment).  Days 10, 12, and 13 were statistically similar, however on day 13 
administration of early estrogen significantly elevated caspase-1 protein in the uterine 
luminal fluid from 50 pg (day 13 CO) to 650 pg (day 15 E).  Days 15 and 17 were similar 

















































































Figure 3.9. In situ hybridization analysis of caspase-1 mRNA expression in porcine 
endometrium during early pregnancy.  Protected transcripts in endometriu  from Days 
13 early estrogen exposure, and day 17 of control pregnancy were visualized by liquid 
emulsion autoradiography and imaged under bright-field and dark-field illumination.  
caspase-1 mRNA expression is abundant in the luminal epithelium (LE) and glandulr 




































Figure 3.10.  No significant main effects or interactions were observed on relative 
mRNA units (mean ± SEM) for endometrial IL-18 (P > 0.05).  Fold differences in 
endometrial IL-18 mRNA expression of control (orange bar), and early estrogen exposure 
(black bar) gilts using real-time quantitative PCR.  Abundance of mRNA was calculated 
from the real-time PCR analysis as described in Methods and Materials. Relative mRNA 
abundance is presented as mean ± SEM.  Bars without a common superscript represent a 
statistical difference (P<0.05) between control and estrogen treated endometrium 






















































Figure 3.11.  A day x treatment interaction (P < 0.05) was observed for relativ  amounts 
of total IL-18 protein in uterine flushing collected from gilts on days 10, 12, 13, 15 and 
17 of pregnancy (orange bars) and early estrogen treated (black ars) gilts (n = 
4/day/treatment).  Days 10, 12, and 13 were statistically similar, however on days 15 and 
17 the early estrogen significantly decreased the amount of IL-18 protein in the uterine 
























































 Between days 11 to 12 of gestation the porcine conceptuses will begin to 
synthesize and secrete estrogen into the uterine lumen signaling maternal recognition and 
establishment of pregnancy (Bazer and Thatcher, 1977).  If the pregnant pig receives 
estrogen stimulation prematurely, days 9 and 10 instead of days 11 to 12, complete 
embryonic mortality will occur by day 30 of gestation (Pope et al., 1986).  Furthermore, 
other research (Morgan et al., 1987, Gries et al., 1989) has indicated that premature 
estrogen stimulation initiates conceptus mortality between days 14-18 of gestation.  Since 
days 14-18 of gestation is the time frame that trophoblast attachment occurs, one may 
attribute the conceptus degeneration to attachment failure.  Ultrastructure changes in the 
glycocalyx were documented by Blair et al. (1991), confirming that earlyxogenous 
administration of estrogen prior to the normal release by the developing conceptuses 
obliterated the glycocalyx covering on the uterine surface microvilli, eliminating the 
attachment substrate for the conceptus.   
Recently, our lab has discovered the expression of the immune modulator, 
chemokine ligand 9 (CXCL9) in the endometrium using microarray technology 
(Ashworth, Geisert and White unpublished results).  Moreover, increases in mRNA 
abundance for this chemokine is temporally expressed during the window of implantation 
in the pig, and is increases 8-fold from day 13 to day 15 of gestation.   Recently, Coma et 
al. (2006) demonstrated IL-18’s ability to induce an increase from basal levels of CXCL9 
expression by 10-fold in human macrophages, and a synergistic 50-fold in the presence of 
both IL-18 and IL-12.  Data from the fore mentioned study’s would be congruent with the 
appearance of IL-18 in the present study, which would make IL-18 a plausible candidate 
for induction of CXCL9.   
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Ross et al. (2003) demonstrated that the periimplantation porcine conceptuses 
secrete large amounts of IL-1β into the uterine lumen during the transition to the 
filamentous morphology (Day 12-15), which rapidly decreases to nadir levels by Day 18 
of gestation.  IL-18 may be an attractive cytokine to compensate for the declining levels 
in IL-1β.  IL-18 is also known as interferon inducing factor due to its ability to induce 
interferon gamma (IFN-γ).  In the elongating porcine conceptuses on day 12, IFN-γ has 
been observed to increase followed by substantial increase during day 15 of gestation, 
which may be attributed to the release of IL-18 from the endometrium.  Moreover, Joyce 
et al. (2006) demonstrated that greatest levels of IFN-γ occur from the trophoblast during 
days 15 through 18 of the porcine pregnancy, which is clearly complimentary to IL-18 
increase during days 15 through 18 of pregnancy in our study.  Both the mRNA and 
protein expression patterns observed in caspase-1are temporally aligned for the proper 
processing of both IL-1β and IL-18 during early pregnancy in the pig.  Conceptus 
caspase-1 mRNA expression is greatest in abundance during days 13 and 17.  
Furthermore, endometrial caspase-1mRNA expression was markedly elevated during 
days 15 and 17 of pregnancy.  These data would infer IL-1β processing by caspase-
1during liberation from conceptus during the initial release of IL-1β around day 12 of 
pregnancy is of conceptus origin since there is an absence of caspase-1 protein found n 
the uterine luminal flushings.  Additionally, the increased expression of caspase-1 mRNA 
observed in the endometrium which mirrors the elevation of caspase-1 protein in uterine 
flushings would be consistent with the increase observed secretion of IL-18 during days 
15 to 18 of pregnancy.  Given these data, we have clearly established evidence for 
cytokine crosstalk between the developing conceptuses and endometrium based on gene 
83 
expression of IL-18 exclusively expressed in endometrium, while completely devoid in 
all days of conceptus during early pregnancy. 
Exposure of pregnant gilts to exogenous estrogen 48 h prior to the normal 
appearance of estrogen by the conceptuses on day 12, results in embryonic mortality 
before day 30 of gestation (Pope et al., 1986).  Our lab previously demonstrated that 
conceptuses degenerated between Days 15 to 18 of gestation following early estrogen 
treatment on days 9 and 10 of pregnancy (Morgan et al., 1987).  Conceptus degeneration 
was correlated with the spaciotemporal loss of the microvilli glycocalyx on the 
endometrial surface epithelium (Blair, et al., 1991).  Although the exactly mechanism by 
which this mortality occurs has yet to be elucidated, the present study was designe  to 
characterize uterine changes in caspase-1 and IL-18, and investigate their assoc ation 
with endocrine disruption in the pregnant gilt and its effects on uterine-conceptus 
attachment and development.   
Following endocrine disruption of the pregnant gilts, we observed marked 
changes in both IL-18 and caspase-1 mRNA and protein expression due to the early 
exposure to estrogen.  Endometrial IL-18 expression was unaffected at the transcriptio al 
level; however the actual secretion of the active IL-18 protein was significantly 
suppressed on days 15 and 17 of pregnancy in gilts exposed prematurely to estrogen.  At 
first analysis these data appear confounding; however, these observed translational 
changes may be due in part to a role played through regulatory RNA’s.  Therefore, the 
levels of decreased IL-18 protein observed in uterine flushings of early estrog n exposed 
endometrium may serve as a source of dysfunction during conceptus attachment.  
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Moreover, in the mouse, decreased levels of IL-18 at the embryo-maternal interf ce have 
been shown to be supportive of recurrent spontaneous abortions (Muranaka et al. 1998). 
Following early estrogen exposure, an increase in caspase-1 mRNA and protein 
was observed prematurely on day 13 of pregnancy.  Thus, this would be consistent with 
other studies previously conducted in our lab demonstrating a 48 h advancement in 
various uterine markers (IGF-I, -II, and COX-1, -2) within the implantation window 
(Ashworth et al., 2005, 2006).  Caspase-1was expressed maximally in the uterine luminal
fluid during day 13 of pregnancy in estrogen treated gilts.  Ashworth et al., (2005) 
demonstrated that early estrogen exposure to pregnant gilts resulted in an early 
proteolysis of the IGFBP’s (-II, and -III) which caused IGF-I, -II ligands to disassociate 
from its respective binding proteins resulting in a disappearance 48 h earlier than normal.  
Furthermore, this premature vanishing of IGF ligands may account for the early el vation 
observed in caspase-1 given the apoptosis suppressive effects of the IGF ligands (Jung et
al., 1996). 
The current study has clearly demonstrated that the pregnant gilt expresses 
caspase-1 in conceptus and endometrial tissues, and they are temporally associated with 
the window of implantation based on appearance.  Additionally, the current study also 
demonstrated that the early porcine pregnant endometrium expresses IL-18 exclusively 
suggesting a crosstalk system between IL-18 endometrial origin and IFN-γ predominantly 
conceptus origin (Joyce et al., 2005).  Furthermore, the current study also demonstrated 
that early estrogen exposure to pregnant gilts resulted in a dysfunction in caspase-1 and 




ENDOCRINE DISRUPTION OF ENDOMETRIAL GENE 
EXPRESSION DURING THE PERIOD OF NORMAL CONCEPTUS 
ATTACHMENT USING THE PIG PSUEDOPREGNANT MODEL 
 
Abstract 
Synchronization of conceptus crosstalk with endometrial development is 
imperative for successful establishment of pregnancy in the pig.  However, 
administration of estrogen earlier than normal conceptus secretion on day 12 of 
pregnancy in the pig is characterized by complete embryonic mortality by day 15.  The 
objective of this study was to characterize the direct effects of early estrog n 
administration on endometrial gene expression during the period of conceptus attachment 
(Days 13-15).   To isolate the direct effects of early estrogen administration on 
endometrial gene expression, the effects of conceptus secretions were remov d by 
utilizing the established pig pseudopregnant model.  The study evaluated the effects of 
estrogen when administered on days 9 and 10 (E9) of the estrous cycle (endocrine 
disruption of pregnancy) or day 11.5 (E11.5) which is the normal period of conceptus 
estrogen secretion.  Endometrial gene expression was evaluated using the GeneChip® 
Porcine Genome Array.  In all, different probe sets were statistically different between at 
least one comparison (D13 E9 vs. D15 E9, D13 E11.5 vs D15 E11.5).  When restricted to 
day D13 E9 vs. D15 E9 comparison 55 genes were statistically different with greater than 
1.7-fold change in expression.  Utilization of k-means clustering, in addition to the 
Database for Annotation, Visualization, and Integrated Discovery (DAVID) identified 
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genes of interest.  Quantitative RT-PCR expression profiles for chemokine liga d 11 
(CXCL-11), chemokine ligand 9 (CXCL-9), guanylate binding protein 1 (GBP1), CD 
163, and CD 18 were supportive of the GeneChip® Porcine Genome Array data.  These 
data provide insight into global uterine transcriptional changes associated w th endocrine 
disruption of the endometrium that are likely fundamentals for the proper establishment 
of pregnancy in the pig devoid of any conceptus effects.   
 
Introduction 
Early pregnancy loss is a major cause of human infertility with reports indicating 
25-31% of women losing their pregnancy during the peri-implantation period (Wilcox et 
al. 1999).  Since implantation is limited to a short and restricted time period, succes ful 
establishment of pregnancy in mammals requires precise communication and synchron  
between the developing conceptus and uterine environment.  The window of implantation 
can be defined as a remodeling of cell surface molecules allowing a close re ationship of 
the conceptus and uterine surface epithelium (Denker, 1993; Glasser and Mulholland, 
1993), which establishes of a specific cytokine environment with which the uterus 
promotes conceptus attachment and placenta development (Kliman, 2000).  During early 
pregnancy in the pig, the peri-implantation period is one of the most critical stages of 
conceptus development.  After ovulation and fertilization, prenatal mortality in thepig 
ranges from 20% to 46% by term (Pope, 1994) with the majority of the loss occurring 
during the peri-implantation stage of development between days 12 to 18 of gestation 
(Stroband and Van der Lende, 1990).  Estrogen synthesis and secretion by the 
conceptuses occurs in a biphasic pattern with an acute intermediate peak on day 12 of 
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gestation followed by a second chronic sustained release of estrogen from days 15 to 28 
of gestation (Geisert et al., 1990).  Incompatibility between the developing conceptus and 
the rapidly changing uterine environment can result in a major constraint to conceptus 
survival.  Asynchrony greater than 24 h between potentially viable conceptuses and the 
uterine environment has been demonstrated to cause conceptus death as early as day 8 of 
gestation (Polge, 1982; Geisert et al., 1991).  
Exposure to estrogen through clinical treatment or endocrine disruptor chemicals 
contributes to human and animal infertility.  Low pregnancy rates are evid nt in women 
following the use of various IVF/ET protocols.  Reduced fertility maybe attribu ed to 
secretion of increased physiological levels of estrogen resulting from ovarian hyper-
stimulation altering the window of uterine receptivity which affect conceptus attachment 
to the uterine surface.  Consequences of asynchronous timing for uterine stimulation by 
estrogen raises concern for reproductive success of humans and animals subjected to 
environmental estrogens, which can function as endocrine disruptors (Cummings, 1997; 
Mendes, 2002; Caserta et al., 2008).   
Pope et al. (1986) demonstrated that administration of estradiol-17β (8 mg/day) 
on days 9 and 10 of pregnancy resulted in complete embryonic mortality by day 30 of 
gestation.  Morgan et al. (1987) indicated that pregnant gilts exposed to estrogen on days 
9 and 10 of pregnancy resulted in the fragmentation and degeneration of conceptuses on 
day 16 of gestation.  On days 14 to 16 of gestation, Gries et al. (1989) observed 
alterations in uterine protein content in the flushings of gilts receiving early xposure to 
estrogen.  Embryonic death due to early estrogen exposure is highly correlated to a 
complete breakdown in the uterine glycocalyx occurring approximately day 14 of 
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gestation (Blair et al., 1991).  Additionally, early estrogen exposure has been show to 
shift the implantation window for the appearance of several growth factors  by 24 to 48 h 
such as the case with uterine secretion of insulin-like growth factor I (IGF-I) and -II,  and 
their binding proteins (Ashworth et al., 2005).  Furthermore, Ross et al., (2007) 
demonstrated that early exogenous estrogen administered to pregnant gilts o days 9 and 
10 of pregnancy altered the timing for 77 endometrial expressed genes between the days 
of 10, 13 and 15 of pregnancy.  These data indicate that early estrogen exposure acts as 
an endocrine disrupter through alterations in the timing of the implantation window and 
endometrial transcriptome at the level of the extracellular matrix around the time of 
placental attachment to the uterine epithelial surface.   
Currently, limited information is available in regards to global gene expression 
responsible for dysfunctional endometrial transcriptional and translational expression 
with estrogen in the absence of conceptuses in the pig.  The current objective utilizes the 
GeneChip® Porcine Genome Array from Affymetrix ® representing approximately 
20,201 genes to identify differentially expressed endometrial genes involved during 
endocrine disruption following early estrogen administration to cyclic pigs.  Treatment of 
gilts with estrogen, the maternal recognition signal in the pig, on day 11.5 extends lif  
span of the corpora lutea which is useful as a psuedopregnant model to isolate the direct 
effects of estrogen on endometrial function.  Identification and characterization of 
endometrial gene expression patterns during endocrine disruption using the 
psuedopregnant pig model will provide a better understanding of the events associated 
with dysfunction of the endometrium but in the unique absence of conceptus 
development or secretions 
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Materials and Methods 
Animals 
Research was conducted in accordance with the Guiding Principles for Care and 
Use of Animals promoted by the Society for the Study of Reproduction and approved by 
the Oklahoma State Institutional Care and Use Committee.  Crossbred cycling gilts of 
similar age (8-10 mo) and weight (100-130 Kg) were checked twice daily for estrus 
behavior (estrus onset = Day 0 of estrous cycle) with intact males.   
 
Experimental Design  
 
  Cycling gilts were randomly assigned one of the following treatment groups: 1) 
Estrogen treatment on day 11.5 (E11.5), gilts (n = 7) received an 2.5 mg i.m. injection of 
estradiol cypionate (A.J. Legere, Scottsdale, AZ) on day 11.5 of the estrous cycle or 2) 
Estrogen treatment on days 9 and 10 (E9), gilts (n = 7) were administered 2.5 mg i.m.
injection of estradiol cypionate on days 9 and 10 of the estrous cycle (E9).  Following 
induction of anaesthesia with 1.8 ml im administration of a cocktail consisting of 2.5 ml 
(Xylazine: 100mg/ml: Miles Inc., Shawnee Mission, KS) and 2.5 ml Vetamine (Ketamine 
HCl: 100 mg/ml Molli Krodt Veterinary, Mundelein, IL) in 500 mg of Telazol 
(Tiletamine HCl and Zolazepum HCl: Fort Dodge, Syracuse, NE), anesthesia was 
maintained with a closed circuit system of halothane (5% flurothane) and oxygen (1.0 
liters/min).  The uterus was exposed via midventral laparotomy and a randomly selected 
uterine horn, and its ipsilateral ovary, excised.  Uterine horns were injected with 20 mL 
phosphate buffered saline (PBS, pH 7.4) via the isthmus and flushings were recovered in 
a petri dish.  Uterine flushings were centrifuged (1000 x g, 10 min, 4°C), supernant 
collected and uterine flushings were stored at -20°C.  Endometrial tissue was removed 
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from the antimesometrial side of the uterine horn, immediately snap frozen in liquid 
nitrogen and stored in at-80°C until RNA extraction. 
 
Tissue Collection and Fixation 
Uterine horns were flushed with 20 ml PBS, flushings were centrifuged to remove 
cellular debris, and the superatnant stored at -20°C.  Endomterial tissue was harvested 




Total RNA was extracted from endometrial tissue using TRIzol reagent 
(Invitrogen, Inc).  Approximately 0.5 g of endometrial tissue was homogenized in 5.0 mL 
of TRIzol using a Virtishear homogenizer (Virtis Company Inc., Gardiner, NY).  RNA 
was resuspended in nuclease free water and stored at -80°C.  Total RNA was quantified 
with a spectrophotometer at an absorbance of 260 nm and purity was verified using the 
260/280 ratio.   
 
Microarray Analysis 
Affymetrix Porcine Chip 
The GeneChip® Porcine Genome Array (Affymetrix, Santa Clara, CA) contains 
23,937 probe sets interrogating 23,256 transcripts, representing 20,201 genes.  Four chips 
were used for each day and estrogen treatment of uterine endometrium for either: E11.5 
(Day 13 and 15) or endocrine disrupted E9 (Day 13 and 15).  RNA utilized for each chip 
represented a set of endometrial total RNA for the respective day or estrogen treatment.  
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Prior to target labeling, RNA was further purified (RNeasy MinElute Cleanup, Qiagen, 
Valencia, CA).  Target labeling, GeneChip® hybridization, scanning and quantitation 
were conducted by The University of Tulsa Microarray Core Facility.   Affymetrix 
GeneChip Operating Software (GCOS version 1.1.1, Affymetrix, Santa Clara, CA) was 
used to quantitate each GeneChip®.  The summary intensities for each probe were loaded 
into DNA-Chip Analyzer (dChip), version 1.3 for normalization, standardization, and 
analysis. 
 
Normalization and Standardization  
For normalization, dChip’s method of invariant set normalization in which the 
chip with the median intensity value was used as the baseline against which the 
brightness of the remaining chips were adjusted in order to be of a comparable level.  To 
reduce variance of expression level estimates by accounting for probe differ nces, 
standardization was conducted by calculating model-based expression indices (MBEI) 
using dChip’s Perfect-Match (PM)-only model.   
 
Log Transformation and Statistical Analysis 
The MBEI were log base 2 transformed to approximate a normal distribution for 
each gene and provide measures by which to conduct the statistical analysis.  Unpaired t-
tests were calculated using dChip to evaluate differences between two groups.  Analysis 
of gene expression was done to compare expression changes between E9 and E11.5 
endometrium utilized in the study.  The false discovery rate (FDR) utilized to res rict the 
list of candidate genes was a P value less than 0.001 as determined by the unpaired t-test 
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and a numerical change in expression of at least 1.7-fold for each endometrial 
comparison evaluated.   
 
GeneChip® Porcine Genome Array Re-annotation 
The annotation was updated by utilizing the provided sequence from Affymetrix 
that was utilized in probe development.  Through the utilization of BLAST [Altschul et 
al., 1990], a human accession number, based on homology, was assigned to each 
Affymetrix ID already correlated to each probe on the chip.  The assignment of a human 
accession number allowed a more complete analysis of the biological processes b ing 
regulated during this endocrine disrupted psuedopregnancy, by enabling the more 
effective use of software such as the Database for Annotation, Visualization and 
Integrated Discovery (DAVID). 
 
Clustering Analysis 
All genes determined to be significantly different based on the p-value less than 
0.001 indicated for all comparisons between day and estrogen treatment of uterine 
endometrium. Genes (n = 117) were utilized for analysis in TIGR MeV v4.3.  We chose 
to sort the 117 genes that were both statistically (P< 0.001) and numerically (± 1.7-fold 
change) different into 7 clusters.  The 7 clusters were identified using the k-means 
learning algorithm following 1000 replications. 
 
Database for Annotation, Visualization and Integrated Discovery 
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Database for Annotation, Visualization and Integrated Discovery (DAVID) 
version 2.0 (http://david.niaid.nih.gov/david/version2/index.htm) is a program that 
enables the utilization of microarray gene lists to generate specific functional annotations 
of the biological processes affected by the treatment as determined through microarray 
experiments [Glynn et al., 2003].  DAVID was utilized to annotate biological themes 
occurring during the E9 day 13 vs E9 day 15 based on the most differential gene 
expression for this study occurring at this time.  During early porcine pregnancy, initial 
conceptus-uterine attachment occurs between days 13 to 15 of pregnancy and is the 
period that early estrogen administration disrupts conceptus development.  All genes 
identified to be both significantly different (P < 0.001) and biologically different (± 1.7-
fold change) for the D13 E11.5 vs. D15 E9 comparisons, and successfully assigned a 
human accession number, were used in the analysis via DAVID.  Utilizing gene ontology 
(GO) terms as identified through biological process, cellular component and molecular 
function; as well as protein domain, and biochemical pathway membership; biological 
themes were generated by grouping like terms thereby creating annotatio  clusters 
associated with each developmental transition.   
 
Identification and Analysis of Network and Canonical Pathways 
Gene expression significantly up regulated by estrogen at FDR<10% were 
analyzed using software from the Ingenuity Pathway Analysis (IPA) systems, version 4.0 
(Ingenuity Systems, Redwood City, CA).  Human annotation that was derived from the 
Affymetrix® Porcine generated gene annotation list compiled from DAVID and was used 
for the IPA analysis of related networks and conical pathways.  As previously discussed 
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in the DAVID analysis, only the D13 E9 vs D15 E9 gene list comparison was used as 
input data in the IPA software.  Each gene identifier to its corresponding gene objct in 
the Ingenuity Pathways Knowledge Base.  These genes of specific focus were placed on a 
global template of molecular networks that have been developed from comprehensive 
information contained in the vast IPA database.  Individual networks were generated 
based on the themes and relative connectivity of the focus genes inputted.  A numerical 
score based on network ranking and gene relevancy is generated in order to rank multiple 
networks within the inputted data set.  IPA uses a right-tailed Fisher’s Exact Test to 
calculate the P-value for the networks.  This generated P-value is indicative of the chance 
that a gene listed in the network is there based on chance.  Genes and or gene products 
are represented in the networks as nodes, and the line connecting them represents a 
biological relationship.  The nodes are colored coded as red and green (up and down 
respectfully) with intensity of color indicating magnitude of direction.   
 The most significant canonical pathways from our study were identified using the 
global template from the IPA library of canonical pathways database.  Significance of the 
association between our input data set and the canonically derived pathways were 
determined based on two parameters: 1) A ratio of the number of genes from the data set
that map to the pathway divided by the total number of genes that map to the canonical 
pathway, and 2) A calculated P-value using fisher’s exact test determining the probability 
that the association between the focus genes in the data set and the canonical pathway is 
due to chance alone. 
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Quantitative One-Step RT-PCR 
Quantitative RT-PCR analysis of transcripts of interest was conducted as 
previously described by our laboratory (Ashworth et al., 2006).  RNA from endometrium 
were utilized for Affymetrix analysis and were aliquoted to be used for PCR analysis.  
Genomic DNA removal and the synthesis of cDNA to be used for quantitative analysis 
were done using the QuantiTect Reverse Transcription kit according to manufacturer’s 
recommendations (Qiagen, Valencia, CA).  Briefly, 0.8 µg of each uterine tissue (n = 4 
gilts /day/trt) were added to a genomic DNA wipeout buffer for 5 min at 37oC, followed 
by a 2 min incubation on ice, then proceeding to the addition of reverse transcription 
buffer, RT primer mix and reverse transcriptase; and incubated at 42oC for 30 min.  
Individual endometrial samples were taken at days 13 and 15 from the E 11.5 gilts and 
E9 gilts (D13 E11.5, D15 E11.5, D13 E9, D15 E9).  The PCR amplification was 
conducted using the Bio-Rad icycler Sequence Detection Systems (Bio-rad Systems).  
The real-time detection during each amplification cycle was done by using a pecific 
sequence nested between the forward and reverse specific primers of the intercalating 
dye, SYBR green.  All primers utilized for quantitative analysis for each trge  gene are 
presented in Table 4.1.  One hundred nanograms of synthesized cDNA were assayed for 
each sample in duplicate.  Thermal cycling conditions for SYBR green detection were 
50oC for 30 min and 95oC for 15 min, followed by 40 repetitive cycles of 95 for 15oC sec 
and variable annealing temperature for 30 sec, 72oC for 33 sec and a variable temperature 
during fluorescent detection for 33 sec.  Fluorescence detection temperature was 
determined by evaluating melting curve analysis for the samples and the no template 
control amplification plot.  Detection temperatures were set at a temperature when the 
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intended target was the only contributing factor to fluorescence.  18S ribosomal RNA 
was assayed as a normalization control to correct for loading discrepancies.  Following 
RT-PCR, quantitation of gene amplification was made by determining the cycle threshold 
(CT) based on the fluorescence detected within the geometric region of the semilog view 
of the amplification plot.   Relative quantitation of target gene expression was evaluated 
using the comparative CT method as previously described (Hettinger et al. 2001; 
Ashworth et al., 2006).  The ∆CT value was determined by subtracting the target CT of 
each sample from its respective ribosomal 18S CT value.  Calculation of ∆∆CT involves 
using the single greatest sample ∆CT value (the sample with the lowest expression) as an 
arbitrary constant to subtract from all other sample ∆CT values.  Relative mRNA units for 
each sample were calculated assuming an amplification efficiency of 2 during the 
geometric region of amplification, and applying the equation, 2∆∆Ct.  Relative units in 
figures 4.1a-4.1e are presented as mean ± SEM.  To compare the expression patterns 
determined through QT-RT-PCR with that determined  
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Table 4.1  Primer and probe sequence information for the quantitative amplification of each target gene. 
 
aThe Affymetrix ID refers to the ID given by Affymetrix for which te probe set was designed. 
bThe target gene name was determined through manual annotation of the EST sequence used by Affymetrix during the generation of 
the probe set. 
cForward and reverse primers for each target gene.  The forward primer sequence is above the reverse for each target gene.  Forward 
and reverse do not necessarily indicate the in vivo direction of transcription. 
dThe intercalating dye, SYBR Green, was used to measure amount of amplified target during each cycle of quantitative RT-PCR.   
eAmplicon size refers to the product size of the amplified PCR product. 























CD18 (Integrin B2) 





using microarray analysis, the mean relative mRNA units determined for each g ne were 
divided by the mean relative mRNA units to produce fold differences presented in Table 
4.2 
Quantitation and Statistical Analysis 
Normalized QT-RT-PCR ∆CT values were analyzed using the PROC MIXED of 
the Statistical Analysis System.  The statistical model used in the analysis tested the fixed 
effect of estrogen on endometrial gene expression (D13 E11.5, D15 E11.5 and D13 E9, 
D15 E9).  Separation of the means was completed using the PDIFF function in SAS.  
Significance (P < 0.05) was determined by probability differences of least squares means 





Chips with more than 5% of probe sets flagged as array outliers are of suspect 
quality.  dChip did not flag any of the arrays as an outlier (when fitted expression for the 
entire probe set has a standard error greater than 3 standard deviations from the mean 
when compared to the other chips).  Accordingly, no tissue was re-hybridized to a new 
array nor was any array dropped from analysis.  Single outliers are lone probes of unusual 
intensity within a chip.  In this set of samples, outlier percentages ranged from 0.02% to 
0.30%.  Single outliers were treated as missing values in subsequent analyses.  The 
percentage of genes called “present” by the GCOS software ranged from 65.49% to 
70.37%.  Table 4.3 lists the intensities, presence call percentages, and outlier percentag s 












Detection Call %c Single Outlier %d 
13 PPa, Chip 1 291 69.90 0.02 
13 PPb, Chip 2 237 71.96 0.02 
13PPc, Chip 3 282 70.83 0.04 
13PPd, Chip 4 238 69.51 0.05 
15PPa, Chip 5 159 68.48 0.04 
15PPb, Chip 6 375 70.38 0.03 
15PPc, Chip 7 238 69.49 0.01 
13PPEa, Chip 8 254 71.05 0.04 
13PPEb, Chip 9 207 67.40 0.09 
13PPEc, Chip 10 271 70.93 0.02 
13PPEd, Chip 11 282 70.10 0.05 
15PPEa, Chip 12 307 70.93 0.10 
15PPEb, Chip 13 330 70.10 0.04 
15PPEc, Chip 14 260 69.80 0.01 
aEach endometrium and status of endometrium was hybridized to three or four chips. 
bUnnormalized median target intensity for each chip.  Prior to analysis in dChip, intensity 
for each chip was normalized by adjusting the brightness of each chip to be comparable 
to the median intensity; Day 14, Chip 16. 
cDetection call percentage refers to the percentage of targets that were identified present 
for each chip. 
dColumn represents the percentage of individual outliers for each chip.  Five percent or 
greater of individual probe set outliers would indicate an array of poor quality
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When the results from the four comparisons were combined, there were 117 
altered probe sets of which 55 remained after deleting those with an “absent” detc ion 
call across all chips in all comparison groups.  Of the 55 genes differentially expressed, 
D13 E9 compared to D15 E9 was comprised of 26 genes that were up regulated due to 
the estrogen treatment.  Conversely, 18 genes displayed down regulated expression when 
comparing the D13 E9 versus the D15 E9.  D15 E11.5 compared to D15 E9 produced 11 
unique genes, however only 2 were statistically significant (1 up and 1 down regulated).  
D13 E11.5 compared to D13 E9 produced 8 differentially expressed genes; all genes for 
this comparison were up regulated.  Lastly, D13 E11.5 compared to D15 E11.5 contained 
only 1 gene differentially expressed which was up regulated.   When the results were 
restricted to unique GenBank Accession numbers, 40 were found to differ significantly n 
their expression in one or more of the four comparisons.  The number of statistically and 
biologically different genes for each comparison between E11.5 and disrupted E9 are 
present in Table 4.4.  
 
Database for Analysis, Visualization and Integrated Discovery 
Utilization of DAVID resulted in the discovery of 5 functional annotation clusters 
representing biological systems affected by the administration of exogenous estrogen on 
days 9 and 10 of pregnancy (Table 4.5).  General functional terms and process involved 
include: regulation of immune response and response to stimuli, leukocyte activation and 















aRepresents the morphological comparison for each row. 
bNumber of genes with a unique identity based on the accession number utilized for the crea ion  
cNumber of unique genes that have at least a 1.7-fold difference in mRNA abundance between the 
E115.5 and E9. 
dNumber of genes increasing or decreasing in mRNA abundance for a given comparis n.  
Comparisona N unique 
Genesb 
N unique, ≥ 1.7-
Fold Differencec 
N unique, ↑ ≥ 1.7-
Fold Differenced  
N unique, ↓ ≥ 1.7-
Fold Differenced  
D13 E11.5  vs D13 E9  19 8 8 0 
D13 E11.5 vs D15 E11.5     4 1 0 1 
D15 E11.5 vs D15 E9           11 2 1 1 




Table 4.5. Functional annotation clusters of biological terms representing processes 





Scoreb Biological Termsc 
1 4.37 Immune response (8), immune system process (8), response to stimulus 
(9) 
2 1.16 Leukocyte activation (3), cell activation (3), multicellular organismal 
process (6), localization (4),  
3 1.06 Signal transduction (8), cell communication (8), cellular process (11) 
4 0.83 System development (5), anatomical structure dev lopment (5), 
multicellular organismal development (5), multicellular organismal 
process (6), developmental process (5), organ development (3) 
5 0.60 Establishment of protein localization (3), protein localization 
(3),macromolecule localization (3), localization (4), establishment of 
localization (3) 
 
aFive most significant annotation clusters identified based on the gene list submi ted for 
analysis through DAVID. 
bEnrichment score is determined through DAVID and ranks the significance of each 
annotation cluster based on the relatedness of the terms and the genes associated with 
them. 
cColumn represents terms in the annotation clusters.  The gene ontology (GO) terms were 
gathered based on the known annotation of the submitted genes with respect to 




 The 7 clusters generated utilizing the K-means clustering algorithm were 
distinguishable by their expression patterns (Figure 4.2 a,b,c,d,e,f, and g,) and 
represented the 117 genes that were determined to meet the FDR threshold for one or 
more of the comparisons between the days and endocrine disrupted status.  The smallest 
cluster contained 1 gene while the largest contained 46 genes.  The mean cluster size was 
nearly 16 genes; however, the median cluster size was 2 genes suggesting that most of the 
clusters represented normal distribution and also unique expression patterns and a few 
larger clusters represented general trends (Figure 4.2 h, and c).  The affym trix ID, 
associated human GenBank accession number, putative identity for each gene and 
expression profile is listed for each gene that was significantly (P < 0.001) and 
biologically different (> 1.7-fold change) between any day and estrogen status of 
endometrium are listed in association with their k-means cluster in the Appendix. 
 
Conical Signaling Pathway Analysis 
Figure 4.3 list the top 12 conical pathways regulated by estrogen in the early 
estrogen exposed gilts.  The top five signaling pathways based on their significance (P ≤ 
0.05) included: antigen presentation pathway, role of NFAT in regulation of the immune 
response, IL-4 signaling pathway, CTLA4 signaling in cytotoxic T-lymphocytes, and 













Figure 4.1 a-h.  Seven clusters were generated using the k-means clustering algorithm to 
associate genes with similar expression patterns for the endocrine disruption caused by 
early estrogen exposure.  117 genes were determine to be significant and biologically 
different between at least one of the comparisons of treatment or day produced a mean






    


















































Figure 4.2. Top pathways regulated by estrogen based on their significance (p-value) 
calculated using the right tailed Fisher’s Exact Test using the complete comparison of 






















Using data analysis from early estrogen exposed endometrium on day 13 vs day 
15, a total of 5 networks were linked to an estrogen response (Figures 4.4).  These 
networks had an IPA score of: 28, 8, 3, 2, and 2 respectively.  These scores represent a 
numerical value of approximate fit for each network and determine focus genes based on 
relativity to the input data set.  The network data we obtained allows us to prioritize and 
fuel new directions based on some of these “key” molecules identified as central hubs in 
these networks. 
 
Networks 1, 2, 3 
 Network one consisted of 11 focus molecules which contained CXCL-11 as the 
major hub in this network (Figure 4.5a).  This network contained the associated function 
to include antigen presentation, cell mediated immune response, and humoral immune 
responses.  Network 2 consisted of 4 focus genes and an IPA score of 8 (Figure 4.5b).  
The genes in this network have ascribed functions such as cell death, hematological 
disease, and immunological disease.  Network 3 consisted of 1 focus genes and an IPA 
score of 3 (Figure 4.5c).  The genes in this network have ascribed functions such as 
cancer, cardiovascular disease, cardiovascular system development and function. 
 
Antigen Presentation Pathway Network 
 Antigen presentation pathway network (Figure 4.6) involved the up regulation of 
transporter 1, ATP-binding cassette, sub-family B (TAP I) expression for movement of 











Figure 4.3a.  Network 1 regulated by estrogen centered around CXCL-11.  This network 
contained a set of focus genes (11) with a score of 28.  The probability of a gene being 
there by chance would be 10-28.  The score is not an indication of the quality or 
significance of the network.  Node (gene) and connecting lines (gene relationship) are 
described in the methods and materials section.  The intensity of the color [red (up) and 
green (down)] of the nodes would be indicative of the magnitude of direction involved in 



















Figure 4.3b.  Network 2 regulated by estrogen centered around IFN-γ.  This network 
contained the maximum amount of focus genes (4) with a score of 8.  The probability of a 
gene being there by chance would be 10-8.  The score is not an indication of the quality or 
significance of the network.  Node (gene) and connecting lines (gene relationship) are 
described in the methods and materials section.  The intensity of the color [red (up) and 
green (down)] of the nodes would be indicative of the magnitude of direction involved in 





















Figure 4.3c.  Network 3 regulated by estrogen centered around HSPG2.  This network 
contained the maximum amount of focus genes (1) with a score of 2.  The probability of a 
gene being there by chance would be 10-2.  The score is not an indication of the quality or 
significance of the network.  Node (gene) and connecting lines (gene relationship) are 
described in the methods and materials section.  The intensity of the color [red (up) and 
green (down)] of the nodes would be indicative of the magnitude of direction involved in 




















Figure 4.4. Signaling Antigen Presentation Pathway regulated by estrogen centered on 
the MHC II pathway.  Node (gene) and connecting lines (gene relationship) are desc ibed 
in the methods and materials section.  The intensity of the color [red (up) and green 
(down)] of the nodes would be indicative of the magnitude of direction involved in the 








II α and β molecules are up regulated in this pathway as well involving extracellular 
antigen presentation.  Moreover, all the antigen presentation pathways involved in this 
signaling network due to premature exposure to exogenous estrogen all supported 
presentation to CD4+ Cytotoxic T-Cells through up regulation of MHC II 
 
Quantitative Real time PCR  
Based on the evaluation through DAVID, k-means clustering, and IPA analysis; 
relative differences between selected mRNA populations was further quantified using the 
two-step qRT-PCR method.  Messenger RNA’s were evaluated using this method and are 
listed in regards with primer sequences used for detection (Table 4.1).  Quantitation was 
completed to analyze the mRNA expression for chemokine ligand 11 (CXCL-11), 
chemokine ligand 9(CXCL-9), guaylate binding protein 1(GBP1), cluster of 
differentiation 163 (CD163), and cluster of differentiation 18, known as integrin 2β  
(CD18).  In general, the expression patterns validated and confirmed the directional 
relation to the changes found on the array (Table 4.2). 
 
Chemokine Ligand 11 
A significant day by estrogen interaction (P < 0.04) on relative abundances of 
mRNA (mean ± SEM) was identified for CXCL-11 (Figure 4.5a).  The mRNA 
expression was not different due to estrogen on day 15.  However, there was a 256-fold 
increase in endometrial gene expression when comparing day 13 to day 15 following 
early estrogen exposure to the endometrium. 
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Chemokine Ligand 9 
A significant effect of day (P < 0.04) was observed in relation to relative mRNA 
abundances of CXCL9 (Figure 4.5b).  Although early estrogen administration had no 
effect on CXCL9 mRNA expression, day 15 gene expression increased 8-fold compared 
to day 13.   
 
Guaylate Binding Protein 1 
GBP1 was significantly affected by day (P = 0.004) and day of estrogen (P = 
0.04) (Figure 4.5c).  Early estrogen exposure of the endometrium contributed to an 
increased GBP1 gene expression resulting in a doubling in abundance of GPB1 mRNA 
on D15 when compared to D13.   
 
Cluster of Differentiation 163 
A slight but significant day of estrogen treatment (P = 0.01) effect for CD 163 
gene expression was observed.  The qRT-PCR results demonstrated about a 2-fold 
increase in CD 163 (Figure 4.5d) due to early estrogen exposure.  Additionally, there was 
a 2-fold increase in CD163 mRNA when comparing on D15 when compared to D13.  
 
Cluster of Differentiation 18 (Integrin β2) 
 A significant day by estrogen treatment interaction (P = 0.009) was observed fo  
gene expression for CD 18 (Figure 4.1e).  Greatest abundance of CD18 mRNA on day 15 









Figure 4.5a.  A significant day by treatment interaction on relative mRNA units (mean ± 
SEM) was identified for CXCL-11 (P<0.03)  Abundance of mRNA was calculated from 
the real-time PCR analysis as described in Methods and Materials. Relative mRNA 
abundance is presented as mean ± SEM.  Bars without a common superscript represent a 
statistical difference (P<0.05) between endometrium exposed to early estrogen when 































































Figure 4.5b. A significant day effect on relative mRNA units (mean ± SEM) was 
identified for CXCL-9 (P<0.04).  Abundance of mRNA was calculated from the real-time 
PCR analysis as described in Methods and Materials. Relative mRNA abundance is 
presented as mean ± SEM.  Bars without a common superscript represent a statis ical 























































Figure 4.5c.  GPB1 was significantly affected by day (P<0.004) and treatment ( P<0.04)in 
regards to relative mRNA units (mean ± SEM) was identified for GBP1.  Abundance of 
mRNA was calculated from the real-time PCR analysis as described in Methods and 
Materials. Relative mRNA abundance is presented as mean ± SEM.  Bars without a 
















































































Figure 4.5d.  A significant treatment effect of estrogen on relative mRNA units (mean ± 
SEM) was identified for CD 163 (P<0.04) Abundance of mRNA was calculated from the 
real-time PCR analysis as described in Methods and Materials. Relative mRNA abundance 
is presented as mean ± SEM.  Bars without a common superscript represent a statistical 



























































Figure 4.5e.  A significant day by treatment interaction on relative mRNA units (mean ± 
SEM) was identified for CD 18 (P<0.01).  Abundance of mRNA was calculated from the 
real-time PCR analysis as described in Methods and Materials. Relative mRNA abundance 
is presented as mean ± SEM.  Bars without a common superscript represent a statistical 
difference (P<0.05) between endometrium that was exposed to early estrogen when 












































Table 4.5. Results from quantitative RT-PCR confirming the changes observed with the Affymetrix Results. Represents validation of 
confirmed directional changes observed during the microarray analysis  
Target Gene¶ AffyChip § P-Value QT-RT-PCR# p-value 
Chemokine Ligand 11 









Chemokine Ligand 9 
13PP vs 15PP 













G-Protein, IFN Inducible 



















CD 18, β2 Intergrin 











¶Primer sets were designed to specifically assay each of the targets using fluorescent (SYBR Green). 
# Comparative CT method was utilized for determining fold differences from the QT-RT-PCR.   


















Table 4.6.  Top 5 networks generated through the IPA analysis software.  These 
networks had an IPA score of: 28, 8, 3, 2, and 2 respectively.  These scores represent a 
numerical value of approximate fit for each network and determine focus genes based on 













Estrogen is critical for the proper establishment of pregnancy in the pig (Bazer 
and Thatcher, 1977) however; it can be detrimental if uterine exposure to estrogen occurs 
prematurely during early gestation (Pope et al., 1986, Blair et al., 1991; Ashworth et al., 
2006).  With the delicate relationship between the optimal point of endometrial exposure 
to estrogen during early pregnancy and its affect on conceptus survivability, one can infer 
a spatiotemporal regulation of essential endometrial factors affecting pregnancy outcome 
occurs through aberrant estrogen exposure.  Furthermore, although the endocrine-
exocrine theory points to estrogen as the maternal recognition of pregnancy signal in the 
pig (Bazer and Thatcher, 1977), the molecular mechanisms behind estrogen’s stimulation 
on the endometrium are not complete.  Our approach isolated the direct effect of estrogen 
and its effects as an endocrine disruptor for the identification of endometrial genes altered 
by improper timing of estrogen stimulation without the presence of conceptus secreted 
factors. 
Utilization of the Affymetrix GeneChip® Porcine Genome Array allowed the 
identification of a plethora of factors that are differentially expressed at the opening of 
the implantation window aberrantly due to early estrogen exposure.  Furthermore, as 
determined though statistical analysis using dChip, 84 of the 117 genes that were 
differentially expressed were due to early estrogen exposure when comparing days 13 to 
15.  These data would suggest when aberrant estrogen exposure disrupts pregnancy the 
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window from days 13 to 15 is an important and critical time period for endometrial 
changes in gene expression and secretions essential for conceptus development and 
survival.  Additionally, the lack of abundance in differential gene expression in 
endometrium between days 13 and 15 of gilts exposed to estrogen at the time that 
conceptus estrogen normally occurs (day 11-12) during early pregnancy indicates that 
early estrogen exposure selectively alters expression of endometrium genes which do not 
normally increase with conceptus estrogen secretion on day 12.  
Cluster analysis was paramount in regards to identification of temporal expression 
patterns associated with estrogen regulation.  When early estrogen disrupts pregnancy, 
the period between days 13 to 15 are the most critically affected with 84 genes found to 
be differentially regulated during this time period.  Furthermore, the 84 differentially 
expressed genes were clustered into 3 groups of genes (Cluster 2, 6, and 7), and of these 
genes 47 were up regulated and 37 were downregulated due to the estrogen.  
Consequently, these genes might serve as an initial biomarker for possible identification 
of endocrine disruption of the early porcine implantation window.   
Expression patterns involving multiple genes were analyzed using DAVID 
annotation cluster of interest.  K-means clusters suggesting biological relevance in 
association of genes that are known to demonstrate either an estrogen response or an 
immunological function critical to pregnancy were picked for possible evaluation nd 
quantified through qRT-PCR.  Due to the roles in immunological regulation, chemokine 
ligand 11 (Hirota et al., 2006), chemokine ligand 9 (Imakawa et al., 2006), guanylate 
binding protein 1 (Kumar et al., 2001), cluster of differentiation 163 (Paidas et al., 2004) 
and cluster of differentiation 18 integrin β2 (Carty et al., 2008) were selected for closer 
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evaluation since they expression was found to be differentially effected by estrogen 
during the window of implantation. 
Chemokines have been implicated with the enhancement of the biological 
immune response as well as having a key role in maintaining homeostasis of the immune 
system.  Chemokines are classified into four distinct groups (CXC, CC, C and CX3C)
based on their inherent (amino acid sequence) and structural properties (Berger et al., 
1999, Rollins et al., 1997).   Early foundational studies limited chemokine expression to 
inflammatory and immune cells exclusively; however, subsequent studies have shown 
that to be false.  Recently, chemokine expression was localized in the murine uterus at the 
time of peri-implantation (Nagaoka et al., 2003a).  Furthermore, localization of 
chemokine receptors has been detected in the decidua and placenta of humans (Red-
Horse et al., 2001).  Chemokine ligand and receptor expression patterns are 
conspicuously expressed in uterus of the human, murine, and ovine during the window of 
implantation and/or attachment of the conceptus suggesting a key role for modulation of 
human endometrial erosion and attachment between the embryo and maternal tissues.  
Specifically, chemokine ligand 11 (CXCL-11) gene expression has been reported to 
increase during the window of implantation in the human (Hirota et al., 2006) and the 
ewe (Imakawa et al., 2006).  Hirota et al., (2006) demonstrated exposure of uterine 
endometrial epithelial cells (EEC) in culture to IFN-γ stimulated secretion of CXCL-11, 
but not endometrial stromal cells (ESC).   Furthermore, CXCL-11 stimulated 
proliferation in the ESC cells but inhibited proliferation in the EEC cells while 
concomitantly stimulating apoptosis.  These data suggest IFN-γ working through CXCL-
11 may play a regulatory role during implantation.  Additionally, Hirota et al. (2006) 
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suggest a prejudice towards the stromal layer for survival conditions, while inducing 
negative conditions in the epithelial layer during endometrial invasion in the mouse.  
Hirota et al. (2006) also demonstrated that CXCR3, the receptor for CXCL-11, is present 
in the epithelial and stromal layers of the endometrium, T cells, and the conceptus 
trophoblastic cells.  These data represent a useful model for motility and chemotaxis 
during the window of implantation in that upon secretion of CXCL-11 from the EEC 
layer, trophoblastic cells and T cells (Th1) migrated accordingly.  Hirota’s data makes a 
nice complement to what our lab has already established to date in the pig.  The 
appearance of CXCL-11 is closely associated with window of implantation in the pig.  
Additionally, our lab has previously characterized IL-18 secretion (Ashworth MD and 
Giesert RD, unpublished results) which originates from the uterine endometrium during 
the period of trophoblast attachment to the uterine surface from Day 13 to 18 of 
pregnancy.  IL-18 must be processed from the latent form to the active molecule through 
processing by caspase-1, which our lab has also characterized during the porcin  
pregnancy (Ashworth MD and Geisert RD, unpublished results).  One could infer based 
on CXCL-11 appearance during the window of implantation, that it may provide a pro-
apoptotic signal to uterine epithelial cells, resulting in a release of caspase-1 from the 
uterine epithelial cells via CXCL-11’s ability to induce apoptosis.  Furthermore, this may 
be a mechanism allowing site specific areas of the endometrium to undergo apoptosis as 
opposed to the whole endometrium, while providing a receptive epithelial layer for 
proper attachment during this period.   
Chemokine ligand 9 (CXCL-9) belongs to the same subfamily as CXCL-11, 
shares the common receptor (CXCR3) with CXCL-11 and has a similar temporal 
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expression pattern during the window of implantation in the sheep (Imakawa et al., 
2006).  Similar to CXCL-11, uterine CXCL-9 secretion is stimulated through 
progesterone and/or estrogen (Kitaya et al., 2004).  Stark contrasts exist between CXCL-
9 and CXCL-11 in that CXCL-9 is induced by the pleiotrophic cytokine IL-18, while 
CXCL-11 and CXCL-10, the only known chemokines controlled by estradiol and 
progesterone and are directly responsible for the migration of perhperial blood NK cells 
into the uterus and creating a residential NK cell then termed uNK cells (Sentman et al., 
2004).  The induction of CXCL-11 into the human endometrium is facilitated through the 
ovarian sex steroids estrogen and progesterone (Sentman et al., 2004); however, wheth  
the steroid affects are direct or indirect have yet to be elucidated.  Furthermore, the study 
also established chemokine receptor CXCR3 is expressed on the surface of uNK cells, 
which serves as ligands for CXCL-9, and CXCL-11.  
Gyuanlate binding protein 1 (GPB1) belongs to the larger family of guanylate 
binding proteins that are characterized as GTPase proteins which contain a conserved 
domain possessing the capacity to undergo oligomerization under augmented GTPase 
activity (van der Bliek et al., 1999).  Additionally, Cheng et al., (1991) characterized 
GPB1 as the most abundant IFN-γ inducible protein in the human body, and numerous 
studies have demonstrated proinflammatory cytokines (IL-1β, IFN-γ, and TNF-α) are all 
inducers of GPB1 (Lubeseser-Martellato et al., 2002).  More importantly, recent studies 
demonstrated GPB1 has an inverse correlation to the expression of matrix 
metalloproteinase-1 (MMP-1) suggesting a possible role in controlling cellular invasion.   
GPB1 has been localized to the human endometrium (epithelial and stromal 
layers) during early conceptus attachment to the uterine surface and invasion (Kumar et 
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al., 2001).    Moreover, the expression exhibited was strongly localized to the endometrial 
glandular epithelial cells and the surrounding stromal cells during the mid secretory 
phase.  However, expression was very weak in the glandular epithelial cells during the 
proliferative or late secretory phase of the pregnancy.  Additionally, GBP1 is induced by 
IFN-γ and –α and the authors found that IFN-γ was a strong inducer of GBP1.  During 
pregnancy in the human, IFN-γ is most abundant during this time frame (Kumar et al., 
2001).   
In the pig, GBP1 has only just recently just been sequenced (Ma et al., 2008).  
According to our data, it appears that estrogen administration can induce GBP1 gene 
expression either directly or indirectly.  Our GBP1 expression data is concurre t with 
IFN-γ expression based on a study conducted during early pig pregnancy by Joyce et al. 
(2005).  Although with our pseudopregnant model is devoid of any conceptus IFN-γ, data 
from Joyce et al., (2005) demonstrated that sparse immune cells such as uNK though out 
the uterus are carring out transcription for IFN-γ.  Furthermore, the IFN-γ expression 
would temporally be expressed around the time of the second phase of estrogen.   
The CD18 ligand is expressed on leukocytes and pairs with either CD11a, b, c, or 
d to form the complete β2 integrin unit.  CD18 plays key roles in leukocyte activation, 
adhesion, and activation of the compliment as well.  Pregnant women with severe 
preeclampsia show signs of elevated leukocyte activation within the fetal circulation 
(Mellembakken et al., 2001).  Furthermore, these authors found that both infants and the 
mothers exhibited increased levels of surface expression of CD11c when the mother had 
preeclampsia.  Mellembakken et al. (2001) attributed the origin of this phenomenon as an 
indicator of activated neutrophils.  Moreover, Saini et al., (2004) repeated the experiment 
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but measured CD18 and CD11a, b, and c.  Their study revealed that CD18 and CD11a 
were profusely upregulated in the severe preeclamsia women and it provided a feed 
forward mechanism to continue to activate neutrophils.  Activated neutrophils can 
decrease blood flow, release proteases and reactive oxygen species that all lead to an 
increase in vasoreactivity.  Exposure of gilts to estrogen on day 9 in the present study 
aberrantly elevated endometrial CD18 gene expression 6-fold on day 15 when 
vasodilation and blood flow would be critical during pregnancy.  The increase observed 
in CD18 transcript may serve as a potential indicator of a dysfunctional window of 
attachment in the porcine pregnancy.   
CD163 is a membrane bound glycoprotein and a member of the B group of the 
scavenger receptor cystein rich superfamily.  CD163 appears to have two functins 
dependant on if it is secreted or bound to the cell membrane.  In the cell bound form 
CD163 participates in hemoglobin clearance, and in its secreted soluble form it exhibits 
cytokine like functions such as anti-inflammatory properties.  CD163 expression 
increases as monocytes mature, inferring it is probably associated with a dis inct class of 
differentiated monocytes (Morganelli et al., 1988).  During pregnancy the placnta 
contains more macrophages and dendritic cells that contain CD163 surface expression 
than anywhere else in the body (Hogger et al., 1998).  In our study, timing of estrogen 
treatment did not affect CD 163 mRNA expression but CD163 did increase between days 
13 to 15.   
Croy et al., (1987) postulated that a thriving porcine pregnancy can be attributed 
to suppression of T cell responses and MHC molecules which allow semiallograft 
conceptus to establish pregnancy and escape immune rejection.  In our microarray dat , 
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network analysis of gene annotations revealed a distinct up regulation of CD4+ T Cell 
signaling components, major histocampatibility complex II (MHC II), and transporter I, 
ATP-binding cassette, sub-family B (TAP I).  At first glance these r ults appear 
confounding due in part to two major reasons: TAP proteins are normally associated with 
the loading of MHC I and not MHC II; however, studies involving conditions such as 
Sarcoidosis have demonstrated that TAP proteins can unusually aid in the loading of self 
antigens from the lysosome onto the MHC II cleft for antigen presentation and stability of 
the MHC itself (Xia et al., 2001).  Second, these data are in disagreement to the observed 
increase in levels of CD8+ T cells observed normally during the implantation window of 
days 10 through 14 of the porcine pregnancy (Bischoff et al., 1995).  In the current study, 
estrogen disruption appears to aberrantly increase CD4+ cell signaling and increase levels 
of MHC II expression.   
In conclusion, over one hundred candidate genes were successfully identified as 
differentially expressed due to premature estrogen exposure through the use of 
Affymetrix GeneChip® Porcine Genome Array.  The current study has provided insight in 
to the complexity and multiple immune factors associated with endocrine disruption of 
the endometrium during early porcine pregnancy.  Furthermore, the analysis of a sociated 
pathways constructed from the raw microarray data provided valuable insight into te 
dysfunctional antigen presentation schemes due to early estrogen exposure.   
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Chapter V 
Regulation and Expression of Uterine BIO-markers in the Porcine Endometrium 
Following Uterine Infusion of Estrogen and IL-1β. 
Abstract 
  Embryonic loss during early gestation limits litter size in swine production.  Failure of 
the conceptus to attach and implant into the uterus may contribute to the high rate of 
embryonic loss observed in swine.  Implantation requires precise communication 
between the conceptus and embryo which includes up regulation of adhesion molecules 
at the maternal/fetal interface for embryo attachment involving pregnancy spe ific 
inflammatory responses.  Trophinin and osteopontin are cell adhesion molecules 
expressed on pig and human endometrial epithelial surface which may function early for 
the attachment of the conceptus trophectoderm and uterine luminal epithelium.  
Leukocytes infiltrate endometrium during implantation, and the enymes cycloox genase 
(COX)-1 and COX-2 are expressed in human and pig endometrium during pregnancy, 
where they are proposed to regulate conceptus implantation and uterine angiogenesis.  
During implantation, increases in interleukin-1β occur in the mouse, human and pig 
which may regulate uterine pro-inflammatory cytokines.  Studies have demonstrated 
estrogen to be obligatory for establishment of pregnancy in the pig.  Furthermore, 
estrogen and interleukin-1β are concomitantly expressed during the window of the 
maternal recognition of pregnancy in the pig. The objective of the current study was to 
evaluate the hypotheses that estrogen plays a regulatory role in the uterin inflammatory 
and attachment window invoked by IL-1β secretions during the establishment of 
pregnancy in the pig.  Cyclic gilts were treated with 5 mg corn oil (CO) or estradiol 
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cypionate (E) on Day 11 of the estrous cycle.  On Day 12, gilts were randomly infused 
with either 15 ug of saline (S) or recombinant porcine IL-1β (rIL-1β).  Uterine horns 
were removed at 4 h or 36 h post-infusion (5 gilts/trt/sampling periods) and endometrial 
mRNA was quantified using quantitative RT-PCR.  Estrogen did not influence (P> 0.1) 
concentrations of endometrial COX-1 and COX-2 mRNA; however, rIL-1β increased (P 
= 0.01) endometrial COX-2 mRNA by 3.5 fold and up-regulated (P = 0.05) endometrial 
IL-1β expression by 3.5 fold.  Moreover, increases observed in endometrial expression of 
osteopontin, trophinin, and interleukin 1 receptor accessory protein were increased (P < 
0.05) at 36 h but not at 4 h post-E treatment.  Estrogen-treated gilts exhibited a 13-fold 
increase in osteopontin and approximately a 4-fold increase in endometrial trophinin 
expression when compared to the gilts treated with CO.  Furthermore, E-treated gilts 
demonstrated an increase in interleukin 1 receptor accessory protein (2.5 fold increase) 
inferring a possible regulatory relationship with the interleukin1β system.  We 
hypothesize that interleukin-1β and estrogen secretion by the pig conceptus differentially 
modulates uterine expression of COX-1, COX-2, trophinin, osteopontin, and the 
interleukin-1 β system providing a regulated inflammatory environment that is essential 
to establishment of pregnancy.              





In the pig, the role and regulation of uterine immunity is poorly understood.  
Successful pregnancy in the pig is associated with acute and long term inflammation 
(Bischof et al., 1994).  Proinflammatory mediators, such as interleukin-1β (IL-1β), are 
secreted maximally on day 12 of gestation by the rapidly developing conceptuses, 
inferring local immunity involved in uterine responses to pregnancy (Ross et al., 2003).  
Studies in the pig have suggested that during pregnancy, the uterine immune system plays 
an active role in establishing pregnancy (Koch et al., 1985).  
During the maternal recognition of pregnancy and window of implantation, 
conceptus IL-1β expressed concomitantly with estrogen secretion may establish an 
immunological dialog between the foreign conceptus tissues and the maternal 
endometrium (Gesiert et al., 1982, Ross et al., 2003).  Caspase-1, also refered to as IL-1β 
converting enzyme, cleaves the 31 kDa inactive form of IL-1β to its biologically active 
18 kDa form.  Although IL-1β and estrogen secretion are severely attenuated by day 15 
of pregnancy, there is a uterine release of IL-18 (Ashworth and Geisert unpublished 
results) and a sustained second phase of conceptus estrogen secretion necessary to 
maintain CL function beyond 28 days of gestation (Geisert et al., 1987).  This second 
phase of conceptus estrogen secretion is temporally associated with a pregnancy specific 
8-fold increase in endometrial caspase-1 mRNA expression (Ashworth and Geisert 
unpublished results), that also activates IL-18 from the pro-form, and produces the 
signaling competent form of the mature IL-18.  Increases in endometrial caspase-1 
expression are not associated with endometrial release of IL-1β as luminal content is 
greatly diminished by days 15 and 18 (Ross et al., 2003b) of pregnancy suggesting based 
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on its appearance IL-18 may be an alternative cytokine substrate for caspase-1 cleavage 
during this time period. 
Failure of the conceptus to attach to the uterine surface may contribute to the high 
rate of embryonic loss observed in swine.  Implantation requires communication between 
the conceptus and maternal tissues which functions include up regulation of adhesion 
molecules at the maternal/fetal interface for embryo attachment involv g pregnancy 
specific inflammatory responses.  Trophinin and osteopontin are cell adhesion bio-
markers expressed on pig (Nakano et al., 2003, White et al., 2006) and human 
endometrial epithelial surface (Sugihara et al., 2008).   
In the pig, leukocytes infiltrate endometrium prior to and during the window of 
implantation (Bishof et al., 1995), and this event is auspiciously around the time an 
observed increase in the enzymes cyclooxygenase (COX)-1 and COX-2, which are 
responsible for the production of the obligatory prostaglandins (PG) that are expressed 
during human (Demers and Gabbe., 1976) and porcine (Ashworth et al., 2006) 
endometrium during early pregnancy.  Prostaglandins are essential, and also postulated as 
a key regulator during conceptus attachment in the pig (Kraeling et al., 1985) and 
facilitate uterine angiogenesis (Ford et al., 1982).  During early gestation, increases in IL-
1β have been observed in several species including the mouse (Sato et al., 2001), human 
(Lappas et al., 2002) and pig (Ross et al., 2003) which may serve to stimulate uterine pro-
inflammatory cytokines, and stimulate remodeling of the extracellular matrix (ECM) 
proteins and matrix metalloproteinases (MMP) through control of master transcription 
during early pregnancy.  In addition to cytokine regulation, foundational studies have 
demonstrated estrogen to be essential for establishment of pregnancy in the pig (Bazer 
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and Thatcher 1977), and induce uterine secretions to aid in proper conceptus sustainment 
and development (Geisert et al., 1982).  Furthermore, studies have demonstrated that 
estrogen and IL-1β are concomitantly expressed in vivo during the window of the 
maternal recognition of pregnancy in the pig.  
Recently, studies have demonstrated that IL-1β stimulates the attachment factor 
trophinin in human endometrial cells (Sugihara et al., 2008), and estrogen stimulates the 
attachment factor osteopontin in porcine uterine endometrial cells in the mouse and pig
(White et al., 2006).  The objective of the current study was to evaluate how estrogen 
plays a regulatory role in the uterine inflammatory and attachment window inv ked 
simultaneously with IL-1β secretions during the establishment of pregnancy in the pig.   
 
Methods and Materials 
 
Animals 
Research was conducted in accordance with the Guiding Principles for Care and 
Use of Animals promoted by the Society for the Study of Reproduction and approved by 
the Oklahoma State Institutional Care and Use Committee.  Crossbred cycling gilts of 
similar age (8-10 mo) and weight (100-130 Kg) were checked twice daily for estrus 




Cyclic gilts (5/trt) received either corn oil (CO) or 5 mg i.m. injection of estradiol 
cypionate (E) (A.J. Legere, Scottsdale, AZ) on day 11 of the estrous cycle.  On day 12
(24 h post-treatment) of the estrous cycle, gilts were subjected to mid-ventral laparotomy.  
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A ligature was placed at the bottom of each uterine horn near the uterine bifurcation.  
One randomly selected uterine horn was infused with saline (2 ml) and the second uterine 
horn infused with 15 µg of recombinant porcine IL-1β (rIL-1β) (Cell Sciences Inc, 
Canton, MA).  The amount of rIL-1β infused into the uterine horn is based on the total 
content of IL-1β in uterine flushing collected on day 13 of pregnancy measured in a 
previous study [Ross et al., 2003].  Because uterine flushings only reflect a single time 
point measurement, the amount of rIL-1β infused was increased by 3-fold.  Uterine horns 
were removed at 4 and 36 h post-infusion (5 gilts/trt/sampling period).   
 
Animal Surgeries and Endometrial Tissue Collection 
Following induction of anaesthesia with 1.8 ml i.m. administration of a cocktail 
consisting of 2.5 ml cocktail (Xylazine: 100mg/ml: Miles Inc., Shawnee Mission, KS) 
and 2.5 ml Vetamine (Ketamine HCl: 100 mg/ml Molli Krodt Veterinary, Mundelein, IL) 
in 500 mg of Telazol (Tiletamine HCl and Zolazepum HCl: Fort Dodge, Syracuse, NE), 
anesthesia was maintained with a closed circuit system of halothane (5% flurothane) and 
oxygen (1.0 liters/min).  The uterus was exposed via midventral laparotomy and the 
uterus and ovaries excised.  Uterine horns were injected with 20 mL phosphate buffered 
saline (PBS, pH 7.4) via the isthmus and flushings were recovered in a petri dish.  
Supernatant collected and clarified uterine flushings stored at -20°C.  Endometrial tissue 
was removed from the antimesometrial side of the uterine horn, immediately snap frozen 
in liquid nitrogen and stored at-80°C until utilized for extraction of protein and RNA.   
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Uterine Tissue fixation/Storage 
Gilts were unilaterally hysterectomized at 4 and 36 h post-infusion (5 
gilts/trt/sampling period).  Uterine horns were isolated and flushed with 20 ml sterile 
phosphate buffered saline (PBS; pH 7.4).  Small 1 cm segments of the uterine 
endometrium from CO and rIL-1β treated uterine horn were fixed for subsequent 
immunocytochemistry with fresh 4% paraformaldehyde in 0.1 M sodium phosphate (pH 
7) for at least 24 h and embedded in Paraplast-Plus (Oxford Labware, St. Louis, MO).  
Additional tissue was embedded in Tissue-Tek Optimal Cutting Temperature (OCT) 
Compound (Miles, Oneonta, NY), slow-frozen over liquid nitrogen, and stored at -80oC 
until utilized for further evaluation.  Endometrial tissues were dissected from the 
underlying myometrium and snap-frozen in liquid nitrogen.   
 
Quantitative RT-PCR Gene Target Description.   
Effects of IL-1β on endometrial gene expression of osteopontin (OPN), trophinin, 
tumor necrosis factor-α (TNF-α), interleukin-1 receptor-1 (IL-1 R1), interleukin-1 
receptor accessery protein (IL-1RAP), IL-18, COX-1, and COX-2 were evaluated.  
Tissue 18S ribosomal RNA was determined and used to normalize gene expression.  
Primers for these target genes have been previously developed and validated in our 




Quantitative RT-PCR analysis of transcripts of interest was conducted as 
previously described by our laboratory (Ashworth et al., 2006).  Endometrial total RNA 
was aliquoted to be used for PCR analysis.  Genomic DNA removal and the synthesis of 
cDNA to be used for quantitative analysis were conducted by using the QuantiTect 
Reverse Transcription kit according to manufacturer’s recommendations (Qiagen, 
Valencia, CA).  Briefly, 0.5 µg of each endometrial sample (n = 5) was added to a 
genomic DNA wipeout buffer for 5 min at 37oC, followed by a 2 min incubation on ice, 
then proceeding to the addition of reverse transcription buffer, RT primer mix and reverse 
transcriptase; and incubated at 42oC for 30 min.  Individual endometrial samples were 
taken at both 4 and 36 h from the steroid treated (CO and E) and infusion treated gilts 
(Saline and rIL-β).  The PCR amplification was conducted using the ABI PRISM 7700 
and Bio-Rad icycler Sequence Detection Systems (PE Applied Biosystems, Bio-rad 
Systems).  The real-time detection during each amplification cycle was done by using 
either a sequence specific dual-labeled fluorescent probe designed to have a 5’ reporter
dye (6-FAM) and a 3’ quenching dye (TAMRA) nested between the forward and reverse 
sequence specific primers or the intercalating dye, SYBR green.  All primers and probes 
utilized for quantitative analysis for each target gene are presented in Tables 5.1 and 5.2.  
One hundred nanograms of synthesized cDNA were assayed for each sample in 
duplicate.  Thermal cycling conditions using the dual labeled probe were 50oC for 30 
min, 95oC for 15 min, followed by 40 repetitive cycles of 95oC for 15 sec and a combined 
annealing/extension stage, 59oC for 1 min.  Fluorescent data acquisition was done during 
the annealing/extension phase when using the dual-labeled probes.  Cycling conditions 
for SYBR green detection were 50oC for 30 min and 95oC for 15 min, followed by 40 
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repetitive cycles of 95 for 15oC sec and variable annealing temperature for 30 sec, 72oC 
for 33 sec and a variable temperature during fluorescent detection for 33 sec.  
Fluorescence detection temperature was determined by evaluating melting curve analysis 
for the samples and the no template control amplification plot.  Detection temperatures 
were set at a temperature when the intended target was the only contributing factor to 
fluorescence.  18S ribosomal RNA was assayed as a normalization control to correct for 
loading discrepancies.  Following RT-PCR, quantitation of gene amplifications were 
made by determining the cycle threshold (CT) based on the fluorescence detected within 
the geometric region of the semilog view of the amplification plot.   Relative quantitation  
of target gene expression was evaluated using the comparative CT m thod as previously 
described [Hettinger et al. 2001; Ashworth et al., 2006].  The ∆CT value was determined 
by subtracting the target CT of each sample from its respective ribosomal 18S CT value.  
Calculation of ∆∆CT involves using the single greatest sample ∆CT value (the sample 
with the lowest expression) as an arbitrary constant to subtract from all other sample ∆CT 
values.  Relative mRNA units for each sample were calculated assuming an amplific tion 
efficiency of 2 during the geometric region of amplification, and applying the equation, 




Table 5.1.  Primer and probe sequence information for the quantitative amplification of each target gene. 
 
aGene bank Assession ID given by NCBI for which the probe set was designed. 
bThe target gene name was determined through manual annotation of the EST sequence used during the generation of the probe set. 
cForward and reverse primers for each target gene.  The forward primer sequence is above the reverse for each target gene, and the 
probe is listed last below the primers.  Forward and reverse do not necessarily indicate the in vivo direction of transcription. 
dFlorescent probe set was used to measure amount of amplified target during each cycle of quantitative RT-PCR.   
eAmplicon size refers to the product size of the amplified PCR product. 





5’Fam’3 174 bp (R) GCAAAGACACCTTCCCGCTTTGAA 
(P)TAGGCTGACCTGTTTCTCCCACT 
Ssc.26146.1.S1_at 
IL-1 β RAP 
(F) TGCATCAACACCAGCCAAAGGATG 5’Fam’3 
304 bp (R) TTAGGCTGACCTGTTTCTCCCACT 
(P)GCATCAACACCAGACCTGTACCTGT 
Ssc.29054.1.A1_at 
IL-1 β RI 
(F) TGCTTTGCTTCTGACTCGGCTCTA 5’Fam’3 




(F) TACATGCCACAGGTCGCTCATCTT 5’Fam’3 




(F) AGGACAACAGCTCCATCATCTGCT 5’Fam’3 




Table 5.2  Primer and probe sequence information for the quantitative amplification of each target gene. 
 
aThe  gene bank Assession ID given by NCBI for which the probe set was designe. 
bThe target gene name was determined through manual annotation of the EST sequence used during the generation of the probe set. 
cForward and reverse primers for each target gene.  The forward primer sequence is above the reverse for each target gene, and the 
probe is listed last below the primers.  Forward and reverse do not necessarily indicate the in vivo direction of transcription. 
dThe Florescent probe set, was used to measure amount of amplified target during each cycle of quantitative RT-PCR.   
eAmplicon size refers to the product size of the amplified PCR product. 









(F) TGCATCAACACCAGCCAAAGGATG 5’Fam’3 




(F) TGCTTTGCTTCTGACTCGGCTCTA 5’Fam’3 




(F) TACATGCCACAGGTCGCTCATCTT 5’Fam’3 




Uterine Luminal Flushing TNF-α Content  
 
  Total luminal content of TNF- α in the uterine flushings were quantified using a 
commercial ELISA (R and D Systems, NJ) in accordance with manufacturer’s 
specifications.  Samples were analyzed in duplicate with a single assay.  The intra-assay 
coefficient of variation for the assay was 4.6%. 
 
Uterine Luminal Flushing IL-1β Content 
 
  Total luminal content of IL-1β in the uterine flushings were quantified using a 
commercial ELISA (R and D Systems, NJ) in accordance with manufacturer’s 
specifications.  Samples were analyzed in duplicate with a single assay.  The intra-assay 
coefficient of variation for the assay was 3.9%. 
 
Quantitation and Statistical Analysis 
Normalized QT-RT-PCR ∆CT values and uterine luminal content of IL-1β and 
TNF-α were analyzed using the PROC MIXED of the Statistical Analysis System.  Due 
to considerable differences in endometrial immunological state, analysis was performed 
separately by sampling times (4 or 36 h).  The statistical model was factorial in nature, 
and the analysis tested the fixed effects of steroid (E or CO), infusion (IL-1β or Saline), 
and the interaction on the targeted endometrial mRNA expression.  Significance (P < 
0.05) was determined by probability differences of least squares means between steroid 
treatment and infusion on endometrium mRNA expression at either 4 or 36 h. If the 
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treatment effect was significant, (P < 0.05), treatment means were sepaated by using the 
PDIFF option of SAS. 
 
Results 
Endometrial IL-1β mRNA Expression 
IL-1β mRNA expression at 4 or 36 h was unaffected by estrogen-treatment.  A 
significant infusion effect (P < 0.05) was observed for endometrial IL-1β mRNA 
abundance at 4 h post-infusion.  At 4 h, endometrial gene expression for IL-1β was 3.5-
fold greater (Figure 5.1a) in the uterine horn of gilts infused with rIL-1β compared to the 
saline infused horn.  Endometrial IL-1β mRNA expression not significantly different (P > 
0.05) between infusion treatments at 36 h (Figure 5.1b). 
 
Endometrial IL-1β RAP Expression 
IL-1β RAP mRNA expression was unaffected due to infusion of rIL-1β at the 4 or 
36 h   A significant steroid effect (P < 0.05) was observed for IL-1β RAP endometrial 
mRNA expression at 4 and 36 h post-infusion.  At 4 h, there was a 5.5-fold elevation in 
endometrial IL-1β RAP mRNA expression in gilts treated with E compared to CO 
(Figure 5.2 a,b).  At 36 h there was a 2.5-fold increase in endometrial IL-1β RAP mRNA 
expression compareed to CO-treated gilts.   
 
Endometrial IL-1β Receptor Type 1 Expression 
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IL-1 R1 endometrial mRNA expression was not effected by estrogen treatment at 
4 or 36 h.  A significant infusion effect (P < 0.05) was observed in endometrial IL-1β R1 
mRNA expression at 4 h (Figure 5.3a).  There was a 4-fold increase in endometrial IL-1 
R1mRNA expression in the uterine horn infused with rIL-1β compared to uterine horn 
that received saline.  Although rIL-1β had a significant effect on endometrial IL-1 R1 
mRNA expression at 4h, it was not significantly different at 36 h (Figure 5.3b) 
 
IL-1β Protein in Uterine Flushing 
A significant infusion (P < 0.05) and steroid effect (P < 0.05) was observed for 
content of IL-1β protein in uterine flushings (Figure 5.4a).  Infusion of rIL-1β increased 
the uterine luminal content of IL-1β from 8000 to 11,000 pg compared to the uterine horn 
receiving saline.  At 36 h, IL-1β and estrogen exposure did not affect uterine secretion of 
IL-1β (Figure 5.4b).   
 
Endometrial COX-1 mRNA Expression 
No significant infusion or steroid effect (P > 0.05) was observed in endometrial 
COX-1 mRNA abundances at 4 h (Figure 5.5a) or 36 h (Figure 5.5a).  Endometrial 
mRNA expression of COX-1 did exhibit a tendency to increase due to estrogen-treatment 
(P = 0.06), however, at 36 h was similar between E and CO gilts.   
 
Endometrial COX-2 mRNA Expression 
COX-2 mRNA expression at 4 or 36 h was not significantly affected by treatment 
of gilts with estrogen. A significant infusion effect (P < 0.05) was observed for 
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endometrial COX-2 mRNA abundances at 4 h (Figure 5.6a). Endometrial mRNA 
expression of COX-2 was increased by approximately 4-fold in the uterine horn infused 
with rIL-1β compared to the horn receiving saline.  Although rIL-1β had a significant 
effect on endometrial COX-2 mRNA expression at 4 h, expression was not different at 
the 36 h (Figure 5.6b) 
 
Endometrial COX-2 Immunohistochemistry (IHC)  
COX-2 protein expression was unaffected due to estrogen at 4 or 36 h. There was 
an increase in localization for endometrial COX-2 protein at 4 h post-rIL-1β infusion 
(Figure 5.7a).  Localization of COX-2 protein was observed primarily in uterine luminal 
epithelium, and to a lesser degree the glandular epithelium.  Infusion of saline into the 
contralateral horn failed to induce COX-2 protein expression in uterine luminal and 
glandular epithelium.   
 
Endometrial Osteopontin mRNA Expression 
Osteopontin mRNA expression was unaffected by infusion with rIL-1β. Although 
estrogen increased endometrial OPN mRNA expression by 3-fold at 4 h, the increase was 
not statistically significant (Figure 5.a).  A significant steroid effect (P < 0.05) was 
detected for endometrial OPN expression at 36 h (Figure 5.8b).  Gilts treated with 
estrogen exhibited a 13-fold increase in the endometrial OPN mRNA expression 
compared to gilts that received CO.   
 
Endometrial TNF-Protein Concentration in Uterine Flushings 
 
 158
A significant steroid effect (P < 0.05) was detected for TNF-α protein content in 
the uterine flushings at 4 h (Figure 5.9a), however estrogen had no effect at the 36 h 
(Figure 5.9a).  Estrogen significantly increased the uterine luminal content of TNF-α 
protein at 4 h compared to saline treated gilts, 10,756 and 8,680 pg respectively.  TNF-α 
protein in the uterine lumen was increased by infusion of rIL-1β (P <0.05) at 36 h but not 
at 4h.  The infusion of rIL-1β increased TNF-α protein in the uterine lumen compared to 
the saline treated horn (36,988 and 9,725 pg respectively). 
 
Endometrial IL-18 mRNA Expression 
Infusion or steroid treatment did not significantly (P > 0.05) effect endometrial 
IL-18 mRNA abundance at either 4 h or 36 h (Figure 5.10a,b).  
 
Endometrial Trophinin mRNA Expression 
Trophinin endometrial mRNA expression was not affected by uterine rIL-1β 
infusion at 4 or 36 h.  A significant steroid effect (P < 0.05) was detected for endometrial 
trophinin mRNA expression at 36 h (Figure 5.11a).  Treatment of gilts with estrogen 
increased the mRNA expression of trophinin by 3.5-fold compared to gilts that received 
CO.  Although estrogen had a significant effect on trophinin mRNA expression at 36 h, 













Figure 5.1. IL-1β mRNA expression was unaffected due to estrogen at 4 or 36 h. A 
significant infusion effect (P < 0.05) was observed for endometrial IL-1β mRNA 
abundance at 4 h post-infusion.  A) At 4 h, endometrial gene expression for IL-1β was 
3.5-fold greater in the uterine horn infused rIL-1β compared to saline (SAL).  B)  
Endometrial gene expression for IL-1β at 36 h was not significantly different (P > 0.05) 
between rIL-1β and SAL infused horns. Abundance of mRNA was calculated from the 
real-time PCR analysis as described in Methods and Materials. Relative mRNA 
abundance is presented as mean ± SEM.  Bars without a common superscript represent a 
statistical difference (P<0.05) between infusion and steroid endometriu  comparing time 






















































































Figure 5.2.  IL-1β RAP mRNA expression was unaffected due to infusion of rIL-1β at 4 
or 36 h.  A significant steroid effect was observed (P > 0.05) for endometrial IL-1β RAP 
mRNA abundance at 4 h (a) and 36 h (b) post-treatment. Estrogen increased IL-1β RAP 
at 4 h approximately 5.5-fold, and over 2.5-fold at 36 h. Abundance of mRNA was 
calculated from the real-time PCR analysis as described in Methods and Materials. 
Relative mRNA abundance is presented as mean ± SEM.  Bars without a common 
superscript represent a statistical difference (P<0.05) between infusion and steroid 

























































































Figure 5.3.  IL-1R1 mRNA expression was unaffected due to estrogen of at 4 or 36 h  A 
significant infusion effect (P < 0.05) was observed for endometrial IL-1β R1mRNA 
abundance at 4 h post-infusion.  A) At 4 h, endometrial mRNA abundances for IL-1β R1 
was approximately 4-fold greater in the uterine horn infused with rIL-1β compared with 
saline (SAL).  B) Endometrial gene expression for IL-1β R1 at 36 h was not significantly 
different (P > 0.05). Abundance of mRNA was calculated from the real-time PCR 
analysis as described in Methods and Materials. Relative mRNA abundance is presented 
as mean ± SEM.  Bars without a common superscript represent a statistical difference 
(P<0.05) between infusion and steroid endometrium comparing 4 and 36 h post-treatment 






























































































Figure 5.4.  IL-1β assay to determine relative amounts of total protein collected from 
gilts at 4 and 36 h post-infusion and/or steroid treatment (n = 5/time/s atus).  A 
significant steroid effect was observed for IL-1β for 4 and 36 h post-steroid treatment (P 
< 0.05), and at 36 h there no significant IL-1β effect (P > 0.05).  Relative optical density 
for each sample was corrected for total protein concentration in the sample.  Data is 





































































































Figure 5.5. COX-1 mRNA expression was unaffected due to estrogen-treatment or 
infusion of rIL-1β at 4 or 36 h. A tendency was observed (P = 0.06) for endometrial 
COX-1 mRNA abundance at 4 h post-estrogen exposure (figure 5.5a), however, there was 
no estrogen effect on COX-1 mRNA expression at 36 h (figure 5.5b).  Abundance of 
mRNA was calculated from the real-time PCR analysis as describ d in Methods and 
Materials. Relative mRNA abundance is presented as mean ± SEM.  Bars without a 
common superscript represent a statistical difference (P<0.05) between infusion and 
















































































Figure 5.6.  COX-2 mRNA expression was unaffected due to estrogen at 4 or 36 h. A 
significant infusion effect (P < 0.05) was observed for endometrial COX-2 mRNA 
abundance at 4 h post-infusion.  A) Endometrial mRNA abundance for COX-2 was 
approximately 4-fold greater in the uterine horn infused with rIL-1β compared to saline 
(SAL).  B) Endometrial gene expression for COX-2 was not significantly different (P > 
0.05) between infused horns. Abundance of mRNA was calculated from the real-tim  
PCR analysis as described in Methods and Materials. Relative mRNA abundance is 
presented as mean ± SEM.  Bars without a common superscript represent a statistical 
difference (P<0.05) between infusion and steroid endometrium comparing 4 h and 36 h 




























































































Figure 5.7.  Localization for endometrial COX-2 protein at 4 h post-saline and rIL-1β 
infusion.  Localization of COX-2 protein was localized primarily to uterine luminal 
epithelium, and to a lesser degree the glandular epithelium.  Infusion of saline into the 
contra-lateral horn failed to induce COX-2 protein expression in uterine luminal and 
glandular epithelium.  Image was optimized using 10x objective.  Tissue-bound primary 
antibody was detected with fluorescein-conjugated secondary antibody (Chemicon 
International, Temecula, CA).  Slides were overlaid with Prolong atifade mounting 
reagent (Molecular Probes, Eugene, OR) and a cover glass added.  Tissues were fixed in -
20°C methanol, washed in PBS containing 0.3% Tween 20 in PBS, blocked in 10% 













































Figure 5.8.  Osteopontin mRNA expression was unaffected by infusion with rIL-1β at 4 
or 36 h.  A significant steroid effect (P < 0.05) was observed for endometrial OPN 
mRNA abundance at 36 h post-infusion.  A) Endometrial gene expression for OPN at 4 h 
was not significantly different (P > 0.05) between estrogen and corn oil treated gilts. B)  
Endometrial mRNA abundances for OPN was approximately 14-fold greater at 36 h in 
gilts treated with estrogen compared with corn oil.  Abundance of mRNA was calculated 
from the real-time PCR analysis as described in Methods and Materials. Relative mRNA 
abundance is presented as mean ± SEM.  Bars without a common superscript represent a 
statistical difference (P<0.05) between infusion and steroid endometriu  comparing time 





























































































Figure 5.9.  TNF-α  assay to determine relative amounts of total protein collected from 
gilts at 4 h and 36 h post-infusion and/or steroid treatment(n = 5/time/status).  A 
significant steroid effect was observed for TNF-α for 4 h post-estrogen treated gilts (P < 
0.05), and significant rIL-1β effect (P < 0.05) was detected at 36 h.  Relative optical 
density for each sample was corrected for total protein concentration in the sample.  Data 


































































































Figure 5.10.  No statistically significant steroid or infusion effect (P > 0.05) was 
observed for endometrial IL-18 mRNA abundance at 4 h (a) or 36 h (b) post-treatment. 
Abundance of mRNA was calculated from the real-time PCR analysis as described in 





































































































Figure 5.11. Trophinin mRNA expression was not affected uterine infusion with rIL-1β 
at 4 or 36 h A significant steroid effect (P < 0.05) was observed for endometrial trophinin 
mRNA abundance at 36 h post-infusion.  Endometrial gene expression for trophinin at 4 
h (Figure 5.10a) was not significantly different (P > 0.05) between infusion horns.  
Endometrial mRNA abundances for trophinin at 36 h (Figure 5.10b) were approximately 
3.5-fold greater (P < 0.05) in the uterine horn infused with rIL-1β compared with saline.  
Relative mRNA abundance is presented as mean ± SEM.  Bars without a common 
superscript represent a statistical difference (P<0.05) between infusion and steroid 

















































































During early pregnancy in the pig, the induction of obligatory prostaglandin syntheis 
may be related to the conceptus synthesis and production of IL-1β which is transiently 
expressed with estrogen during establishment of pregnancy and rapid trophoblastic 
elongation (Tou et al., 1996b; Ross et al., 2003a).  Interleukin-1β s capable of inducing 
phospholipase A2 mRNA expression (Kol et al., 2002), and cycoloxygenase-2 mRNA 
expression (Huang et al., 1998) in reproductive tissues of various species.  The presence 
of both IL-1β receptors (IL-1β R1, -2) required for proper IL-1β signaling in the 
elongating pig conceptuses (Ross et al., 2003a) suggest that this may be a valid role of 
conceptus synthesized and released IL-1β.  However, the transient, pregnancy specific 
up-regulation of both receptors in the uterine endometrium suggests a role for the 
cytokine with respect to induction of a uterine response as well.  Interleukin-1 receptor 
type 1 (IL-1R1) and IL-1 receptor accessory protein (IL-1β RAP) are both required for 
IL-1β signaling to occur.  The present study indicated that IL-1β acts to increase IL-1β 
and IL-1β R1 mRNA, while estrogen stimulates an increase in IL-1β RAP mRNA.  The 
expression of IL-1R1 in the conceptus and endometrium in the presence of elevated IL-
1β levels suggests that the secretion of IL-1β may have both an autocrine and paracrine 
effect on the endometrium (Ross et al., 2003a).  Ross et al. (2003a) hypothesized that due 
to the potential autocrine signaling, conceptus synthesis and release of IL-1β may be a 
potential contributor to trophoblastic elongation.  Moreover, the sharp decline in IL-1β 
protein in the porcine uterine flushings observed by Ross (2003) and Ashworth (2006) 
may be the result of an increase in IFN-γ.  The extremely sharp decline in protein around 
day 15 of pregnancy in the pig is conspicuously around the time of a copious increase in 
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conceptus originated IFN-γ, which has been demonstrated to attenuate IL-1β protein 
expression levels in vivo in the mouse (Xia et., 2007).  These results may provide a 
possible mechanism by which the porcine embryo can rapidly turn off its own production 
of IL-1β protein in the uterine environment, and in part may need to move to a more 
productive cytokine during the time of attachment to the uterine surface. 
The inflammatory response invoked by the conceptus, most likely through the actions 
of IL-1β, would be one of the fundamental mechanisms created by the conceptus for 
crosstalk with the endometrium.  Moreover, studies in the mouse have demonstrated that 
TH2 proliferation requires IL-1β expression by antigen presenting cells.  These data 
suggest a possible role of IL-1β in regulating the magnitude of the maternal immune 
response which is permissive to the allograft conceptus antigens in the pig.  Thus, the 
precise actions of IL-1β have not been completely elucidated, however, it appears that it 
has an exerted effect on the TH1 and TH2 repertoire at the site of attachment, which are 
both obligatory for early establishment of pregnancy and acceptance of paternal 
alloantigens (Mellor and Munn, 2000).   
Uterine immunological stimulation is followed by the formation of a conceptus-
endometrium extracellular matrix (ECM).  IL-1β has been shown in human studies to 
promote the formation of the ECM through the induction of cell surface integrin binding 
factors (Yang et al., 1999).  The current study demonstrated a need for both IL-1β and 
estrogen for proper production and maintenance of the ECM through matrix 
metalloproteinase (MMP) regulation (Salamonsen and Wolley 1999).  Additionally, the 
current study provides evidence that estrogen acutely increased the content of TNF-α in 
the uterine luminal fluid 4 h post-estrogen exposure.  Given these data, recent studies 
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have demonstrated that the ECM linker molecule tumor necrosis factor α s imulated gene 
6 (TSG-6), which is stimulated by TNF-α, is found in the uterine luminal fluid of the 
pregnant gilt, complexed with key ECM components during pregnancy (Ashworth and 
Geisert, unpublished results).  This may be one pathway for estrogen to begin to stimulate 
ECM production.  Also, the current study demonstrated that the key attachment factors
OPN and trophinin are exclusively up-regulated through estrogen exposure in the porcin
endometrium at 36 h post-estrogen treatment and not through IL-1β secretion.  These 
data are congruent with studies demonstrating trophinin is regulated at some level 
through estrogen exposure in the mouse (Suzuki et al., 2007), and OPN is regulated 
through estrogen in the porcine uterus (White et al., 2006).  Cyclooxygenase -1 and -2 are 
the major source for the production of the required prostaglandins needed during early 
pregnancy.  During ECM stability, PG’s have been shown to induce TSG-6 to aid in 
ECM integrity.  Furthermore, the current study provided evidence that IL-1β increases 
endometrial COX-2 mRNA abundance and induced expression in COX-2 protein in the 
uterine luminal epithelium.  These data would be consistent with changes in COX-2 
expression during early pregnancy in the pig reported by Ashworth et al. (2006).  
Therefore, conceptus IL-1β secretion may help maintain ECM intergrity indirectly 
through induction of endometrial COX-2.   
Data from the current study suggests that IL-1β acts predominantly as an acute 
inflammatory response and up-regulation of IL-1β’s own mRNA and protein, and its 
ancillary signaling appendages such as IL-β R1.  This activation is rapid and appears to 
be lost quickly without continual stimulation.  Furthermore, other up-regulated genes
from the infusion of IL-1β are acute inducible products of the NF-kB pathway, 
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suggesting IL-1β inducing the NF-kB works through the IL-1β R1.  These data would be 
in concurrence with data from Strakova et al., (2005), where the baboon psuedopregnant 
female do not express COX-2 protein in the endometrium but in the presence of the 
conceptus IL-1β secretions COX-2 is induced.  In contrast, with exception of IL-1β RAP, 
estrogen activation of several genes occurs after 24 h.  The estrogen induction of 
trophinin and OPN further dictates the role of estrogen as ECM supportive and facilitates 






Porcine Endometrial Expression of Acute Phase Extraceullar Matrix Components  
(ECM) Following Estrogen Disruption of Pregnancy. 
 
Abstract 
In the pig, administration of estrogen to gilts on days 9 and 10 of pregnancy causes 
conceptus fragmentation and death between days 15 to 18 of gestation. Conceptus 
degeneration is associated with breakdown of the microvilli surface glycocax on the 
lumenal epithelium (LE). We previously identified endometrial expression of inter-alpha-
trypsin inhibitor (ITI) and hyaluronic acid (HA), which are key components of 
extracellular matrix (ECM). Tumor necrosis factor stimulated gene-6 (TSG-6) serves as a 
linker for ECM expansion and is stimulated by prostaglandin E (PGE). We hypothesized 
that early estrogen administration alters the normal expression of ECM components 
forming LE glycocalyx.  Bred gilts (4gilts/trt/day) were treat d with either 5 mg estradiol 
cypionate (E) or corn oil (CO) on days 9 and 10 of gestation.  Uterus was surgically 
removed on either day 10, 12, 13, 15 and 17 of gestation and endometrial tissue snap 
frozen in liquid nitrogen.  Endometrial TNF-α, kallikrein 4, TSG-6, IL-6, and ITIH 
expression was detected throughout normal pregnancy.  TSG-6 protein was detected 
across all days of gestation and was not affected by E. Uterine content of PGE increased 
across the days of pregnancy (P<0.001). Present study demonstrates that E-treatmen  
does not alter the pattern of endometrial ITIH and TSG-6 gene expression which may 





Porcine conceptuses attach to the glycocalyx present on the apical border of the 
surface epithelium occuring during the window of implantation on days 13 through 16 
which is preceeded by rapid expansion of the trophoblastic membrane on day 12 of 
pregnancy (King et al., 1982; Stroband and Van der Lende, 1990; Geisert and Yelich, 
1997).  Elongation of the trophoblastic membrane involves changes in cellular 
morphology through activation of a plethora of embryonic factors (Ross et al., 2008) as 
well as the presentation of uterine factors associated with adhesion and attachment to the 
epithelial surface that will allow incessant attachment of the placenta throughout 
gestation (Bowen et al., 1996; Jaeger et al., 2001).  Apposition and adhesion of the 
trophectoderm to the uterine epithelial apical surface provides a localized incrase in 
transcapillary transport (Keys and King, 1988) as well as an increase in uterine blood 
flow (Ford and Christensen, 1979).  The increase in vascular flow occurrs concomitantly 
with estrogen synthesis and secretion by the elongating conceptuses (Ford et al., 1982; 
Geisert et al., 1982), which is essential for the maintenance of the corpora lutea and 
establishment of pregnancy in the pig. 
Many of the endometrial responses evoked by the developing porcine conceptuses 
during this period of early development and uterine attachment bear a resemblance to the 
acute phase response induced during tissue inflammation (Salier et al, 1996; Geisert and 
Yelich, 1997).  A glycoprotein member of the acute phase proteins, inter-α-trypsin 
inhibitor heavy chain 4 (ITIH4), has previously been isolated and characterized in the 
porcine endometrium (Geisert e al., 1998).  ITIH4 is one of four members of the inter-α-
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trypsin inhibitor heavy chain family of protease inhibitors, which is composed of three
other heavy chains (ITIH1, ITIH2 and ITIH3) and one light chain, termed bikunin (Salier 
et al., 1996).  Stabilization of the extracellular matrix occurs via the linkage of the 
various family members (Bost e al., 1998).  Binding of bikunin to ITIH occurs in three 
forms, pre-α-inhibitor (PαI), inter-α-like inhibitor (IαLI) and inter-α-inhibitor (IαI).  PαI 
is a complex of bikunin bound to a single heavy chain of ITΙΗ3, IαLI is comprised of 
bikunin and ITΙH2 (Enghild et al., 1991) while covalent binding of bikunin to ITIH1 and 
ITIH2, forms IαI (Bost et al., 1998).  Bikunin attaches to the heavy chains through 
binding to a chondroitin sulfate chain.  The serine protease inhibitory activity of 
IαΙ complex originates from bikunin, a 30 kDa serine protease inhibitor containing two 
kunitz-type inhibitory domains (Xu et al., 1998), as the heavy chains are devoid of 
protease inhibitory activity.  ITIH4 is exclusive from other inter-α-trypsin inhibitor heavy 
chains as the Asp-Pro-His-Phe-Ile-Ile sequence for binding to bikunin is absent (Enghild 
et al., 1989; Salier et al., 1996; Bost et al., 1998;) and, in contrast to the other ITIH, is a 
substrate for the plasma serine protease kallikrein (Nishimura et al., 1995).  Since ITIH 
function as hyaluronic-binding proteins, so IΤΙ has been proposed to serve an essential 
role with stabilization of the extracellular matrix (Bost et al., 1998).  Evidence for a role 
of the ITI family in expansion of the cumulus oocyte complex (Chen et al., 1994; Chen et 
al., 1996) supports a principal function of the ITI family in matrix stabilization through 
interaction with hyaluronic acid.  The noninvasive, superficial epitheliochorial 
placentation in the pig is associated with an attenuation of the uterine epithelial 
glycocalyx as well as interdigitation of the trophoblast to the uterine microvilli (Dantzer, 
1985).  Although there is limited information concerning the apical interactions between 
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the trophoblast and uterine surface epithelium, results suggest that changes in the 
glycocalyx play a major role in initial trophoblastic attachment (Bowen et al., 1996; 
Jaeger et al., 2001).  Detection and characterization of ITIH4 (Geisert t al., 1998) and 
bikunin (Hettinger et al., 2001) in the porcine endometrium suggests that the IΤI family 
may be associated with constituentive maintenance of the uterine apical glycocalyx 
necessary for trophoblastic attachment in the pig (Stroband and Van der Lende, 1990).  
Furthermore, ITIH4 expression in the endometrium was present throughout the estrous 
cycle, and early gestation.  Gene expression appeared enhanced under the influenceof 
progesterone in the mid-luteal phase of the estrous cycle and during placental attachment 
in early gestation (Geisert et al., 1998).  ITIH4 has been characterized as an acute phase 
protein (Gonzales-Ramon et al., 1995), which can be induced by interleukin-6 (IL-6), a 
transcriptional regulator associated with acute-phase reactions (Sarafan et l., 1995).  
Bhanumathy et al. (2002) demonstrated that murine liver explants dramatically in reased 
ITIH4 expression following treatment with IL-6.  However, the proinflammatory 
cytokines interleukin 1β (IL-1β) and tumor necrosis factor alpha (TNFα) do not invoke an 
increase in ITIH4 expression, suggesting it may play an integral part in stabilizing the 
extracellular matrix (ECM) (Chen et al., 1994).  Applying Chen’s ovarian ECM model 
for oocyte ovulation, Geisert and coworkers (1998) suggested a similar role for ITIH4 
stabilization of the uterine epithelial surface glycocalyx to prevent conceptus cellular 
erosion and invasion into the uterine stroma. 
 Rheumatoid arthritis studies have shown that patients with increased 
concentrations of ITI-HA in the synovial fluids are closely associated with chronic 
inflammation (Hutadilok et al., 1988).  During inflammation tumor necrosis factor-
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stimulated gene 6 (TSG-6) has been detected in synovial fluid (Wisniewski et al., 1993, 
1997).  Secretion of TSG-6 in rheumatoid arthritis patients allows binding to HA and 
either ITIH1 or ITIH2 (Mukhopadhyay et al., 2001), which can act as a linker module 
between different serum derived hyaluronin associated protein-hyaluronic acid omplex 
(SHAP-HA) molecules to stabilize the ECM in attempt to inhibit erosion of joints.  The 
large mosaic hyaluronan-proteoglycan aggregated complexes may anchor to cells through 
hyaluronan binding to cell surface receptors such as CD44 (Chow et al., 1995).  During 
stabilization of the ECM, ITIH1 and ITIH2 are released from its covalent bond with 
bikunin and transferred to HA (Jessen and Odem, 2003).  Furthermore, bikunin released 
from the complex can suppress inflammation through inhibition of plasmin (Wisniewski 
et al., 1996).   
There are two decisive time periods during early pregnancy which most 
embryonic mortality occurs in the pig.  The periimplantation period (Days 10 to 15), and 
post-placental attachment and expansion of the trophoblast (Days 18 to 40) have been 
shown to be the periods of greatest loss in regards to litter size.  Pope et al (1994) 
estimated 30% of conceptus death occurs in early gestation (Days 10-18).  Furthermore, 
Pope et al. (1986) demonstrated that administration of estradiol-17β (5 mg/day) on days 9 
and 10 of pregnancy resulted in complete embryonic mortality by day 30 of gestation.  
Morgan et al. (1987) indicated that pregnant gilts exposed to estrogen on days 9 and 10 of 
pregnancy resulted only in fragmented and degenerated conceptuses recovered by day 16 
of gestation.  On days 14-16 of gestation, Gries et al. (1989) observed alterations in 
uterine protein content in the flushings of gilts receiving early estrogen.  Embryonic death 
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due to early estrogen exposure is highly correlated to a complete brake down in the 
uterine glycocalyx occurring approximately day 14 of gestation (Blair et al., 1991).   
The objective of the present study was to evaluate if endocrine disruption of 
pregnancy alters ITIH 1, 2, 3, 4, TNF-α, kallikrein 4, TSG-6, and bikunin gene 
expression in the endometrium through alterations in PGE2 concentrations in the uterus 
during early pregnancy of the pig. 
 
MATERIALS AND METHODS 
 
Animals 
Research was conducted in accordance with the Guiding Principles for Care and 
Use of Animals promoted by the Society for the Study of Reproduction and approved by 
the Oklahoma State Institutional Care and Use Committee.  Crossbred cycling gilts of 
similar age (8-10 mo) and weight (100-130 Kg) were checked twice daily for estrus 
behavior (estrus onset = Day 0 of estrous cycle) with intact males.  Gilts assigned to be 
bred were naturally mated with fertile crossbred boars at first detection of estrus, and 
subsequently at 12 and 24 h post estrus detection. 
 
Early Exposure of Pregnant Gilts to Estrogen 
Bred gilts were randomly assigned one of the following treatment groups:  
Control (n = 20), i.m. injection of corn oil (2.5 ml) on days 9 and 10 of gestation or E (n 
= 20), 5 mg i.m. injection of estradiol cypionate (A.J. Legere, Scottsdale, AZ) on Days 9 
and 10 of gestation.    Gilts were hysterectomized on either day 10, 12, 13, 15 and 17 of 
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pregnancy.  Following induction of anaesthesia with 1.8 ml im administration of a 
cocktail consisting of 2.5 ml (Xylazine: 100mg/ml: Miles Inc., Shawnee Mission, KS) 
and 2.5 ml Vetamine (Ketamine HCl: 100 mg/ml Molli Krodt Veterinary, Mundelein, IL) 
in 500 mg of Telazol (Tiletamine HCl and Zolazepum HCl: Fort Dodge, Syracuse, NE), 
anesthesia was maintained with a closed circuit system of halothane (5% flurothane) and 
oxygen (1.0 liters/min).  The uterus was exposed via midventral laparotomy and a 
randomly selected uterine horn, and its ipsilateral ovary, excised.Uterine hors we e 
flushed with 20 ml PBS, conceptuses  were collected, flushings centrifuged to remove 
cellular debris, and the superatnant stored at -20°C.  Endometrial tissue was harvested 
from the uterine horn and snap frozen in liquid nitrogen for subsequent RNA analysis 
both as previously described (Ross et al., 2006). 
 
RNA Extraction  
 Total RNA was extracted from endometrial tissue using RNAwiz reagent 
(Ambion, Inc. Austin, TX).  Approximately 0.5 g of endometrial tissue was homogenized 
in 5.0 mL of RNAwiz using a Virtishear homogenizer (Virtis Company Inc., Gardiner, 
NY).  RNA was resuspended in nuclease free water and stored at -80°C.  Total RNA was 
quantified with a spectrophotometer at an absorbance of 260 nm and purity was verified
using the 260/280 ratio.   
      
Quantitative 1-Step RT-PCR 
 Quantitative analysis of endometrial (ITIH 1, 2, 3, 4, TNF-α, kallikrein 4, IL-6, 
TSG-6, and bikunin) mRNA were analyzed using quantitative real time reverse 
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polymerase chain reaction (RT-PCR) as previously described by our laboratory 
(Hettinger et al., 2001).  The PCR amplification was performed in a reaction volume f 
15 µl using an ABI PRISM 7500 Sequence Detection System (PE Applied Biosystems, 
Foster City, CA).  The transcripts were evaluated using dual labeled probes with 6-Fam 
(5’ reporter dye), and TAMRA (3’ quenching dye).  Primer and probe sequences for the 
amplification of (ITIH 1, 2, 3, 4, TNF-α, IL-6, TSG-6, kallikrein 4, and bikunin) (Table 
1) were generated from porcine sequences previously established in our lab (Geisert et 
al., 2003).  Total RNA (100 ng) was assayed in duplicate using thermocycling conditions 
for one-step cDNA synthesis of 30 min at 48°C and 95°C for 10 min, followed by 45 
repetitive cycles of 95°C for 15 sec and 60°C for 1 min.  Ribosomal 18S RNA was 
assayed in each sample to normalize RNA loading.  Using the comparative CT m thod 
(Ashworth et al., 2006), relative quantification and fold gene expression difference 
between treatment and day were determined for the endometrial samples.  Diff rences in 
mRNA expression of (ITIH 1, 2, 3, 4, TNF-α, IL-6, TSG-6, kallikrein 4, and bikunin) 
were determined by subtracting target CT of each sample from its respective ribosomal 
18S CT value, which provides the sample ∆CT value.  Calculation of the ∆∆CT involves 




Table 6.1.  PCR primer and probe sequences used for quantitative RT-PCR.   
 GenBank 
Gene         Forward Primer/Reverse Primer/Probe      Accession  
ITIH1  Forward 5’-TGACTGGCGTGGACACTGA-3’ Y11546 
 Reverse 5’-GCACAGGGTGTCCTCTTTCTG-3’ 
 Probe 5’-CCCCACTTCATCATCCGCGTGC-3’ 
 
ITIH2  Forward 5’-CGCGGTAGGACCTTCAGTGA-3’ Y11545 
 Reverse 5’-GAAGTGCGGGTCATTTTCGA-3’ 
 Probe 5’-AGGTAATGCCTCCTCCACACGTGATGA-3’ 
 
ITIH3  Forward 5’-TGGTTTGTTCACGACAATGG-3’ D84320 
 Reverse 5’-AGGACGACTCTGTCGATCGG-3’ 
 Probe 5’-TGTCCCCGACCTGTTCTGAGTGG-3’ 
 
ITIH4  Forward 5’-TGCGTACAAGTGGAAGGAAACA-3’ U43164 
 Reverse 5’-CCCGCCTTGTCCATGGT-3’ 
  Probe          5’-TCTACTCAGTGATGCCCGGCCTCAA-3’   
 
Bikunin           Forward        5’-TGTGGAGGCCTGCAGTCTC-3’ X53685  
  Reverse        5’-CATCAAACGCCCAGAGCTG -3’ 
  Probe          5’-CATCGTCTCCGGCCCCTTGCC-3’ 
 
Kallikrien 4  Forward        5’-ATGTTCCTCCTGCTGACAGC-3’          X54374 
  Reverse         5’- CCCTGGACACCTCTGTCACC-3’ 
  Probe            5’- ATTCCTACACCATCGGGCTGGGTCT-3 
 
TNF-α  Forward        5’- CAAGGACTCAGATCATCGTCTCA-3’          X45736 
  Reverse         5’- CGGCTTTGACATTGGCTACAA-3’   
  Probe            5’- ACCTCAGATAAGCCCGTCGCCCAC   
             
TSG-6  Forward        5’- TACAAGCTTACCTACGCAGAGGC-3’        X84554 
  Reverse        5’- TTTCTGGCTGCCTCTAACTGCT-3’ 
  Probe            5’- AGCGGTGTGTGAATACGAAGGTGGCCGTCT-3’ 
 
IL-6   Forward        5’- AGCTATGAACTCCCTCTCCACAAG-3’        X64354 
  Reverse        5’- TGCTTCTGGTGATGGCTACTGCCTTCCCT3’ 





as an arbitrary constant to subtract from all other ∆CT sample values.  Fold differences in 
gene expression of the target gene are equivalent to X-∆∆CT, where X is the efficiency of 
the amplification reaction.  
 
Western Blot analysis of TSG-6 
Cytoplasmic protein was extracted from endometrial tissue using T-PER 
reagent (Pierce Inc., Rockford, IL) to which a protease inhibitor cocktail, HALT 
(Pierce Inc., Rockford, IL) was added.  A total of 250 mg of endometrial tissue was 
homogenized in 5 mL T-PER reagent on ice using a Virtishear homogenizer ( Virtis 
Company Inc., Gardiner, NY).  Following homogenization samples were centrifuged at  
10,000 x g for 5 min, supernatant collected and stored at -20°C until utilized for western 
blot analysis.  Cytoplasmic protein was assayed by Bradford Assay.  Samples were boiled 
at 95°C for 90 sec in equal volumes of sample denature buffer (0.125 M Tris-HCL [pH  
6.8], 205 mg glycerol, 4% SDS, 10% β-mercaptoethanol, and 0.0025% bromophenol blue 
and  protein was separated electrophoritcally in a 10% polyacrylamide gel.  Proteins were 
transferred to a PVDF membrane (Millipore Corp. Bedford, MA) by using a semi-dry 
immunoblot apparatus (MilliBlot-SDS System) at 350 V for 3 h.  Membranes were 
washed with Tris-buffered saline (TBS, 10mM Tris, 150mM NaCl) containing 0.05% 
Tween 20 [TTBS] and then blocked with 5% nonfat dried milk for 1 h.  After washing 
3X with TTBS for 10 min, the membrane was incubated for 2 h with a rat anti-human 
TSG-6  monoclonal antibody (1:10,000) (Gift from Dr Day, UK).  After washing 3X with
TTBS for 10 min each, the membrane was incubated with goat anti-rat secondary 
antibody (1:1000) (Bio-Rad, Hercules CA) for 1 h.  Membranes were washed with TTBS 
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3X for 10 min followed by addition of color development solution (Bio-Rad Immuno-
Blot kit: Bio-Rad Hercules, Ca).   
 
Enzyme-Linked PGE2 Competitive Binding Assays 
Total content of prostaglandin E2 (PGE2) in the uterine flushings collected were 
quantified using a commercial ELISA (R&D Systems, Minneapolis, MN) in accordance 
with manufacturer’s specifications.  All standards and samples were assayed in duplicate.  
The intra-assay coefficient of variation for the PGE2 assay was 5.6 % 
 
Statistical Analysis 
 Data were analyzed by least squares ANOVA using the Proc Mixed model of th  
Statistical Analysis System (SAS, 1988).  The statistical model used to evaluate 
endometrial ITIH 1, 2, 3, 4, TNF-α, TSG-6, IL-6, kallikrein 4, and bikunin mRNA 
expression and uterine flushing PGE2 content included the effects of day, treatment (Con, 
E), and the day x treatment interaction.  If the treatment effect was significant, (P < 0.05), 
treatment means were separated and compared by t-test using the PDIFF option of SAS.  
Additionally, due to unequal variances of PGE2 the original data was transformed using 
log and square root transformations for the statistical analysis.   
 
Results 
Conceptus Development and Viability 
Normal spherical conceptuses were recovered from the flushing media of Con and 
E-treated gilts on day 10 of pregnancy.  On day 12 of pregnancy, a select few pregnancies 
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contained spherical conceptuses, but filamentous concetuses were recovered in the 
majority of the gilts.  Viable peri-attachment conceptuses were recovered in both Con and 
E-treated gilts on day 13 of pregnancy; however, conceptuses collected on days 15 and 
17 of the E-treated gilts were fragmented and degenerated.  
 
ITIH 1, 2, 3, and 4, mRNA Expression 
 Endometrial mRNA expression for ITIH 1 and 3 (Figures 6.1 and 6.3) were 
unaffected by day of pregnancy or E treatment (P > 0.05).  Endometrial mRNA 
expression for ITIH 2 was significantly affected by treatment (Figure 6.2).  Endometrial 
gene expression for ITIH 4 was significantly affected by day of pregnancy (Figure 6.4). 
 
Bikunin mRNA Expression 
Endometrial gene expression for bikunin was not altered due to E-treatment, 
however there was a significant effect on day of pregnancy (P < 0.05). Although bik nin 
expression was similar on days 10, 12, and 13 of pregnancy, expression increased by 3-
fold on day 15 and 5-fold on day 17  
 
Kallikrein 4 mRNA Expression 
 Endometrial mRNA expression for kallikrein 4 exhibited a significant treatmn  
by day interaction (P < 0.05).  Kallikrein 4 mRNA expression was the highest in Con 
gilts on day 12 but E-Treatment severely attenuated kallikrein 4 mRNA expression by 




TNF-α Gene Expression 
 Endometrial gene expression for TNF-α (Figure 6.7) demonstrated a significant 
day effect (P < 0.05).  TNF-α gene expression was greatest on day 15 of pregnancy and 
lowest on days 10, 12, and 13.  Days 10, 12, and 13 were statistically the same, while day 
17 was different from days 10, 12, 13, and 15.   
 
IL-6 Gene Expression 
 Endometrial gene expression for IL-6 exhibited a significant day effect (P < 0.05).  
Gene expression was the lowest in Con gilts on day 12 of pregnancy (Figure 6.8).   
 
TSG-6 Gene Expression 
Endometrial gene expression for TSG-6 (Figure 6.9) was unaffected by day of 
pregnancy or E-treatment (P > 0.05).   
 
TSG-6 Western Blot analysis  
 Western blot analysis of endometrial cytoplasmic protein detected a 36-kDa 
immunoreactive product to the TSG-6 antiserum free and TSG-6 ITIH complex controls 














Figure 6.1  Relative changes in mRNA abundances in endometrial ITIH 1 gene 
expression on days 10, 12, 13, 15, and 17 following either control animals (Orange bars) 
or E-treated animals (Black bars).  No differences were detected between means for ITIH 

























































Figure 6.2  Relative changes in mRNA abundances in endometrial ITIH 2 gene 
expression on days 10, 12, 13, 15, and 17 following either control animals (Orange bars) 
or E-treated animals (Black bars).  A significant treatment effect was detected between 

















































































Figure 6.3  Relative changes in mRNA abundances in endometrial ITIH 3 gene 
expression on days 10, 12, 13, 15, and 17 following either control animals (Orange bars) 
or E-treated animals (Black bars).  No differences were detected between means for ITIH 

























































Figure 6.4  Relative changes in mRNA abundances in endometrial ITIH 4 gene 
expression on days 10, 12, 13, 15, and 17 following either control animals (Orange bars) 
or E-treated animals (Black bars).  A significant day effect was detected between means 










































































Figure 6.5 Relative changes in mRNA abundances in endometrial Bikunin gene 
expression on days 10, 12, 13, 15, and 17 of either control animals (Orange bars) or E-
treated animals (Black bars).  No differences were detected between means for bikunin 
gene expression due to estrogen treatment, however there was a significant effe t on the 




















































ELISA Assay of Prostaglandins in Uterine Flushings  
 No treatment effect was detected for total uterine content of PGE2.  Content of 
PGE2 in the uterine flushings was effected by day (P<0.001).  Uterine PGE2 content was 
lowest (6.23 ng) on day 10 of gestation (Figure 6.11), increasing 100-fold after conceptus 
elongation (Day 13).  Uterine content of PGE2 reached a maximum (1700 ng) by day 17 
of gestation.  No treatment effect was detected for total uterine content of PGE2 in uterine 
flushings expressed in the uterine luminal flushings (Figure 6.10B) were unaff cted by ay 
and endocrine disruption of pregnancy.   
 
Discussion 
The noninvasive form of implantation in the pig results from endometrial 
secretion of protease inhibitors that regulate the highly invasive activity of the trophoblast 
(Roberts et al., 1993).  Furthermore, although pig conceptuses are extremely proteolytic 
and invasive outside the uterine environment (Samuel and Perry, 1972), endometrial 
secretion of protease inhibitors permits trophoblastic attachment to the glycocal x on the 
apical uterine surface epithelium (Stroband and Van der Lende, 1990).  Placentation in 
the pig is associated with a reduction of the uterine epithelial glycocalyx as well as 
interdigitation of the trophoblastic and uterine microvilli (Danzter, 1985).  Although there 
is limited information concerning the apical interactions between the trophoblast and 
uterine surface epithelium, results suggest that change in the glycocalyx plays a major 













Figure 6.6.  Relative changes in mRNA abundances in endometrial kallikrein 4 gene 
expression on days 10, 12, 13, 15, and 17 of either control animals (Orange bars) or E-
treated animals (Black bars).  A significant treatment * day interaction was detected 
between means for kallikrein 4 gene expression (P < 0.05).  Days with differing 




































































Figure 6.7.  Relative changes in mRNA abundances in endometrial TNF-α gene 
expression on days 10, 12, 13, 15, and 17 of either control animals (Orange bars) or E-
treated animals (Black bars).  No differences were detected between means for TNF-α 
gene expression due to estrogen treatment, however there was a significant effe t on the 








































































Figure 6.8.  Relative changes in mRNA abundances in endometrial IL-6 gene expression 
on days 10, 12, 13, 15, and 17 of either control animals (Orange bars) or E-treated 
animals (Black bars).  A significant day effect was detected between mea s for IL-6 gene 
expression due to specificity of day of pregnancy (P < 0.05).  Days with differing 




























































Figure 6.9.  Relative changes in mRNA abundances in endometrial TSG-6 gene 
expression on days 10, 12, 13, 15, and 17 following either control animals (Orange bars) 
or E-treated animals (Black bars).  No differences were detected between means for TSG-






















































Figure 6.10.  A) Western blot analysis of endometrial TSG-6 expression of free TSG-6 
(36 kDa)  Free TSG-6 and TSG-6 complexed with ITIH (~139 kDa).  B)  Free TSG-6 and 
TSG-6 complexed with ITIH expressed in the uterine luminal fluid of the control animals 
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Q75 rat anti-human TSG-6 (200 ng) mAB (1 in 10,000) 















Figure 6.11. Total uterine luminal content of PGE2 in the uterine luminal flushings on 
days 10, 12, 13, 15, and 17 following either control animals (Orange bars) or E-treated 
animals (Black bars).  Days with different superscripts represents significant differences 


















































We have previously demonstrated that estrogen administration causes disruption of the 
apical uterine surface glycocalyx (Blair et al., 1991).  Breakdown of the epithelium 
glycocalyx was associated with the loss of an endometrial 30 kDa glycoprotein which 
was determined to be a cleavage product of ITIH4 (Geisert et al., 1998).  All ITIH’s 
possess a von Willebrand type-A domain which functions as a target for adhesion 
molecules such as integrins, collagen, proteoglycans and heparin.  Previously, our lab 
demonstrated through western blot analysis of uterine flushings and endometrial cultures 
established that associations between the ITIH’s and bikunin (light chain) occur in the pig 
(Geisert et al., 2003).  Since the release of bikunin may be necessary for the association 
of hyaluronic acid with ITIH 1, 2, 3 (Jessen et al., 1994), and loss of bikunin gene 
expression causes infertility in mice through disruption of the cumulus oophorus (Zhuo et 
al., 2001), it is possible that disruption of  ITIH and/or bikunin might occur with estrogen 
treatment.  However, our results indicate that estrogen treatment on day 9 does not alter 
endometrial gene expression of bikunin or ITIH1, 3, and 4.   
TSG-6, which is a secreted product, has been demonstrated to be involved with 
extracellular matrix formation through forming complexes with the ITIH’s (Carrette et 
al., 2001).  Our study demonstrated the presence of TSG-6 and that TSG-6 protein forms 
a complex with the ITIH’s as found in the uterine flushings of the pregnant gilt. 
Therefore, the all components for forming the apical glycocalyx in the pig LE s present.  
However, estrogen treatment of gilts did not alter TSG-6 mRNA expression. 
Kallikrein 4 gene expression was significantly depressed on day 12 of pregnancy 
in gilts treated with estrogen on day 9.  There is a large increase in IGF-1 and 2 in the 
uterine lumen on day 12 of pregnancy in the pig (Geisert et al., 2001).   IGF binding 
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proteins (IGFBP) are a substrate for kallikrein 4 which is a member of the serin  protease 
family.  The proteolysis of IGFBP’s around day 12 of pregnancy would be coincidental 
with the observed increase in bioavailible IGF’s within the uterine luminal fluid (Geisert 
et al., 2001) and the increase in kallikrein 4 mRNA expression making kallikrein 4 an 
excellent candidate for IGFBP proteolysis.  However, recent studies conducted by 
Ashworth et al (2005) demonstrated that estrogen disruption of pregnancy resulted in 
early proteolysis of IGFBP’s on day 10 of porcine pregnancy.  Albeit, we did observe a 
severe attenuation in kallikrein 4 due to estrogen treatment on day 12, kallikrein 4 mRNA 
was not increased on day 10.  Thus, kallikrein 4 expression does not have a temporal 
relationship with the premature release of IGFBP’s observed by Ashworth et al (2005).  
Given these results, kallikrein 4 appears to be regulated by estrogen at some level, but the 
mechanism and target of the endocrine dysfunction still remains unclear.   
TNF-α was unaffected by estrogen treatment but was affected by day of 
pregnancy.  Consequently, the TNF-α increase we observed in PGE2 production would 
provide a possible means for the expression levels observed in TSG-6 protein.  Although 
TSG-6 gene expression was unaffected by estrogen treatment, it is the first time TSG-6 
protein has been localized to the porcine uterus complexed with the ITIH’s during 
inflammation TSG-6 is detected in synovial fluid (Wisniewski et al., 1993, 1997).  
Secretion of TSG-6 in rheumatoid arthritis patients allows binding to HA and either
ITIH1 or ITIH2 (Mukhopadhyay et al., 2001), which can act as a cross linker between 
different SHAP-HA molecules to stabilize the ECM in attempt to inhibit erosion of joints.  
The large mosaic hyaluronan-proteoglycan aggregated complexes may anchor to cells 
through hyaluronan binding to cell surface receptors such as CD44 (Chow et al., 1995).  
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During stabilization of the ECM, ITIH1 and ITIH2 are released from its covalent bond 
with bikunin and transferred to HA (Jessen and Odem, 2003).  Furthermore, bikunin 
released from the complex can suppress inflammation through inhibition of plasmin 
(Wisniewski et al., 1996).  The proposed model for ECM stabilization is depicted in 
(Figure 6.12).   
Studies have demonstrated that TSG-6 gene expression can be induced by TNF-α, 
IL-1β, and PGE2 (Fujimoto et al., 2002).  Furthermore, the current study has 
demonstrated a linked product containing TSG-6 and ITIH’s through western blotting.  
Therefore, ITIH 2 appeared to be the only ITIH altered by the early estog n exposure 
and this becomes paramount in regards to the ECM stabilization.  ITIH2 has a direct 
involvement in the formation of the required heterodimerization with ITIH1, and the 
attenuated gene expression levels may be a persistent problem leading to decreased levels 
of ITIH2 in the uterine surface creating a dimer deficiency for ITIH1.  Additionally, 
future studies will be required to clarify if the gene expression exhibiting ITIH2 
deficiency is translated deficiency in the ITIH2 protein product in the uterine lum n.  .  
Future studies will be needed to understand the role of bikunin, ITIH and TSG-6 plays 












Figure 6.12. Postulated role of ITIH and TSG-6 involvement with stabilization of the 
hyaluronan-containing extracellular matrix (ECM) of the complex between CD 44 
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Endometrial IL-6 mRNA expression was found to be significantly decreased on 
day 12 of pregnancy compared to the other days measured (10, 13, 15, and 17).  This is in 
agreement with the results of Anegon et al., (1994) who demonstrated that conceptus 
mRNA expression of IL-6 was lowest around day 11 to 12 during conceptus 
development.  Our data and Anegon’s data suggest there is a temporal down regulation of 
IL-6 gene expression in both conceptus and maternal tissues during the critical period of 
maternal recognition of pregnancy; the reason has yet to be elucidated 
In the current study, we have shown that the transcriptome for ITIH 1,-3, and-4 
appear to be controlled through aspects other than estrogen regulation.  Conversely, ITIH 
2 appears to be regulated at some level through the appearance of estrogen, and ITIH 4 
appears to be day dependent based on its appearance during pregnancy.  However, for all 
the ITIH’s there may be an additional layer of regulation at the regulatory RNA level, 
which may be regulated through estrogen either directly or indirectly but this remains 






SUMMARY AND CONCLUSION 
 
The establishment of pregnancy in any mammalian species requires specific timed 
molecular events at the conceptus uterine interface during days 11 to 15 of gestation.  It is 
during this period that the conceptuses produce both IL-1β and estadiol-17β concomitant 
with the rapid elongation of the conceptus trophectoderm.  Sufficient secretory capacity 
of the pig conceptus (Polge et al., 1966; Dziuk, 1968) and an adequate extent of 
trophoblastic elongation (Stroband and Van der Lende, 1990) are requirements for the 
establishment of pregnancy and conceptus survival in the pig.  Acquiring these major 
conceptus developmental landmarks requires the temporal and spatial expression of the 
appropriate mRNA transcripts to generate a phenotype suitable for continued growth and 
development.  However, little information has been isolated specifically identifying 
endometrial transcripts devoid of any conceptus contributions that are critical for this 
stage of endometrial development.  
 Not only is appropriate conceptus development critical for the establishment of 
pregnancy in the pig, uterine endometrial function regulating uterine receptivity and 
conceptus attachment are necessary components for pregnancy establishment.  Two 
major factors regulating endometrial function during the period of conceptus attachment 
and implantation are conceptus synthesis and release of estradiol-17β and conceptus 
release of IL-1β. 
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Cooperatively, the research presented in this dissertation uses separate approaches 
to better understand the biology of pregnancy establishment in pigs with respect to 
uterine dynamic changes during days 10 to 18 of gestation.  This diminutive period of 
development regarding the length of gestation is critical due to the numeruous 
physiological events occurring in both the conceptus and the endometrium required for 
pregnancy establishment in the pig.  Conceptus trophoblastic elongation is simultaneous 
with endometrial programming that allows uterine receptivity, and uterine receptivity can 
be modified in response to conceptus secretory factors, such as estradiol-17β (Geisert et 
al., 1982b) and IL-1β (Ross et al., 2003b). 
Estrogen is critical for the proper establishment of pregnancy in the pig (Bazer 
and Thatcher, 1977) however; it can be detrimental if uterine exposure to estrogen occurs 
prematurely during early gestation (Pope et al., 1986, Blair et al., 1991; Ashworth et al., 
2006).  With the delicate relationship between the optimal point of endometrial exposure 
to estrogen during early pregnancy and its affect on conceptus survivability, one can infer 
a spatiotemporal regulation of essential endometrial factors affecting pregnancy outcome 
occurs through aberrant estrogen exposure.  Furthermore, although the endocrine-
exocrine theory points to estrogen as the maternal recognition of pregnancy signal in the 
pig (Bazer and Thatcher, 1977), the molecular mechanisms behind estrogen’s stimulation 
on the endometrium are not complete.  Our approach isolated the direct effect of estrogen 
and its effects as an endocrine disruptor for the identification of endometrial genes altered 




During the microarray study of this thesis, utilization of the Affymetrix 
GeneChip® Porcine Genome Array allowed the identification of a plethora of fact rs that 
are differentially expressed at the opening of the implantation window aberrantly due to 
early estrogen exposure.  Furthermore, as determined though statistical analysis using 
dChip, 84 of the 117 genes that were differentially expressed were due to early estrogen 
exposure when comparing days 13 to 15.  These data would suggest when aberrant 
estrogen exposure disrupts pregnancy; the window from days 13 to 15 is as an important 
and critical time period for endometrial changes in gene expression and secretions 
essential for conceptus development and survival.  Additionally, the lack of abundance in 
differential gene expression in endometrium between days 13 and 15 of gilts exposed to 
estrogen at the time that conceptus estrogen normally occurs (Day 11-12) during early 
pregnancy indicates that early estrogen exposure selectively alters expression of 
endometrial genes which do not normally increase with conceptus estrogen secretion on 
day 12.  
Therefore, cluster analysis was paramount in regards to identification of temporal 
expression patterns associated with estrogen regulation.  When early estrogen disrupts 
pregnancy, the period between days 13 to 15 are the most critically affected with 84 
genes found to be differentially regulated during this time period.  Furthermore, the 84
differentially expressed genes were clustered into 3 groups of genes (Cluster 2, 6, and 7), 
and of these genes 47 were up regulated and 37 were downregulated due to the estrogen.  
Consequently, these genes might serve as an initial biomarker for possible identification 
of endocrine disruption of the early porcine implantation window.   
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Chemokines have been implicated with the enhancement of the biological 
immune response as well as having a key role in maintaining homeostasis of the immune 
system.  Chemokines are classified into four distinct groups (CXC, CC, C and CX3C)
based on their inherent (amino acid sequence) and structural properties (Berger et al., 
1999, Rollins et al., 1997).   Early foundational studies limited chemokine expression to 
inflammatory and immune cells exclusively; however, subsequent studies have shown 
that to be false.  Recently, chemokine expression was localized in the murine uterus at the 
time of peri-implantation (Nagaoka et al., 2003a).  Furthermore, localization of 
chemokine receptors has been detected in the decidua and placenta of humans (Red-
Horse et al., 2001).  Chemokine ligand and receptor expression patterns are 
conspicuously expressed in uterus of the human, murine, and ovine during the window of 
implantation and/or attachment of the conceptus suggesting a key role for modulation of 
endometrial erosion and attachment between the embryo and maternal tissues.  
Specifically, chemokine ligand 11 (CXCL-11) gene expression has been reported to 
increase during the window of implantation in the human (Hirota et al., 2006) and the 
ewe (Imakawa et al., 2006).  Hirota et al., (2006) demonstrated exposure of uterine 
endometrial epithelial cells (EEC) in culture to IFN-γ stimulated secretion of CXCL-11, 
but not the uterine endometrial stromal cells (ESC).   Furthermore, CXCL-11 stimulated 
proliferation in the ESC cells but inhibited proliferation in the EEC cells while 
concomitantly stimulating apoptosis.  These data suggest IFN-γ working through CXCL-
11 may play a regulatory role during implantation.  Additionally, Hirota et al. (2006) 
suggest a prejudice towards the stromal layer for survival conditions, while inducing 
negative conditions in the epithelial layer during endometrial invasion in the mouse.  
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Hirota et al., (2006) also demonstrated that CXCR3, the receptor for CXCL-11, is also
present in the epithelial and stromal layers of the endometrium, T cells, and the conceptus 
trophoblastic cells.  These data represent a useful model for motility and chemotaxis 
during the window of implantation in that upon secretion of CXCL-11 from the EEC 
layer, trophoblastic cells and T cells (TH1) migrated accordingly.  Hirota’s data makes a 
nice complement to what our lab has already established to date in the pig.  The 
appearance of CXCL-11 is closely associated with window of implantation in thepig.  
Additionally, the current study characterized IL-18 secretion which originates from the 
uterine endometrium during the period of trophoblast attachment to the uterine surface 
from day 13 to 18 of pregnancy.  IL-18 must be processed from the latent form to the 
active molecule through processing by caspase-1.  One could infer based on CXCL-11 
appearance during the window of implantation, that it may provide a pro-apoptotic signal 
to uterine epithelial cells, resulting in a release of caspase-1 from the uterine epithelial 
cells via CXCL-11’s ability to induce apoptosis.  Furthermore, this may be a mechanism 
allowing site specific areas of the endometrium to undergo apoptosis as opposed to the 
whole endometrium, while providing a receptive epithelial layer for proper attachment 
during this period.  Similar to CXCL-11, uterine CXCL-9 secretion is stimulated through 
progesterone and/or estrogen (Kitaya et al., 2004).  Stark contrasts exist between CXCL-
9 and CXCL-11 is that CXCL-9 is induced by the pleiotrophic cytokine IL-18, while 
CXCL-11 and CXCL-10 and the only known chemokines controlled by estradiol and 
progesterone and are directly responsible for the migration of perhperial blood NK cells 
into the uterus and creating a residential NK cell then termed uNK cells (Sentman et al., 
2004).  The induction of CXCL-11 into the human endometrium is facilitated through the 
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ovarian sex steroids estrogen or progesterone (Sentman et al., 2004); however, wh ther
the affects are direct or indirect from the steroids have yet to be elucidated.  Furthermore, 
the study also established chemokine receptor CXCR3 is expressed on the surface of 
uNK cells, which services the ligands CXCL-9 and -11.  According to data in the study,
the overall chemokine theme suggests clearly that CXCL11 is estrogen regulated, while 
based on temporal expression CXCL9 is IL-18 induced.  These alterations in gene 
expression demonstrated in the uterine endometrium are similar to the asynchron  
between the endometrium and conceptus described by Polge (1982) where embryos 
transferred greater than 48 h out of synchrony with the uterine endometrium fail to 
establish pregnancy.  These data suggest that exogenous estrogen administration causes 
significant alterations in endometrial gene expression on days 12 and 13 of gestation and 
may prevent attachment and promote immunological rejection of the conceptus resulting 
in its deterioration by day 15 of gestation.  However, the underlying implication is that 
during normal gestation, conceptus induced changes through endogenous estradiol-17β 
secretion occur synchronously to the dramatic expression and phenotypic changes that 
enable the conceptus to survive in a uterine environment following estrogen stimulation. 
Estrogen is a critical component for the establishment of pregnancy in the pig 
(Bazer and Thatcher, 1977) but can also be detrimental if uterine endometrial exposure to 
estrogen occurs at an abnormal time during early gestation (Pope et al., 1986, Blair et al., 
1991; Ashworth et al., 2006).  The critical relationship between the temporally acceptable 
point of endometrial exposure to estrogen during pregnancy and its affect on conceptus 
survivability suggests that spatiotemporal regulation of key factors affecting pregnancy 
outcome occur through estrogen.  Also, while it is widely accepted that estrogen is th  
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maternal recognition of pregnancy signal, the molecular mechanisms behind estrogen 
stimulation are not well described.  Our approach has allowed the identification of 
endometrial genes affected by estrogen stimulation in the presence of IL-1β 
The opening of the implantation window is a critical process which occurs during 
peak progesterone production by the corpora lutea, is characterized by uterine receptivity 
to conceptus attachment, and occurs in all reproductively capable gilts, regardless if 
mating, fertilization and early conceptus development have transpired.  Endometrial 
phenotype during uterine receptivity is poised to secrete prostaglandins in an endocrine 
fashion, resulting in luteolysis and a return to estrus or release prostaglandins in and 
exocrine fashion, sustaining the corpora lutea; and establish a communication network 
with the developing conceptus, thereby commencing gestation.  The downregulation of 
progesterone receptor (Fazleabas et al., 1999; Spencer and Bazer, 1995; Meikle et al., 
2001; Hartt et al., 2005) and the activation of NFκB (Nakamura et al., 2004a) during 
pregnancy establishment are not unique to the pig (Lessey et al., 1988, 1996).  We were 
interested in the molecular factors that contribute to this endometrial phenotype. 
 This study evaluated potential mechanisms by which endometrial modifications 
can occur through the interplay between estrogen around the time of maternal 
recognition, and the conceptus secretions of IL-1β into the uterine lumen.  In the current 
study, the data suggest that IL-1β actions are predominantly that of acute inflammatory 
responses and up regulation of IL-1β’s own mRNA and protein, and its ancillary 
signaling appendages such as IL-R1.  Additionally, of the genes observed in this study, 
IL-1β regulation of the mRNA expression was limited to the 4 h sampling point post-
infusion.  Furthermore, genes in the current study up regulated from the infusion of IL-1β 
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are acute inducible products of the NF-κB pathway, suggesting IL-1β inducing the NF-
κB working through the IL-1β R1.  These data would be in concurrence with data 
observed from Strakova et al., (2005), where the authors observed that the baboon 
psuedopregnant animal did not express COX-2 protein in the endometrium; however, in 
the presence of the conceptus IL-1β secretions COX-2 was induced.  In contrast, gene 
induced through the actions of estrogen for the observed mRNAs were induced at the 36 
h sampling point except for IL-1β RAP, which was induced at the 4 and 36 h sampling 
periods by estrogen.  The estrogen induction of trophinin and OPN further dictates the 
role of estrogen as ECM supportive and facilitates attachment based on its timing and 
appearance during the window of implantation.  The involvement of steroid hormones, as 
well as their receptors, has in many studies been shown to affect NFκB activity in a 
variety of tissues.  Estrogen, progesterone, and their receptors have been shown in 
multiple tissue types to regulate NFκB activity (Kalkoven et al., 1996; Ghilsetti et al., 
2005, Hardy et al., 2006) and as described, these mechanisms associate well with the 
steroid hormone regulation of the estrous cycle and early pregnancy in the pig. 
While the IL-1β study provided delightful insight into cytokine control during 
days 12 through 15 of the porcine pregnancy, the IL-18 study conducted in this thesis 
provided some very insightful data by which these days were under the control of IL-18. 
Ross et al. (2003) demonstrated that the peri-implantation porcine conceptuses secret  
large amounts of IL-1β into the uterine lumen during the transition to the filamentous 
morphology (Day 12-15), which rapidly decreases to nadir levels by Day 18 of gestation.  
IL-18 may be an attractive cytokine to compensate for the declining levels in IL-1β.  IL-
18 is also known as interferon inducing factor due to its ability to induce IFN-γ.  In the 
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elongating porcine conceptuses on day 12, IFN-γ has been observed to increase 
substantially during day 15 of gestation, which may be attributed to the release of IL-18 
from the endometrium.  Moreover, Joyce et al., (2006) demonstrated that greatest levels 
of IFN-γ occur from the trophoblast during days 15 through 18 of the porcine pregnancy, 
which is clearly complimentary to our IL-18 increase during days 15 through 18 of 
pregnancy.  Furthermore, both the mRNA and protein expression patterns observed in 
caspase-1are temporally aligned for the proper processing of both IL-1β and IL-18 during 
early pregnancy.  Conceptus caspase-1 mRNA expression is greatest in abundance during 
days 13 and 17.  Furthermore, endometrial caspase-1mRNA expression was markedly 
elevated during days 15 and 17 of pregnancy.  These data would infer IL-1β processing 
upon or during liberation from conceptus origin during the initial release of IL1β around 
day 12 of pregnancy, based on an absence of caspase-1 protein found in the uterine 
luminal flushings.  Additionally, the increased expression of caspase-1 mRNA levels 
observed in the endometrium with an elevation of caspase-1 protein in uterine flushings 
would be consistent with our increase in observed secretion of IL-18 during days 15 to 
18.  Given these data, we have clearly established evidence for cytokine crosstalk 
between the developing conceptuses and endometrium based on gene expression of IL-18 
exclusively expressed in endometrium, while completely devoid in all days of conceptus 
during early pregnancy. 
The noninvasive form of implantation in the pig results from endometrial secretion of 
protease inhibitors that regulate the highly invasive activity of the trophoblast (Roberts et 
al., 1993).  Furthermore, although pig conceptuses are extremely proteolytic and invasive 
outside the uterine environment (Samuel and Perry, 1972), endometrial secretion of 
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protease inhibitors permits trophoblastic attachment to the glycocalyx on theapical 
uterine surface epithelium (Stroband and Van der Lende, 1990).  Placentation in the pig is 
associated with a reduction of the uterine epithelial glycocalyx as well as interdigitation 
of the trophoblastic and uterine microvilli (Danzter, 1985).  Although there is limited 
information concerning the apical interactions between the trophoblast and uterine 
surface epithelium, past results suggest that change in the glycocalyx plays a major role 
in porcine placental attachment (Bowen et al., 1996; Jaeger et al., 2001). All ITIH’s 
possess a von Willebrand type-A domain which functions as a target for adhesion 
molecules such as integrins, collagen, proteoglycans and heparin.  Previously, our lab 
demonstrated through western blot analysis of uterine flushings and endometrial cultures 
established that associations between the ITIH’s and bikunin (light chain) occur in the pig 
(Geisert et al., 2003).  Since the release of bikunin may be necessary for the association 
of hyaluronic acid with ITIH 1, 2, 3 (Jessen et al., 1994), and loss of bikunin gene 
expression causes infertility in mice through disruption of the cumulus oophorus (Zhuo et 
al., 2001), it is possible that disruption of  ITIH and/or bikunin might occur with estrogen 
treatment.  However, our results indicate that estrogen treatment on day 9 does not alter 
endometrial gene expression of bikunin or ITIH1, 3, and 4.  TSG-6, which is a secreted 
product, has been demonstrated to be involved with extracellular matrix formation 
through forming complexes with the ITIH’s (Carrette et al., 2001).  Our study 
demonstrated the presence of TSG-6 and that TSG-6 protein forms a complex with the 
ITIH’s as found in the uterine flushings of the pregnant gilt. Therefore, the all 
components for forming the apical glycocalyx in the pig LE is present.  However, this 
study determined estrogen treatment of gilts did not alter TSG-6 mRNA or protein 
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expression.  Nevertheless, the current study was the first to determine that TSG-6 does 
form a complex with ITIH 1 and 2 in the uterine flushings of the pregnant gilt.   
The current dissertation has supplied a wealth of information that could be used 
for the generation of a plethora of hypothesis’ to describe the specific functions of genes 
that regulate conceptus trophoblastic elongation, estrogen’s molecular role as the 
maternal recognition of pregnancy signal and chemokine activation and function as it 
relates to the obligatory chemotaxis during pregnancy establishment in the pig. 
Current technologies, such as RNA interference, regulatory RNAs, and use of 
asymmetrical models such as psuedopregnancy to answer critical biological c nditions 
observed during pregnancy, and disruption of pregnancy. Through miRNA arrays and 
independant studies, this may allows pecific targets through which modifications can be 
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TABLES CHARACTERIZING COMPLETE ENDOMETRIAL GENE 
EXPRESSION DATA FOR ALL COMPARISONS DURING ENDOCRINE 





Table A.1a.  Differentially expressed genes UP-REGULATED during endocrine disruption of 13PP compared to 13PPE 






Predicted Soluble carrier family 34 (Sodium phosphate) 
Transcript Variant 2 0.0009 3.18 CO942177 114593382 
Ssc.11858.1.S1_at FMOD: fibromodulin 0.0003 2.64 CN163410 397329 
Ssc.23305.1.S1_at Bovine Transmembrane Protein 144 0.0010 2.31 NM_001101989   
Ssc.14436.1.S1_at 
Macaca mulatta ubiquitin specific protease 14 (tRNA-
guanine Transglycosylase) 0.0006 1.98 XM_001090667   
Ssc.24625.1.A1_at 
MRNA, clone:AMP010061G05, expressed in alveolar 
macrophage 0.0008 1.9 CK461494   
Ssc.21253.1.S1_at 
strongly similar to NP_038919.1 SAM pointed domain 
containing ets transcription factor [Mus musculus] 0.0001 1.82 BX667251   
Ssc.7139.1.S1_at MRNA, clone:LVRM10061G07, expressed in liver 0.0004 1.79 BX925457   
Ssc.5282.1.S1_at 
moderately similar to NP_570968.1 cAMP responsive 
element binding protein 3-like 4 [Homo sapiens] 0.0001 1.77 BF077968   
Ssc.19509.1.A1_at 
MRNA, clone:AMP010057H06, expressed in alveolar 
macrophage 0.0008 1.64 CF362615   
Ssc.5041.1.A1_at 
Transcribed locus, moderately similar to 
NP_001028886.1 nucleolar protein 1, 120kDa [Homo 
sapiens] 0.0005 1.63 CN154405   
Ssc.9986.1.A1_at Transcribed locus 0.0008 1.45 CN157453   
Ssc.2542.1.S1_at MRNA, clone:TES010023G04, expressed in testis 0.0000 1.42 BQ603949   
Ssc.12977.1.A1_at MRNA, clone:OVRM10041E01, expressed in ovary 0.0001 1.33 BI404425   
Ssc.8630.1.A1_at Transcribed locus 0.0009 1.28 BF713211   
Ssc.23810.1.S1_at MRNA, clone:OVRM10040C07, expressed in ovary 0.0005 1.26 CK453668   
Ssc.9353.1.A1_at Transcribed locus 0.0007 1.25 BF710330   
Ssc.16669.1.S1_at 
MRNA, clone:AMP010044G02, expressed in alveolar 

















Change ACCESSION Human 
Ssc.13262.1.S1_at 
EIF4EBP1: eukaryotic translation initiation factor 4E 






Table A.1a.  Differentially expressed genes DOWN-REGULATED during endocrine disruption of 13PP compared to 15PP 
PROBESET GENE ACCESSION GENE ID P-Value 
Fold 
Change Human 







Table A.2b.  Differentially expressed genes DOWN-REGULATED during endocrine disruption of 13PP compared to 15PP 







Ssc.25116.1.A1_at Transcribed locus CK463855   0.0001 -1.37   
Ssc.6526.1.S1_a_at 
MRNA, clone:LVRM10138D07, expressed in 
liver BI359943   0.0009 -1.4   
Ssc.6526.3.A1_a_at 
similar to LPS-responsive vesicle  trafficking, 







Table A.3a  Differentially expressed UPREGULATED genes during endocrine disruption of 13PP compared to 15PP 
PROBESET GENE 
Fold 
Change P-Value ACCESSION 
Human 
GENEID 
Ssc.30027.1.A1_at CXCL-11 30.08 0.0004 NM_001128491 5689773 
Ssc.29054.1.A1_at guanylate binding protein 1, interferon-inducible, 6.41 0.0009 NM_001128473.1 166706902 
Ssc.26146.1.S1_at (C-X-C motif) ligand 9 5.35 0.0000 NM_001114289 4505186 
Ssc.17821.1.A1_at Pleckstrin 5.19 0.0007 NP_062422 11464971 
Ssc.204.1.S1_at CYP3A29: cytochrome P450 3A29 4.64 0.0004 NM_214423.1 403324 
Ssc.507.1.A1_at TYROBP: TYRO protein tyrosine kinase binding protein 4.51 0.0005 AF152021.1 38157998 
Ssc.12825.1.A1_at NKp80 NK receptor 4.05 0.0006 NM_001101276.1 13016700 
Ssc.3879.1.S1_at strongly similar to plexin C1 [Mus musculus] 3.82 0.0009 NP_061267.1 54712 
Ssc.9229.1.S1_at MRC1: mannose receptor, C type 1 3.7 0.0001 AY368183.1 38569736 
Ssc.548.1.S1_a_at MMP7: matrix metallopeptidase 7 (matrilysin, uterine) 3.38 0.0003 NM_214207.1 397411 
Ssc.15565.1.S1_at 
lymphocyte cytosolic protein 2 (SH2 domain containing 
leukocyte protein of 76kDa) 3.3 0.0002 NM_001076844.1 47078282 
Ssc.9778.1.S1_at proteoglycan 1 precursor-like, Transcript Variant 1 3.18 0.0002 XM_001928855.1 100049692 
Ssc.11073.1.S1_at LMP7: proteasome subunit LMP7 3.09 0.0009 NM_213935.1 396975 
Ssc.19943.2.S1_at Ssc.19943.2 2.88 0.0006 BX675463 
Ssc.15370.1.S1_at MRNA, clone:AMP010, expressed in alveolar macrophage 2.68 0.0005 BX666577 
Ssc.15419.1.S1_at Bruton agammaglobulinemia tyrosine kinase (BTK) 2.4 0.0002 NM_001034589.1 77736124 
Ssc.13777.1.S1_at SLA-DMA alpha 2 domain 2.35 0.0009 AB117618.1 36062 
Ssc.27863.1.S1_at TAP1: Transporter 1, ATP-binding cassette, sub-family B 2.33 0.0002 BI337485 3759115 
Ssc.14561.1.S1_at CD18: CD18 leukocyte adhesion molecule 2.2 0.0009 NM_213908.1 47522671 
Ssc.15296.1.S1_at Similar to CD53 (Bovine) 2.2 0.0007 NM_001034232 61553526 
Ssc.1177.1.S1_at C1S: complement component 1, s subcomponent 2.14 0.0006 NM_001005349.1 26 4688 
Ssc.15739.1.S1_at IL2R-G: interleukin 2 receptor, gamma 2.09 0.0010 EU026383.1 4557881 
Ssc.16012.1.S1_at Caspase-1 (ICE) 2 0.0006 NM_214162.1 47523411 
Ssc.19101.1.A1_at CD1 Cluster gene 1.93 0.0004 AB221038.1 118764585 




Ssc.16038.1.S1_at MHC class II antigen 1.79 0.0003 AB012858.1 194040228 
Ssc.19778.1.S1_at MRNA, clone:THY010107H05, expressed in thymus 1.65 0.0003 BX675283 
Ssc.11243.1.A1_at Transcribed locus 1.64 0.0006 BI181152 
Ssc.16008.1.S1_at FCNB: ficolin 1.64 0.0002 NM_214160.1 
Ssc.26300.2.S1_at 
Transcribed locus, moderately similar to XP_947303.1 
PREDICTED: similar to unc-93 homolog B1 isoform 1 
[Homo sapiens] 1.6 0.0007 BX918761 
Ssc.28997.1.S1_at Transcribed locus 1.6 0.0008 CA781087 
Ssc.19364.1.S1_at SBAB-707F1.3: complement component 2 1.58 0.0002 BI360075 
Ssc.5489.3.S1_at MRNA, clone:SPL010046C07, expressed in spleen 1.58 0.0004 BE663177 
Ssc.27070.1.A1_at Transcribed locus 1.57 0.0000 CN166386 
Ssc.6433.1.S1_at 
Transcribed locus, strongly similar to NP_066363.1 
hypothetical protein LOC57169 [Homo sapiens] 1.56 0.0003 BX672562 
Ssc.13354.1.A1_at Transcribed locus 1.49 0.0008 CN166737 
Ssc.1403.1.S1_at Clone rcad21b_e4.y1.abd, mRNA sequence 1.45 0.0007 CB478967 
Ssc.16529.2.S1_at 
MRNA, clone:AMP010064D06, expressed in alveolar 
macrophage 1.4 0.0002 CB288184 
Ssc.22354.1.A1_at 
Transcribed locus, strongly similar to NP_061134.1 Jun 
dimerization protein p21SNFT [Homo sapiens] 1.36 0.0002 CK461037 
Ssc.2064.1.A1_at 
Transcribed locus, moderately similar to XP_946275.1 
PREDICTED: similar to Transmembrane 7 superfamily 
member 1 [Homo sapiens] 1.32 0.0006 CK458372 
Ssc.18934.1.S1_a Transcribed locus, strongly similar to XP_991749.1] 1.32 0.0004 CN159172 
Ssc.3848.1.S1_at MRNA, clone:OVRM10058D03, expressed in ovary 1.32 0.0003 CN166777 
Ssc.14480.1.S1_at 
CAMK2D: calcium/calmodulin-dependent protein kinase 
(CaM kinase) II delta 1.3 0.0009 NM_214381.1 
Ssc.1853.1.S1_at MRNA, clone:LNG010060B03, expressed in lung 1.23 0.0010 CN157731 
Ssc.19154.1.S1_at 
Transcribed locus, strongly similar to NP_059089.1 
caseinolytic protease, ATP-dependent, proteolytic subunit 















Table A.3  Differentially expressed DOWN-REGULATED genes during endocrine disruption of 13PP compared to 15PP 
Ssc.19550.1.S1_at MRNA, clone:SPL010050C11, expressed in spleen 1.17 0.0004 CN162516   
Ssc.12303.1.S1_at 
Transcribed locus, moderately similar to XP_947327.1 
PREDICTED: similar to Tripartite motif protein 16 
(Estrogen-responsive B box protein) [Homo sapiens] -1.22 0.0005 BQ604664   
Ssc.6310.1.A1_at Antigen NY-BR-84-like protein mRNA, partial sequence -1.26 0.0007 CN154592   
Ssc.10843.1.A1_at 
EIF4A2: eukaryotic translation initiation factor 4A 
isoform 2 -1.27 0.0000 BM083158   
Ssc.6526.3.A1_a_a
t Similar to LPS Trafficiking Rheus macca -1.31 0.0009 CN160927   
Ssc.10991.2.S1_at 
strongly similar to NP_997696.1 HLA-B associated 
transcript 5 [Rattus norvegicus] -1.31 0.0007 AW312320   
Ssc.16363.1.S2_at TMOD3: tropomodulin 3 (ubiquitous) -1.32 0.0010 CN153516   
Ssc.7939.2.A1_at Transcribed locus -1.32 0.0003 BF710416   
Ssc.11803.1.A1_at 
Transcribed locus, strongly similar to NP_060531.1 
PRP38 pre-mRNA processing factor 38 (yeast) domain 
containing B [Homo sapiens] -1.34 0.0009 BI185841   
Ssc.21990.1.S1_at Transcribed locus -1.34 0.0008 BX666595   
Ssc.14107.1.S1_at Transcribed locus -1.35 0.0009 CK449583   
Ssc.27826.1.S1_at Transcribed locus -1.35 0.0004 BG834080   
Ssc.10991.1.A1_at 
Transcribed locus, strongly similar to NP_997696.1 
HLA-B associated transcript 5 [Rattus norvegicus] -1.43 0.0007 BI182984   
Ssc.5503.2.S1_at Transcribed locus -1.43 0.0005 BF193281   
Ssc.6526.1.S1_a_at MRNA, clone:LVRM10138D07, expressed in liver -1.5 0.0001 BI359943   
Ssc.29458.1.A1_at Transcribed locus -1.51 0.0009 CO956431   
Ssc.9822.1.A1_at Transcribed locus -1.51 0.0002 BI399019   
Ssc.8161.2.A1_at Transcribed locus -1.56 0.0009 BQ601084   
Ssc.18021.1.A1_at Transcribed locus -1.58 0.0006 CF180456   




Ssc.1377.3.S1_at MRNA, clone:LNG010080E11, expressed in lung -1.7 0.0008 BP157471   
Ssc.25082.1.S1_at Transcribed locus -1.76 0.0003 CN160088   
Ssc.7954.1.A1_at Transcribed locus -1.8 0.0008 BQ599859   
Ssc.24625.1.A1_at 
MRNA, clone:AMP010061G05, expressed in alveolar 
macrophage -1.81 0.0006 CK461494   
Ssc.9003.1.A1_at MRNA, clone:OVRM10211E06, expressed in ovary -1.87 0.0002 CO992161   
Ssc.9039.1.A1_at Transcribed locus -1.87 0.0009 CF366256   
Ssc.8331.1.S1_at Transcribed locus -1.9 0.0008 BF713029   
Ssc.14436.1.S1_at 
Macaca mulatta ubiquitin specific protease 14, Transcript 
Variant 1 -1.92 0.0004 XM_001090667   
Ssc.5082.1.A1_at Transcribed locus -1.96 0.0003 BI233968   
Ssc.11801.3.A1_at asparagine-linked glycosylation 9 homolog -1.99 0.0004 NM_001077691 118026936 
Ssc.7451.1.S1_at Bos taurus ras homolog gene family, member U -2.14 0.0001 NM_001098147 45827773 
Ssc.9039.2.S1_at protein tyrosine phosphatase, receptor -2.16 0.0002 
XM_001174413.
1 5788 
Ssc.5372.1.S1_at Similar to KIAA0644 Gene product -2.53 0.0005 NM_014817.3 9865 
Ssc.23305.1.S1_at Similar to Transmembrane protein 144 -2.65 0.0009 NM_001101989 156120626 
Ssc.30424.1.A1_at solute carrier family 38, member 1 [Homo sapiens] -2.75 0.0006 NM_001077484 117168276 
Ssc.18135.1.S1_at proline/arginine-rich end leucine-rich repeat protein -3.04 0.0006 NM_054077 41349453 
Ssc.22988.1.S1_at phosphatidylcholine transfer protein -3.12 0.0007 NM_174835 156151416 










































1. Uterine tissue should be excised and immediately processed.  In general, a s ction 
of the uterine horn (not greater than 1.0 cm) is placed in 40 ml of freshly 4% 
paraformaldehyde (w/v) in phosphate buffered saline (PBS).  It is important to 
keep a very high fixative volume to tissue ratio. 
 
2. The section of uterine horn in a fixative should be gently agitated on a rocker or 
orbital shaker for 24h @ RT. 
 
3. After 24 h, the fixative shall be drained out, and replaced with 40 ml of 70%    
EtOH (v/v in H20) and gently agitated overnight at RT. 
 
4. After 24 h, the 70% EtOH should be replaced with fresh 70% EtOH, and tissue 
permanently stored at RT. 
 
  Solution preparations 
 
  4% Paraformaldehyde 
 
1. Heat 2/3 final volume to 60 C in fume hood with stir bar. 
2. Add granulated paraformaldhyde slowly, add 1 to 2 drops of 1N 
NaOH (this will help clear solution ) 
3. When solution is clear, remove from heat 
4. Add 1X PBS to make final desired volume 
5. After solution is cool, adjust pH to 7.2  
 
10X PBS (1 Liter) 
  80g NaCl 
  2g KCl 
  14.4g  Na2HPO4 or (11.5g Na2HPO4
 . 7 H20) 
  2.4g KH2PO4 
 
















1. Trim blocks so that they are about 1cm square on the block surface.  This is easier 
to handle in long strips (Ribbons) 
a. Face Blocks to get tissue (Cut at 20 µM) embedded in paraplast 
b. After facing blocks turn the block face down on ice (freeze H20 in a flat 
dish).  Place 5-6 blocks on the ice at a time. 
c. Use 37oC water (with small amount of gelatin dissolved) to expand 
sections in the ribbons.  
d. Use positively charged slides to hold sections to slide. 
 
Linearization of Plasmids for in vitro Transcription (IVT)  
1. Digest 20 µg of DNA with appropriate restriction enzyme for >2h at appropriate 
temperature. 
   DNA  20 µg 
   10X REB 20 µl 
   Enzyme 10 µl 
   Water  to 200 µl 
 
2. Extract once with an equal volume of PCI (Phenol:Chloroform:Isoamly alcohol) 
and once again with chloroform 
3. Precipitate DNA with 3 vol 100% EtOH, 1/10 vol 3M NaOAc and 5 λ of 
Dextrane T500 (10mg/ml) 
4. Place at -80 C for 15 min, then spin down for 10 min at MAX speed @ RT 
5. Remove EtOH, and wash pellet with 150 µl of 70% EtOH 
6. Remove all 70% EtOH and resuspend pellet  in 40 λ of Rnase-free water.  The 
DNA is at approximately 0.5 µg/µl 
 
 



















Preparation of Probe 
 
1. Set up probe synthesis reaction (enough for about 10 slides) in a 1.5 mL tube.  Use 
RNAse free tubes and pipet tips. 
  
Order Solution   10 Slides 20 Slides 40 Slides 
1 Water (Ambion DEPC) 4.0 µL  8.0  16.00 
2 5X Transfer Buffer (Vortex) 2.5 µL  5.0  10.0 
3 100 mM DTT    1.25  2.50  5.0 
4 2.5 mM rACG   1.25  2.50  5.0 
5 DNA (10mg/ml)  1.0 µγ  2.00  4.0 
6 Rnasin (Keep Cold)  0.5 µL  1.00  2.0 
7 UTP (35S)-40 mCi/mL 1.25  2.50  5.0 
8 Either T7, SP6 or T3 Poly 0.75  1.50  3.0 
Remember you need to know directions of the insert from the plasmid (T7 or 
SP6) to get antisense or sense gene (Sense is Control!). 
 
2. Vortex tube, Quick spin and then incubate for 2 h at 37 C in heat block 
 
3. Prepare CENTRI-SEP column (Princeton Separations, Inc-CAT# CS-90) 
-Need two columns for 4X reaction.  The column can only handle 100 uL of fluid.  
Need to rehydrate the column at least 1 h before the probe reaction is added to the 
column. 
a) Add 80 uL Ambion water to the column 
b) Invert and gently vortex 
c) Sit upright for at least 30 min –leave bottom cap on (don’t start flow yet). 
 
4. After 2 h incubation add 3uL RQ1-DNAse I (Promega) and 0.5 uL RNasin to tubes.  
If 4X reaction (40 slides) double the volume-6uL RQ-1-DNase, 1.0 uL RNasin.  
Vortex, centrifuge briefly and incubate for 15 min at 37oC. 
 
5. After incubation add 20 mL yeast tRNA (10mg/ml) and 40 uL (1-2 X reaction) 
-Phenol:Chlorofrom:Isoamyl alcohol (Ratio 25:24:1; light sensitive, store at –4oC). 
 -For 3-4X Rxn 40 mL yeast tRNA and 80 uL PCI.  Vortex well.  When pipetting 
from PCI, make sure to get lower layer where phenol is bottom layer, and water is on 
top. 
 **Water Saturated Phenol is for RNA, Tris buffered phenol is for DNA** 
   
  a) Centrifuge at full speed on a microcentrifuge (27,000 x g) for 5 min 
 b) Remove top layer with a pipet (filtered) and place in a new bullet tube (Don’t 
get bottom layer) 
 






a.  Vortex and spin at full speed for 5 min 
-Complete SEP column preparation:  Take top and bottom cap off.  Place 
in tube and use finger to push (top pressure) a drop from the bottom to 
start flow.  After spinning tubes with probe, SEP columns in centrifuged 
and position the column so the notch on the rim faces out (top of rotor).  
Centrifuge at 750 x g for 2 min.  Use column immediately- do not let it 
dry out. 
b. Add PCI:CI purified probe to Centrisep column (place in middle of matrix and 
don’t touch matrix with pipet tip). 
c. Centrifuge column for at 750 x g for 2 min. then discard the column.  Purified 
probe is the flow through remaining in the tube. 
 
7.  Precipitate with 60 uL 3M NaOAc (pH 5), 1 uL yeast tRNA, 5uL Dextran T500 
(10mg/ml) and 300uL EtOH for 1-2X reactions.  Double for 3-4X reactions. 
 
8. Spin bullet tubes at maximum speed for 10 min Pour off liquid in radioactive waste. 
 
9. Wash pellets with 70% EtOH 
 
10. Wash pellets in 50 uL (1X-2X) or 100 uL (3X-4X) of 100 mM DTT. Can use pipet to 
break-up pellet. 
 
11. Count in β-counter (1-2 uL). 
 
Calculation for probe Hybridization  
Antisense -20 slides: 5 X 106 cpm/slide 
20 slides X 70 uL hybridization soln/slide=1400 uL (may add for 1-2 more slides) + 
Volume of probe (Need 5 million cpm/slide) 
 
Final solution should be 10% DTT (100 mM DTT) so, divide the amount of hybridization 
solution + amount of probe and divide the sum by 9 to determine amount of 1M DTT to 
add. 
 
Need only 1-2 slides for sense Probe. 
Vortex, quick spin and incubate at 70 C for 10 min to denature probe. 
 
Summary 
cRNA probes (5 X 106 cpm/slide) with hybridization Solution containing 100 mM DTT 










Preparation of Slides 
1. Xylene (CitrSolve CAT# 22-143975)  CitriSolve will have a layer on the bottom, 
so be careful not to pour in the tanks.  Make sure tank solvent is clean between 
runs.  Treat for 5 min and agitate every 1-2 min “Critical” repeat 2X.  Check to 
make sure the paraplast is cleared from slides. 
2. 100%EtOH fro 1 min -2X (agitate slides through procedure) 
3. 95% EtOH 1 min-2X 
4. 70% EtOH 3 min- 1X 
5. PBS for 5 min-2X 
6.   Fresh 4% paraformaldhyde (PAF) 20 min-1X  
  - Dissolve 4g PAF/100ml of PBS-Need 400-500mL 
To Make:  Fill beaker with ddH20 to about 60%  of final volume (Do Not 
Heat Water).  Add PAF (20g/500mL) and about 1.25g NaOH 
pellets/500 mL.  Stir on stir plate in hood until it goes into 
solution~10 min, then add enough 10X PBS to make final 
concentration 1X.  pH to 7.2 with 12N NaOH “slowly” and bring 
to volume with ddH20 
7. PBS for 5 min-2X 
8. Proteinase K for 7.5 min-1X 
     For 500mL: 
     25 mL 1M Tris (pH 8.0) 
     5 mL 0.5 M EDTA 
     1 mL Proteinase K (10mg/mL) stock kept in freezer 
     Q.S. with ddH2O 
 
9.   4% PAF for 15 min 1X(Can reuse the PAF from first wash in step 6)-Dispose 
PAF in waste bottle 
10.   ddH2O for 1 min-1X 
11.   PBS for 5 min-2X 
12.   70% EtOH for 3 min-1X 
13.   95% EtOH for 1 min-2X 
14.  100% EtOH for 1 min-2X 
15.  Air dry slides at RT (10 min) on paper towels in tray.  While drying slides start 




1. Following the denaturation of the probe (70 C), add the Hyb soln to the middle of 
the slide.  Set pipetman at 75 µL, but when adding don’t blowout last fluid to 
avoid air bubbles. 
2. Put on coverslip 
a. Touch middle soln with coverslip and drawback to edge.  Slowly drop 
cover slip on slide!   
3. Place a layer of 3MM paper in a pyrex baking dish that has been wetted with 250 
mL of 50% Formamide / 5X SSC 
 
 286
a. Formamide is stored in freezer as stock! Must thaw out before use.  Once 
thawed keep in the cooler. 
4. Cover pyrex dish with plastic wrap and seal.  Place in an incubator at 55 C for at 
least 16 h  
5. Make 50% formaldehyde /2X SSC/50 mM BME-*Leave BME out until just 
before use the next day [make sure BME is not old] 
a. Make 1 liter =500 mL formaldehyde /100 mL 20X SSC=h20 to 1000mL 
(add 3.5 mL BME next day) 
b. Make 5X SSC/10 mM BME-*Leave BME out until just before use next 
day.  500 mL=125 mL 20X SSC+H20 to 500 mL (add 350 uL BME Next 
Day) 
c. Place soln in incubator at 55 C for next day use!!! 
6. Add BME to solutions the next day 
a. 50% Formaldhyde/2X SSC/50 mM BME (3.56 mL/liter) 
b. 5X SSC/10 mM BME (350 uL/500 mL) keep in incubator at 55 C 
c. Place the 50% formaldehyde /2X SSC/50 mM BME in 65 C water bath or 
incubator.  Use glass slide holders. 
7. Gently remove coverslips by sliding down into radioactive waste container (use 
empty NaCl container).  If coverslip sticks to slide, dip in buffer and slide off.  
Place slides in rack with 55 C 5X SSC/10 mM BME. 
a. Place in 55 C incubator for 30 min-agitate every 10 min 
8. Dump out baking dish (In isotope sink).  Wash with 10% Count-off (rinse bottle) 
then rinse with DDH20.  Dry table and rinse large double taped pipets 
9. Dump first hybridization wash into radioactive liquid waste [35S].  Add 50% 
Formaldhyde/2X SSC/50 mM BME and place in 65 C incubator or water bath for 
20 min 
10. Dump second wash of hybridization in radioactive liquid waste.  Add TEN (0.5M 
NaCl/10mM Tris(pH 8)/5mM EDTA) for 10 min at RT 
a. 10X TEN (1 Liter) 
b. 292.2g NaCL 
c. 10 mL 1M TrisCL (pH 8) 
d. 10 mL 0.5 M EDTA 
11. 1X TEN 10 min 37 C.  Repeat twice. 
12. 1X TEN with RNase A (10ug/mL) -500 mL (0.5 mL Rnase stock 10mg/ml) in the 
freezer).  Incubate 37 C for 30 min. 
13. 1X TEN 15 Min at 37 C 
14. 50 % Formamide/2X SSC/50 mM BME at 65oC for 20 min. 
15. 2X SSC at RT for 15 min 
16. 0.1X SSC RT for 12 min 
17. 70% EtOH/0.3 M Ammonium Actetate at RT for 5 min.  Repeat once. 
18. 95% EtOH/0.3 M Ammonium Acetate for RT for 1min. 
19. 100% EtOH at RT for 1 min.  Repeat once. 
20. Air dry and expose to Kodak Biomax Film overnight.  Develop next day to 
estimate length needed to develop slides. 
a. Place slides in order in film case-tape down corners to keep from moving 
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b. Use Kodak BioMax MR film-packaged in single sheets.  Make sure 
emulsion side down (Non-shiny side)-notched should be in upper left 






1. Thaw Kodak NTB2 emulsion vials at 42 C in a light tight container (wrapped in 
foil). 
 
  -Emulsion is aliquoted in vials (5mL) stored in a box covered in a foil  
  pack in a black plastic bag in the refrigerator.  MUST BE LIGHT   
  TIGHT!!! 
 
  -Take strips of foil to wrap two vials in dark room.  Don’t use safe light,  
  just wrap in total darkness.  As an alternative, use orange safe light.   
  Make sure the vials are completely wrapped in foil and the lids are on  
  tight. 
 
  -The slide dipper takes two vials to fill it.  This is enough to cover 50-60  
  slides 
 
-Make up the slide boxes to holes slides following covering with 
emulsion. Place a slide about 3-4 notches from the top of the box.  Take 
two kimwipes and cross them.  Place some dridrite in the middle and roll 
up to place above the slide box.  Put paper towel cut to the bottom of the 
box.  Wrap up dridrite in paper towels to place in the bread box when 
slides have been dipped. 
 
2. Need to bring 50 ml conical tube with 10 mL ddH20 placed in 42 C water bath 
with vials (Make sure light is on).  Can get by with as soon as it reaches 
TEMP./FOR 20 SLIDES.  In the dark room with the orange filter, gently mix the 
emulsion with ddh20 in the conical tube.  No air bubbles (rotate tube side to side).  
Emulsion is 1:1 with water. 
3. Fill slide dipper that has been placed in the 42 C H2O bath. 
4. Dip each slide to the bottom of the slide dipper.  Wipe off excess, polish back to 
remove film from edge. 
5. After dipping , place towels in light tight box.  Leave lids off during this time.  
Allow to dry for 6 to 8 hours.  Rotate slides 3-6 hours. 
6. After 3-6 hours drying go to dark room and place lids on slide boxes.  Wrap in 
foil, store at 4C for number of days or weeks based on exposure to X-ray film. 
7. To develop allow slides to reach RT 
8. Kodak D-19 developer (78.3g / 500 mL) for 4 min-1x 
9. ddH2O- 0.5 min-1X 




Fixer (Kodak Rapid Fixer with Hardener): 
 
171 mL water 
59.5 mL Solution A (Fixer) 
6.5 mL Solution B (Hardener) 
 
11. Water for 5 min 
12. Hematoxylin (diluted with ddH2O 1:3) for 30 seconds 
13. Water for 30 sec 
14. Water for 5 min.  Repeat until hematoxylin quits leaching into water. 
15. 70 EtOH-3 min  
16. 95 EtOH-1 min 2X 
17. 100 EtOH-1 min 2X 
18. Xylene for 3 min 3X 
19. Permount and coverslip 
 
 
Other In Situ Hybridization Solutions: 
 
5X SSC/10 mM BME (500mL) 
125 mL 20X SSC 
350 µl BME 
q.s. ddH2O 
 
50% Formamide/2X SSC/50 mM BME (800 mL) 
400 mL Formamide 
80 mL 20X SSC 
2.72 mL BME 
q.s. ddH2O 
 
20X SSC (1 liter) 
175.4 g NaCl 
88.2 g Sodium citrate 
Dissolve in 800 mL ddH2O, adjust pH to 7.0 with a few drops of 10N NaOH.  Bring to    volume 
with ddH2O and filter sterilize.  DEPC treat and autoclave. 
 
10X TEN (1 Liter)     
292.2g NaCL (5M)      
10 mL 1M TrisCL (pH 8) – (100 mM)    
10 mL 0.5 M EDTA – (50 mM)     
 
50X Denhardt’s (500 mL) 
5 g Ficoll 400 
5 g Polyvinylpyrrolidone 
5 g BSA (Pentax Fraction V) 




Hybridization Solution (100 mL)    
50 mL Formamide – (50%)     
6 mL 5M NaCL – (0.3 M)     
2 mL 1M Tris-HCl pH 8.0  - (20mM)    
1 mL 0.5 M EDTA pH 8.0 – (5mM)    
1 mL 1M Sodium Phosphate pH 8.0 – (10 mM) 
2 mL 50X Denhardt’s (1X) 
10 g Dextran Sulfate (10%) 
5 mL of 10 mg/mL Stock Yeast tRNA (0.5 mg/mL) 
q.s. H2O to 20 mL 
Store Frozen in -20C  
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